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Abstract
Rab GTPases are known to define the vesicle trafficking pathways that underpin cell
polarisation and migration. In this study it was demonstrated that Rab4, Rab11, Rab14
and the candidate Rab GDP-GTP exchange factor (GEF) FAM116A are all required for
cell migration. This work also demonstrates that Rab14 and its GEF FAM116A localise
to and act on an intermediate compartment within the transferrin recycling pathway
acting upstream of Rab11 and downstream of Rab5.
Further analysis revealed that a Rab14-dependent intermediate recycling compart-
ment that is discrete from early and recycling endosomes, has an important function
for cargo sorting in migrating cells. Cells depleted of Rab14 show increased levels
of N-cadherin at junctional complexes and these cell-cell adhesions are unable to
be resolved preventing cell migration. This results from decreased shedding of N-
cadherin at the cell surface that is usually cleaved by A Disintegrin and Metalloprotease
(ADAM) family protease ADAM10. In FAM116A- and Rab14-depleted cells, ADAM10
is trapped and therefore accumulates in a transferrin-positive endocytic compartment,
and the cell-surface level of ADAM10 is correspondingly reduced. Rab14 and its GEF
FAM116A define an endocytic-recycling pathway that is essential for the trafficking of
ADAM10 and therefore in turn regulate cell-cell junctions and cell migration.
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1 INTRODUCTION
1 Introduction
The origin of the eukaryotic cell is considered a milestone in the evolution of life, as
it defines all complex cells and is the fundamental basis of almost all multicellular or-
ganisms. For multicellular organisms to function, there must be precise co-ordinated
control of the individual cells that it comprises. Cells must be able to communicate and
respond to both each other and their surroundings such that they can form complex
tissue structures. Furthermore, they must be able to respond to changes in their en-
vironment. For example, during wound healing there must be specific modulation of
cell-cell contacts, so that cells can migrate into the wound and begin to close it whilst
other cells proliferate or even lay down new extracellular matrix. Unless there is pre-
cise co-ordination and extracellular organisation such essential processes could not
take place.
However, successful extracellular co-ordination depends entirely on successful in-
tracellular organisation of the many complex cell types that constitute this tissue. In
order to achieve this intracellular regulation, eukaryotic cells have a highly organised
and complex structure. Eukaryotic cells are divided into a number of different compart-
ments within the cell; these compartments are called organelles.
1.1 Membrane Trafficking Pathways
Organelles provide unique chemical environments within eukaryotic cells, which can
be used to carry out specific and often opposing functions, such as protein synthesis
and degradation within the same cell. To provide the organelle specificity a unique
composition of protein and lipids are required and various components need to be ex-
changed between one organelle and the other; for this process membrane trafficking
15
1 INTRODUCTION
is required (Jahn and Scheller, 2006; Mizuno-Yamasaki et al., 2012).
Membrane trafficking defines a number of steps by which proteins and lipids are
moved between compartments in small carrier membranes known as vesicles. This
trafficking is a tightly regulated and organised process that generates and maintains the
different properties for each individual organelle. Regulatory and accessory proteins
are required to organise the numerous steps involved in trafficking the vesicle from
one compartment to the other (Jahn and Scheller, 2006; Bonifacino and Lippincott-
Schwartz, 2003; Bonifacino and Glick, 2004).
1.1.1 Defined stages of vesicle trafficking
Donor compartments at specific vesicle sites initiate the beginning of vesicle traffick-
ing. Cytosolic coat proteins being recruited to the specific site promote the forma-
tion of the vesicle. The coat proteins that cover the vesicle in mammalian cells are
placed in three categories: the clathrin coats which are involved in trafficking between
the plasma membrane (PM), the trans Golgi network (TGN) and endosomal compart-
ments. The coat associated protein complex I (COPI) coat which is involved in the
Golgi to Endoplasmic Reticulum (ER) trafficking and the coat associated protein com-
plex II (COPII) coat which is involved in the anterograde trafficking from the ER to
the Golgi (Bonifacino and Lippincott-Schwartz, 2003). The Golgi is divided into sub-
compartments termed cis-Golgi, trans-Golgi and medial-Golgi the final compartment
being the trans-Golgi network (TGN) (Griffiths and Simons, 1986). It is in the TGN that
the cargo is sorted into clathrin-coated vesicles (McNiven and Thompson, 2006) and
trafficked to the PM or other compartments (Gu et al., 2001).
As the coat or coat associated proteins recognise sorting signals, their association
16
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leads to concentration of cargo at the site of the vesicle formation. Further coat com-
ponents are then added causing polymerisation of the coat into a regulatory lattice
(Figure 1.1, page 18). The polymerisation forces the flat membrane patches to form
vesicles (Bonifacino and Lippincott-Schwartz, 2003). The neck of the vesicle is then
the only thing connecting the vesicle to the donor membrane and is finally detached by
directly being severed either by the coat proteins or accessory proteins like dynamin;
this process is known as abscission (McNiven and Thompson, 2006). After abscission
has taken place the vesicle is detached from the donor membrane, the newly formed
vesicle is uncoated. Accessory proteins that trigger the uncoating cause the loss of the
coat from the vesicle (Bi et al., 2002; Lafer, 2002). The coat proteins are then recycled
to the site at which the vesicle was formed and they are then involved in further for-
mation of more vesicles. Vesicles then move along the cytoskeletal structures towards
their target membrane where tethering proteins are required for target recognition of
the vesicle site (Sztul and Lupashin, 2006). Tethers are proteins that form structures
that bind to proteins on the vesicle and the target (Pfeffer, 1999).
The docking of the vesicle to the acceptor membrane requires specific attachment
from soluble NSF attachment protein receptors (SNARES) (Weber et al., 1998; Jahn
and Scheller, 2006). SNAREs are found on both the donor membrane and the vesicle.
All SNAREs have a so called SNARE motif. Four SNARE motifs form a complex of
parallel α- helices, where each α-helix is provided from a different SNARE motif (We-
ber et al., 1998). This complex forms essential stability and is called the SNAREpin,
and it is the SNAREpin that allows fusion of the vesicle (Weber et al., 1998; Bell et al.,
2001).
Fusion of the vesicle allows the cargo to be released into the acceptor compartment.
The SNAREpin is then unwound by the combination of NEM-sensitive factor (NSF)
17
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and the soluble NSF attachment protein (SNAP). The SNAREs and cargo receptor
molecules are then recycled back to the donor membrane (Clary et al., 1990) (Figure
1.1, page 18).
Figure 1.1: Overview of vesicle transport. The coat is assembled at the donor membrane
before the budding of the vesicle occurs followed by abscission of the new vesi-
cle. Recycling of the coat proteins and uncoating of the vesicle then occurs before
the vesicle moves along the cytoskeletal structures and tethers to the target mem-
brane. The docking of the vesicle forms trans-SNARE complexes and the SNARE-
pin forms allowing fusion. After the release of the cargo, the SNAREs and cargo
receptor are recycled back to the donor compartment (modified from Bonifacino
and Glick, 2004).
There are two pathways within the cell that follow the mechanism described above:
the exocytic pathway (ER > Golgi > PM) and the endocytic pathway (PM > Endosomes
> Lysosomes) (Mizuno-Yamasaki et al., 2012). Cargo taken up from the plasma mem-
brane and transported inside the cell follows the endocytic pathway, and cargo that is
produced by the cell and transported to various endpoints within the cell or is secreted,
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follows the exocytic pathway.
In clathrin dependent endocytosis, activated receptors accumulate in the clathrin
coated pit (CCP). These CCPs are then pinched off to form clathrin coated vesi-
cles (CCV). The vesicle is coated with clathrin and adaptor proteins called Adaptor
Protein (AP)-2, which drives vesicle trafficking at the plasma membrane, and AP-1,
which drives trafficking at the TGN (McNiven and Thompson, 2006). Cargo trafficked
through the endocytic pathway, are taken up from the PM, fuse with early endosomes
(EEs), and the cargo that needs to be recycled is trafficked through the recycling en-
dosomes (RE) and back to the PM (Maxfield and McGraw, 2004). Any cargo that is
destined for degradation remains in the EEs, which then mature into late endosomes
(LEs) or the multivesicular body (MVB). The MVB then generates vesicles that remove
the active receptors from the cytoplasm and therefore stops all signalling events (Katz-
mann et al., 2002). The MVB finally fuses with the lysosomes and the content is then
degraded (Futter et al., 1996).
Proteins that are trafficked through the exocytic pathway are synthesised at the ER
in a process carried out by ribosomes that are attached to the ER. These proteins
then leave the ER in vesicles coated with COPII where they fuse with each other and
form the ER-Golgi intermediate compartment (ERGIC) (Appenzeller-Herzog and Hauri,
2006). The proteins are then sorted and modified accordingly in the Golgi apparatus.
The ER proteins then recycle back from the Golgi to the ER in vesicles coated with
COPI.
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1.2 Small GTPases control membrane trafficking
The Ras superfamily of proteins, one of the largest families in the human genome,
consists of over 200 proteins each approximately 25 kilo Dalton (kDa) in size. These
are divided into five main groups including the Ras, Rab, Rho, Ran and Arf subfamilies
(Wennerberg et al., 2005). Two of these subfamilies, the Rab and Arf/Arls play crucial
roles in membrane trafficking (Figure 1.1, page 18) (Novick and Zerial, 1997; Mizuno-
Yamasaki et al., 2012).
1.2.1 GTPases act as molecular switches
GTPases function as molecular switches that alternate between two conformational
states: an active form where the GTPase is Guanosine 5’ Triphosphate (GTP) bound
and an inactive form where the GTPase is Guanosine 5’ Diphosphate (GDP) bound
(Stenmark, 2009). This changing conformational state is vital to the proteins ability to
bind to its specific effector proteins, and thus control trafficking. The GTPase is acti-
vated by exchange of GDP for GTP, this is regulated by guanine nucleotide exchange
factors (GEFs). GEFs function by destabilising and opening the nucleotide-binding cleft
leading to the dissociation of GDP from the GTPase (Vetter and Wittinghofer, 2001).
GTP is then able to associate with the empty binding site. GTPase activating proteins
(GAPs) enhance the weak basal GTP hydrolysis activity of the GTPase and therefore
promote inactivation by hydrolysing the bound GTP to GDP and an inorganic phos-
phate (Cherfils and Chardin, 1999).
1.2.2 The structure of small GTPase proteins
All members of the Ras superfamily are characterised by a G domain responsible for
binding guanine nucleotides (Bourne et al., 1991). Structurally the G domain is made
up of six β-strands, enclosed by five α-helices (Vetter and Wittinghofer, 2001). Within
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the G domain, the G-box consisting of five conserved sequence motifs (G1-G5) co-
ordinates nucleotide binding (Bourne et al., 1991). G1 and G4 interact directly with
the nucleotide with interaction contributions from the G1 phosphate-binding loop motif
(P-loop) and the G4 nucleotide base (Vetter and Wittinghofer, 2001). Guanine binding
specificity results from a hydrogen bond which forms between an aspartate side chain
and the base of the guanine ring. This bond does not form when the guanine is sub-
stituted for adenine preventing ATP binding to the GTPase. Following binding the G3
motif promotes GTP hydrolysis.
Specific effector proteins, whose activities are relegated by GTPases have a much
higher affinity for the active GTP bound state. The specificity of the interaction between
GTPases and effector proteins cannot be solely mediated through the switch regions;
instead effector proteins bind to the switch regions to differentiate between the GTP and
GDP state. Other regions within the GTPase provide specificity towards their effectors,
these regions are possibly the GTPase subfamily specific regions (Pereira-Leal and
Seabra, 2000). When the GTPase changes its conformational state upon the hydrolysis
of GTP to GDP, the interaction between the GTPase and the effector protein is lost
(Pereira-Leal and Seabra, 2000).
1.3 Rab GTPases and membrane trafficking
Rab proteins were identified in 1983 as Ras-like proteins Associated to the Brain (Rab)
(Gallwitz et al., 1983). However soon after their identification, it became clear that these
proteins were involved generically in membrane trafficking. Rab proteins constitute the
largest known subfamily within the Ras superfamily of small GTP-binding proteins, and
these proteins are integral to the regulation of intracellular trafficking pathways (Novick
and Zerial, 1997). As many as 67 mammalian Rab proteins have been identified (Rojas
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et al., 2012), each with specific intracellular localisations, as well as specific patterns
of tissue distribution (Figure 1.2, page 22, see also Appendix section 5.1) (Pereira-
Leal and Seabra, 2000; Zerial and McBride, 2001). Due to the intricacy of evolution
producing increasing cellular complexity there is great need for compartmentalisation
within the cell and intracellular transport fills this role in all cell types in multicellular
organisms. Rab proteins are therefore an essential part of multicellular life (Zerial and
McBride, 2001).
Figure 1.2: Intracellular Localisation of Mammalian Rab Proteins. A summary of the in-
tracellular localisation of Rab proteins in both endocytic and exocytic pathways
in mammalian cells. Rab GTPases involved in the endocytic pathway are Rab5,
Rab4, Rab14, Rab11, Rab7, Rab9 and Rab35. RabGTPases involved in the exo-
cytic pathway are Rab1, Rab2, Rab6, Rab8, Rab10, Rab19, Rab30, Rab33b and
Rab43. However, some Rabs, facilitate cross-talk between both pathways.
There is strong evidence from numerous studies confirming that Rab proteins are
distributed to specific intracellular compartments and regulate transport between or-
ganelles (Figure 1.2, page 22) (Novick and Zerial, 1997; Zerial and McBride, 2001).
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Rab proteins reversibly associate with the membranes of these differing organelles by
hydrophobic geranylgeranyl groups that are attached to one or two carboxy-terminal
cysteine residues, and this association allows them to transport signals throughout the
cell and thus is an intrinsic part of their role in regulating membrane traffic (Stenmark,
2009). Furthermore, through their indirect interactions with motors, SNARES and coat
components, Rab GTPases act as vital organisers in almost all membrane trafficking
processes that occur in eukaryotic cells (Stenmark, 2009).
1.4 Rabs regulate multiple steps of vesicle trafficking
A total of five different levels of trafficking have been identified (Figure 1.1, page 18),
and there is evidence supporting a role for Rabs in each of these steps (Segev, 2001).
Rabs are firstly involved vesicle formation and cargo recruitment (McLauchlan et al.,
1998), followed by movement of the vesicle and remodelling of the target membrane
(Hammer and Wu, 2002; Christoforidis et al., 1999). Next, Rabs control tethering,
which docks the active vesicle to its target membrane (Nielsen et al., 2000). Finally
there is recent evidence suggesting that Rabs are able to regulate the SNAREpin for-
mation and therefore have a role in membrane fusion (Stenmark, 2009). Although the
Rab itself does not seem to be directly involved in the regulation of SNARE function,
it has been suggested that the Rab27a effector protein Synaptotagmin-like protein 4
(SLP4) binds to Syntaxin and promotes docking to the PM (McBride et al., 1999; Si-
monsen et al., 1999).
1.5 Rab GTPases act as molecular switches
Rab GTPases like all members of the Ras superfamily function as molecular switches
that alternate between an active and an inactive form. According to the prevailing
model, GTPases are GDP-bound in the cytosol and for Rab GTPases a GDP- Disso-
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ciation Inhibitor (GDI) can maintain this inactive state. GDI can remove the inactive
proteins from the membrane (Novick and Zerial, 1997; Zerial and McBride, 2001), af-
ter which there are one or more factors that recognise this GTPase-GDI complex and
disrupt it causing the GTPase-GDI to be released into the cytosol allowing it to then
bind to a new membrane (Soldati et al., 1994; Ullrich et al., 1994). Once the protein
binds to the membrane, GDP is exchanged to GTP following a small delay. Nucleotide
exchange is not a requirement but by activating the protein it becomes resistant to
removal by the GDI (Ullrich et al., 1994). GDI prevents the protein from binding to ran-
dom membranes and has a role in the selective recruitment to the target membrane
(Horiuchi et al., 1995). The GTPase-GDI complex and the release of GDI are essential
in the transport machinery due to the specificity that determines where the protein is
recruited on the membrane and exerts its activity (Figure 1.3, page 25) (Novick and
Zerial, 1997; Zerial and McBride, 2001).
The exchange of GDP to GTP is catalysed by guanine nucleotide exchange factors.
These GEFs recognise specific residues in the switch regions and promote GDP re-
lease (Delprato et al., 2004). Due to the high concentration of GTP in the cytosol GTP
binding occurs as soon as the GDP is released (Stenmark, 2009). Specific effector
molecules such as sorting adaptors, tethering factors, phosphatases, motors and ki-
nases, can be recruited or activated by the GTP-bound Rab through the interactions
with both switch and interswitch regions (Delprato et al., 2004). The GTP to GDP con-
version occurs through GTP hydrolysis, which is determined by intrinsic GTP activity
but is also catalysed by GTPase Activating Proteins (GAPs) (Stenmark, 2009). GEFs,
effector molecules and GAPs determine which nucleotide is bound to the Rab protein
on the membrane, hence regulating the conversion of an active Rab protein to Rab-
GDI. These factors regulate the activity and equilibrium of Rab proteins between the
cytosol and the membrane (Figure 1.3, page 25) (Novick and Zerial, 1997).
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Figure 1.3: A Functional Cycle of GTPase Proteins. Conversion of the GDP-bound protein
into the GTP-bound protein happens through the exchange of the GDP to GTP.
This conversion relies on the GEF catalysing the GDP and causing a conforma-
tional change. The active protein (GTP bound) is then recognised by many effector
proteins and is hydrolysed by the GAP back into the inactive form (GDP bound)
with the release of an inorganic phosphate.
1.6 Rab GEFs
A crucial component of the function of Rab GTPases is the requirement for activation at
a specific membrane surface (Pfeffer and Aivazian, 2004). This is achieved by specific
GEFs that promote the release of GDP and binding of GTP (Barr and Lambright, 2010).
The known GEFs typically fall into discrete families defined by a number of con-
served, but structurally unrelated protein domains and protein complexes (Barr and
Lambright, 2010). These are known as the TRAPP-1 complex that activates Ypt1/Rab1
(Wang et al., 2000; Cai et al., 2007), Vps9 domains that activate Ypt51p/Rab5 subfam-
ily GTPases (Delprato et al., 2004; Delprato and Lambright, 2007), Sec2p/Rabin pro-
teins activating the Sec4p GTPases (Walch-Solimena et al., 1997; Hattula et al., 2002;
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Dong et al., 2007), the Ric1p-Rgp1p complex that activates Ypt6p and could possibly
activate Rab6 (Siniossoglou and Pelham, 2001), the Mon1p-Ccz1p complex that acts
on Ypt7 and Rab7 (Nordmann et al., 2010; Gerondopoulos et al., 2012), and there is
also the RCC1 domain protein claret, which could possibly act as a GEF for the Rab
lightoid in Drosophila (Ma et al., 2004).
Recent studies have shown that the Differentially Expressed in Normal tissues and
Neoplasia (DENN) domain proteins form a large family of Rab GEFs (Levivier et al.,
2001; Sato et al., 2008; Allaire et al., 2010; Yoshimura et al., 2010) (Figure 1.4, page
27). All known DENN proteins consist of a full DENN domain that comprises three
upstream (u-DENN), core (DENN), and downstream (d-DENN) subregions (Levivier
et al., 2001) (Figure 1.4, page 27). DENN domain proteins were first identified as
Rab GEFs by the biochemical purification of a Rab3 GEF purified from bovine brain
(Wada et al., 1997). Studies in mammalian cells confirmed that the RME-4 homologue
DENND1A/connecdenn was in fact a Rab35 GEF (Allaire et al., 2010; Marat et al.,
2011; Yoshimura et al., 2010). Further investigation into DENN domain proteins from
our own laboratory confirmed that DENND2 acts on Rab9, DENND4 acts as a GEF for
Rab10, DENND3 acts on Rab12, DENND5A/B acts on Rab39, MTMR5 and MTMR13
act on Rab28 and MADD acts on Rab27a and Rab27b (Yoshimura et al., 2010).
In addition to the group of DENN domain proteins there is a small group of proteins
that contain some but not all of the DENN homology. These proteins are known as
Avl9, FAM116A, FAM116B, FAM45A and KIAA1147. Although all of these proteins
contain some similarity to the DENN domain proteins FAM116A and FAM116B contain
the highest degree of sequence similarity and have been named in previous studies as
DENND6 (Marat et al., 2011) (Figure 1.4, page 27).
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Figure 1.4: DENN domain proteins form a large family within human cells. A schematic di-
agram illustrating the human DENN and DENN-related proteins with the upstream
(u-DENN), core DENN and downstream (d-DENN) regions indicated. Additional
domains that are likely to be of relevance for DENN targeting or regulation are also
colour coded (Yoshimura et al., 2010).
When the Rab protein is in an active form it recruits effector proteins onto specific
membranes (Grosshans et al., 2006). These effector proteins can be cytosolic pro-
teins or membrane proteins and complexes. Although Rabs can have multiple effector
proteins, all of them are very specific to that particular Rab (Pfeffer, 2001). The Rab
concentrates the effector molecules onto the membrane providing identification due to
the effector proteins being specific to that particular Rab (Pfeffer, 2001). Although this
mechanism applies to the entire organelle, it is also applied in sub-domains. Recycling
endosomes are a good example of this with the endocytic recycling pathway being
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characterised by Rab5, Rab4 and Rab11 (Ullrich et al., 1996; Sonnichsen et al., 2000)
(Figure 1.5, page 28).
Figure 1.5: Rab proteins define specific pathways. The endocytic pathway is defined by
specific Rab proteins. The easiest way to look at this pathway is with a transferrin
uptake assay. The transferrin is taken from the plasma membrane into the early
endosomes and this is trafficked by Rab5, it is then taken into the recycling endo-
somes by Rab4 followed by Rab11 which traffics the transferrin back to the plasma
membrane.
1.7 Rab GTPases involved in receptor signalling, cancer and cell
migration
Despite the limited research to date, there is now growing interest in the potential role of
Rab GTPases in cancer. Rabs are known to be vital for cell signalling and membrane
trafficking, both of which can have important implications for growth and migration.
This suggests that any changes in Rab functioning, could potentially influence initial
tumourigenesis, primary tumour growth and ultimately metastasis and establishment
at a distant site.
Receptor signalling and membrane trafficking have a very close relationship. For ex-
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ample, activation of growth factor receptors, or the binding of a hormone to a receptor,
will initiate trafficking to the lysosomes where degradation then takes place (Stenmark,
2009). Alternatively, receptors can also be recycled via several signalling pathways re-
sulting in the trafficking of receptors from the plasma membrane to endosomes, where
recycling endocytosis then occurs via the endocytic pathway (von Zastrow and Sorkin,
2007). Rab GTPases are among the many regulators that are involved in receptor
signalling to the endosomal membrane trafficking machinery (von Zastrow and Sorkin,
2007; Stenmark, 2009).
The role of these Rab GTPases in the endocytic pathway is commonly linked with
cell growth and proliferation as many membrane receptors of mitogenic ligands such
as Epidermal Growth Factor Receptor (EGFR) and other members of the receptor
tyrosine kinase family, employ this pathway. Therefore, slight deviations in the traf-
ficking and signalling by Rabs involved in this machinery, can readily influence overall
cell growth and proliferation (Blume-Jensen and Hunter, 2001). It is known that many
tumours have increased activity of receptor tyrosine kinases either through overex-
pression or regulation-impairing mutations (Blume-Jensen and Hunter, 2001). Equally,
Rab mutants have been shown to influence EGFR signalling and degradation at differ-
ent stages of the endocytic route. Therefore it is possible that endocytic Rabs could
enhance or prolong mitogenic EGFR signalling and thereby contribute to tumourigene-
sis (Chia and Tang, 2009). In recent years, Rab-GTPase directed endocytic trafficking
pathways have even begun to emerge as key transport events required for these cell
polarisation and migration events (Caswell et al., 2009).
Rab-mediated trafficking of not only growth factor receptors, but also other signalling
pathways such as the Wnt signalling pathway could also potentially be tumourigenic.
The Wnt signalling pathway has been extensively implicated in cancer. However it
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is still unclear if canonical Wnt signalling requires Rab proteins yet there is growing
evidence demonstrating that xenopus Rab40 has been involved in the non-canonical
Wnt pathway (Polakis, 2007). In Drosophila, Rab6 and Rab11 have been shown to be
involved in modulating Notch signalling, which has been implicated in both tumourige-
nesis and cancer suppression (Miele et al., 2006).
This suggests that Rab GTPases may therefore be able to drive tumourigenesis by
influencing these growth factor signalling pathways. For example, increased Rab ex-
pression could result in increased activation of cell proliferation or survival pathways
through the modulation of growth factor receptor endocytosis and signalling through
signalling endosomes (Chia and Tang, 2009).
In relation to cell signalling and cell migration, it is the Rab11 family of GTPases
that are the best understood. Rab4, Rab11 and Rab25 play key roles in the transport
of different integrin complexes in migrating cells (Caswell et al., 2007, 2009), and are
vital to cell polarisation during asymmetric cell divisions (Emery et al., 2005). Rab11
family GTPases are typically associated with different stages of the endocytic recy-
cling pathway (Ullrich et al., 1996; Sonnichsen et al., 2000; De Renzis et al., 2002),
for which the transferrin receptor is the most studied cargo (see Figure 1.5, page 28).
As part of their cellular function, Rab GTPases cycle between GDP and GTP bound
states at membrane surfaces where they couple to effector proteins that mediate inter-
actions between membrane surfaces or membranes and the cytoskeleton (Zerial and
McBride, 2001; Pfeffer and Aivazian, 2004). Accordingly, Rab11 and its effector, Rab-
Coupling Protein (RCP) promote α5β1-integrin and promotes its delivery to the tips of
elongated pseudohyphae during invasive cell migration in 3D matrices (Caswell et al.,
2007). Rab4 promotes the recycling of αVβ3-integrin and cell migration through the
RUN and FYVE domain effector protein RUFY1 (Roberts et al., 2001a).
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Misregulated expression of several Rab proteins has been identified in a number of
different cancer tissues (Chia and Tang, 2009). Analysis of tongue squamous cell car-
cinoma has revealed a high occurrence of Rab1a, an essential ER to Golgi regulator
protein. Furthermore, a similar pattern of Rab1a expression has been noted in a vari-
ety of premalignant lesions (Chia and Tang, 2009). Another ER-Golgi transport protein,
Rab2, is often found in high levels in peripheral lymphocytes of patients with haema-
tological and solid tumours (Culine et al., 1994). High levels of the brain enriched
protein Rab3, is also found in cancers of the nervous system and neuroendocrine cells
(Lankat-Buttgereit et al., 1994).
Rab5a and Rab5b are essential regulators of growth factor receptor-mediated endo-
cytosis, and thus dysregulated expression could be potentially tumourigenic. Indeed,
upregulation of Rab5 has been noted in malignant and metastatic lung adenocarci-
noma (Ottonello et al., 1999). Similarly, Rab5a and Rab7 are both upregulated in
autonomous thyroid adenomas compared to the surrounding tissues (Chia and Tang,
2009). However, Rab5b has been conversely shown to be present in much lower levels
in highly metastatic melanoma cells. The reason for the difference in expression still
remains unclear but could to be due to gene inactivation during the tumour progres-
sion, which is not only the case in Rab5 but also in other Rabs (Ottonello et al., 1999;
Chia and Tang, 2009).
To date, the most documented Rab protein associated with cancer is Rab25, which
belongs to the Rab11 subfamily (Rab11, Rab4 and Rab25) (Pereira-Leal and Seabra,
2001). Growing evidence indicates that Rab25 is enriched in organs that contain ep-
ithelial cells, with high expression levels being found in gastrointestinal mucosa and in
particular, the highest expression being noted in ileum and colon (Goldenring et al.,
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1993). Furthermore, high expression levels of Rab25 have now been demonstrated in
lung, kidney, ovarian and breast cancer (Goldenring et al., 1993). Association be-
tween Rab25 and apical recycling has been demonstrated in Madin-Darby Canine
Kidney (MDCK) cells, indicating that Rab25 regulates apical endocytosis and transcy-
tosis (Goldenring et al., 1993). It is clear that Rab25 has an important pathogenic role,
specifically in cancers of epithelial origins (Chia and Tang, 2009).
1.8 Cell migration
Cell migration is important for the generation of tissues, wound repair, immune system
function, and can also occur in diseases like cancer as part of metastasis (Fletcher
and Rappoport, 2010). It is fundamental in contributing towards both development and
disease. Mis-regulation of this migration can have very devastating effects from con-
genital deformations to allowing tumour cells to migrate away from their primary site to
form distant metastases (Ulrich and Heisenberg, 2009).
Cells can migrate individually as single cells, for example as seen in Drosophila dur-
ing border cell migration, or in the normal functioning of leukocytes, lymphocytes and
fibroblasts (Biname et al., 2010). However, cells can equally move as sheets when the
cells are connected to one another, such as seen in endothelial cells during angiogen-
esis and in epithelial cells as part of the wound healing process in vertebrates (see
Figure 1.6, page 33) (Ridley, 2001; Ulrich and Heisenberg, 2009). Various molecular
pathways can determine individual or collective tumour cell migration. Both individ-
ual and collective migration involves increased control of cell to extracellular matrix
(ECM) interaction and this is provided by matrix degrading proteases and integrins (Ri-
dley, 2001). Collective migration has specific characteristics including cell-cell adhe-
sion through adhesion receptors such as cadherins, as well as cell-cell communication
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via gap junctions. Lymphoma, leukaemia and small-cell lung carcinoma have all been
shown to undergo amoeboid migration, however; sarcomas and glioblastomas under-
take mesenchymal type migration. Epithelial cancers such as breast, prostate and
colon carcinoma travel in small groups or clusters allowing for the levels of differenti-
ation to remain high. Benign vascular tumours and some epithelial cancers move as
multicellular sheets that do not detach from one another, and although these cancers
are invasive they are very rarely metastatic (Friedl and Wolf, 2003).
Figure 1.6: The Migration Strategy. Various molecular pathways can determine individual or
collective tumour cell migration. Lymphoma, leukaemia and small-cell lung car-
cinoma have all been shown to undergo amoeboid migration, however, sarcomas
and glioblastomas undertake mesenchymal type migration. Epithelial cancers such
as breast, prostate and colon carcinoma travel in small groups or clusters in order
for the levels of differentiation to remain high. Benign vascular tumours and some
epithelial cancers move as multicellular sheets that do not detach from one another
(modified from Friedl and Wolf, 2003).
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There are four stages of cell migration: (i) a response to an external stimulus causing
polarisation of the cell, (ii) the leading edge of the cell forms a protrusion, (iii) adhesion
to the extracellular matrix (ECM) or other cells and (iv) the trailing end of the cell re-
tracting causing the cell to move forward (Ulrich and Heisenberg, 2009). For this to be
successful, there must be careful co-ordinated and temporal regulation of changes to
the cytoskeleton, adhesion molecules and the extracellular matrix.
Cell migration is predominantly triggered by extracellular signals, which can take the
form of either signals from the extracellular matrix or signals from neighbouring cells
(Bishop and Hall, 2000; Franz et al., 2002). Cell surface receptors detect these stimuli
and act to transduce the signal into a response from the cell by means of their trans-
membrane receptor properties, such that they produce a signalling cascade. Many
different intracellular signalling molecules are known to be involved in cell migration
such as small G-proteins (GTPases) and Mitogen Activated Protein Kinases (MAPK)
(Ridley, 2001; Fukata et al., 2003). These small G-proteins, such as Cdc42, Rac and
Rho, play an early role in responding to stimuli and act to send out initial signals that
lead to polarisation of the cell (Etienne-Manneville, 2008).
1.9 Adhesion molecules are required for cell migration
A complex network of cellular trafficking pathways is required for a cell to migrate and
polarise. These pathways include trafficking target membrane proteins that are re-
quired for sensing extracellular cues, as well as being involved in the creation and
remodelling of cell adhesions and cell-cell junctions (Huttenlocher, 2005; Mellman and
Nelson, 2008; Caswell et al., 2009; Ulrich and Heisenberg, 2009; Baum and Georgiou,
2011).
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The movement of a cell in most environments begins with the membrane from the
front of the cell attaching it to the actin cytoskeleton. This causes traction forces and
allows the cell to move forward, whereby the adhesion molecules are disassembled at
the rear of the cell (Parsons et al., 2010).
In recent years, Rab GTPase directed endocytic trafficking pathways have begun to
emerge as key transport events that are required for the remodelling of cell adhesion
and cellular junctions, and are also involved in the polarisation of the cell and migration
(Caswell et al., 2009; Baum and Georgiou, 2011). The Rab5-related GTPase Rab21
functions in β1-integrin trafficking and cell invasion (Pellinen et al., 2006; Hooper et al.,
2010; Mai et al., 2011). The transport of signalling receptors is vital for proper axonal
guidance, and this requires Rab27 (Arimura et al., 2009). The most well characterised
roles are that of the Rab11 family of GTPases, Rab4, Rab11 and Rab25, which are es-
sential in the transport of different integrin complexes in migrating cells (Caswell et al.,
2007, 2009), Epithelial Cadherin (E-Cadherin) trafficking during adherens junction for-
mation (Le et al., 1999), and in cell polarisation during asymmetric cell divisions (Emery
et al., 2005).
1.10 Integrins
The integrin family of cell adhesion receptors control a number of different functions
within the cell that are essential for the initiation, progression and metastasis of solid
tumours. The importance of α and β integrins has been heavily studied and has now
become a very attractive target for solid tumour cancer therapy (Desgrosellier and
Cheresh, 2010). Integrins are involved in interactions that occur between the cell and
the Extracellular Matrix (ECM) that surrounds it (Caswell and Norman, 2006).
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Integrins are heterodimers and consist of 19 α-integrin and 8 β-integrin subunits and
these subunits produce 25 integrin αβ heterodimers that bind directly to the compo-
nents of the ECM and form receptors in virtually all cell types (Caswell et al., 2009).
The first crystal structure of the extracellular domains of αVβ3 provided the understand-
ing of how the α and β subunits join together to form the ligand-binding site (Adair et al.,
2005). It was the crystal structure that suggested that the extracellular domain in the
inactive form of the integrin formed a V shape and the extracellular domain in the ac-
tive state is extended suggesting that the binding of the integrin to the ligand causes
this extension (Humphries, 2000). Both the subunits are type I transmembrane pro-
teins that contain short cytoplasmic domains and large extracellular domains (Springer
and Wang, 2004; Arnaout et al., 2005). Twelve integrins contain the β1 subunit and
five contain the αV subunit but there are some subunits that appear in only single het-
erodimers (Humphries et al., 2006).
Integrin affinities for their extracellular ligands such as collagen or fibronectin are
regulated by signalling at a cellular level thus resulting in the description of integrin
activation as ‘inside-out’ signalling (Shattil et al., 2010). However no enzymatic activity
has been shown in the cytoplasmic tails of the integrins indicating that the ‘inside-out’
signalling is dependent on adaptor proteins or scaffold proteins enabling the integrin
to bind to kinases such as the focal adhesion kinase or Src (Giancotti and Ruoslahti,
1999). Although integrins are best known for their function in adhesion, the activation
of integrins is also essential for a number of different cellular events such as leukocyte
transmigration and platelet aggregation (Hynes, 2002).
Furthermore, integrins play a very important role in a number of cellular processes
linked with progression of diseases like cancer through the interactions they make with
the ECM. These interactions can be influenced by signals from both outside or within
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the cell as integrins are able to act as bidirectional transducer molecules (Hynes, 2002;
Caswell et al., 2009).
Another way in which integrins can transmit ‘outside-in’ signalling is through their ca-
pability to influence the way in which growth factor receptors react to the ligands. These
growth factor receptors could be EGFR or Fibroblast Growth Factor Receptor (FGFR)
(Walker and Assoian, 2005).
Integrins are trafficked via the endosomal pathway and this is known to influence
their function (Pellinen and Ivaska, 2006; Caswell and Norman, 2008). The trafficking
pathways of the integrins not only dictate the polarisation distribution but also in what
particular way the integrin and the growth factor receptors signal to the migratory cell
(Caswell et al., 2009).
It is clear therefore that the activation of integrins plays a crucial role in regulating
the polarity of a migrating cell and the assembly and reassembly of the ECM, thereby
suggesting that integrins may be critical to regulation of overall tumour mestastasis.
This pivotal role has lead to an increase in research into potential methods of blocking
activation of these integrins as a part of anti-adhesive therapy as a possible mechanism
for controlling tumour metastasis (Kim et al., 2011).
1.11 Cadherins
Cells are connected to one another and also the ECM by a large number of various
cellular junctions. Adherens junctions are particularly important for physical adhesions
of cells to their surroundings, hence the name adherence or adherens junctions (Yap
et al., 1997). Adherens junctions are special forms of adhesive-based contacts that
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are cadherin based and these junctions are essential for tissue organisation during de-
velopment, as well as playing a critical role in the determination and maintenance of
tissue organisation in adult organisms (Yap et al., 1997).
Cadherins are one of the major family members of adhesion molecules and support
calcium dependent cell-cell adhesions in all solid tissues in the body (Yap et al., 1997).
Cadherins in association with the actin cytoskeleton can regulate cell-cell recognition
events that then bring about morphological transitions that maintain the structure of
tissues in adult organisms (Aberle et al., 1996). All members of the adhesion molecule
superfamily are transmembrane proteins and have a variable number of extracellular
cadherin domains (Overduin et al., 1995).
The classical cadherins are single-span transmembrane proteins located primarily
within adherens junctions and mediate calcium-dependent cell-cell adhesion (Angst
et al., 2001). They can interact with a complex network of signalling and cytoskeletal
molecules by transferring information intracellularly. E-Cadherin and N-Cadherin are
the two classical cadherins that have been extensively studied and it has long been
known that expression of either of these cadherins on the cell surface is involved in cell
sorting (see Figure 1.7, page 39) (Yap et al., 1997).
38
1 INTRODUCTION
Figure 1.7: Cadherins involved in cell migration Cell migration and polarisation are under-
pinned by a complex network of cellular trafficking pathways required. Signalling
receptors need to be recycled in order for the cell to become polarised and move in
the correct direction ie towards the wound. Integrins need to be recycled creating
and remodelling the adhesions and allowing the cell to move. Cell to cell junctions
ie cadherins need to be remodelled in order for the cell to be able to separate from
its neighbours.
Cadherins are homophilic molecules and cells adhere to their neighbouring cells only
if these are expressing the identical cadherin member to themselves. Therefore when
cells are in culture the cells will sort themselves from each other by only adhering if they
are expressing the same cadherin (Nose et al., 1988). During development, changes
in the cadherins expressed in the cells allow segregation of cells to distinct tissues
therefore influencing the organisation of a number of cell types into tissues (Takeichi,
1991). Adhesive specificity arises from both affinity differences between cadherin sub-
types and their expression levels (Foty and Steinberg, 2005). Furthermore, cadherins
will segregate at high shear force but can cross adhere at low shear force and be-
cause cells remain in contact with each other longer at lower shear forces the kinetics
of cadherin-cadherin interactions may play a role in the determination of cell specificity
(Duguay et al., 2003).
In humans there are over 80 members of the cadherin superfamily (Derycke and
Bracke, 2004). There are four cadherin subfamilies conserved between C. elegans,
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Drosophila and humans: classic cadherin, fat-like cadherins, seven-pass transmem-
brane cadherins and DrosophilaCad 102F. The classic cadherins themselves consist
of four subgroups: Type I classic cadherins that include Epithelial Cadherin, Neuronal
Cadherin, Placental Cadherin and Retinal Cadherin (Boggon et al., 2002).
The classic cadherin family members contain five cadherin domains and a conserved
cytoplasmic tail that interacts with multiple proteins that functionally link cadherins to
the underlying cytoskeleton (see Figure 1.8, page 41) (Ozawa et al., 1990b). It is the
cytoplasmic region of the cadherin that binds to β-catenin and to p120 (Pokutta and
Weis, 2007). β-catenin in turn binds to α-catenin, which has a number of binding part-
ners, one of which is actin (Pokutta and Weis, 2007). The cadherin-catenin complex
mediates adhesion but only when the adhesion involves classic cadherins (Nagafuchi
and Takeichi, 1988; Ozawa et al., 1990a).
Neuronal Cadherin (N-Cadherin) was identified for the first time in 1982 (Grunwald
et al., 1982). It is a 130 kilo Dalton (kDa) molecule and was discovered in the chick
neural retina that was protected from proteolysis by calcium (Grunwald et al., 1982).
In 1984 a molecule called A-CAM was identified and shown to localise at the ad-
herens junctions; A-CAM is now known as N-Cadherin (Volk and Geiger, 1984). The
fibroblast growth factor receptor (FGFR) is known to be associated with the function
of N-Cadherin. N-Cadherin has many functions in the nervous system with the key
roles being regulation of the growth of axons, and guidance to synaptic formation and
synaptic plasticity (Doherty and Walsh, 1996). Neurite outgrowth can be inhibited by
many blocking buffers that inhibit FGFR function if the neurite growth is controlled by
N-Cadherin (Williams et al., 1994). The cytoplasmic part of N-Cadherin is complexed
with a multitude of regulators for cadherin such as the catenins p120 catenin, β-catenin
and α-catenin. The binding with p120 and N-Cadherin is increased when the p120 is
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Figure 1.8: Domain structure of Classical Cadherins. The best understood cadherins are
the “classical” cadherins of vertebrates, and the closely related desmosomal cad-
herins. Classical and desmosomal cadherins have ectodomains composed of five
extracellular cadherin (EC) repeats, a single transmembrane region, and a cyto-
plasmic domain that interacts with either β-catenin (classical cadherins), γ-catenin
and α-catenin which then in turn binds to actin.
phosphorylated.
β-catenin is a protein that contains 781 amino acids and is very highly conserved.
E-Cadherin binds to β-catenin on the arm domain of the protein whereas α-catenin
binds just before the arm domain (Huber et al., 1997). The E-Cadherin binding site of
the protein is also the binding site for other ligands and is known to be involved in Wnt
signalling (Choi et al., 2006). P120 is a protein that binds to the cytoplasmic region
of the cadherin (Daniel and Reynolds, 1995; Thoreson et al., 2000). Although the role
of P120 remains unclear it is thought to play a role in controlling the regulators of the
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actin cytoskeleton (Anastasiadis and Reynolds, 2001).
α-catenin is a protein that is homologous to the focal adhesion molecule vinculin.
There have been a lot of binding partners already identified for α-catenin but not all of
them have been verified biochemically (Kobielak and Fuchs, 2004). α-catenin forms a
homodimer, but when it binds to β-catenin it dissociates to form a 1:1 heterodimer
(Koslov et al., 1997; Pokutta and Weis, 2000). It was previously believed that α-
catenin links the β-catenin-cadherin complex to actin, providing the stable linkage that
is needed between the extracellular contact and the cytoskeleton, due to the ability of
α-catenin to bind to both β-catenin and F-actin. However more recent reports suggest
that this is not the case as purified recombinant proteins showed that α-catenin cannot
bind to β-catenin and actin simultaneously. This is even the case when it is in the pres-
ence of proteins that have been reported to bind both actin and α-catenin like native
membranes or the cytosol (Yamada et al., 2005).
The adhesive function of cadherins is a dynamic process and cells responding to
physiological and environmental cues regulate this (Yap et al., 1997). It is thought that
in developing organisms, the levels of E-Cadherin based adhesion are increased (Vest-
weber et al., 1987; Winkel et al., 1990), and the levels of C-cadherin are reduced by
activin, and this decrease in the levels of adhesions enables all the intercellular move-
ments (Brieher and Gumbiner, 1994).
Distinctive types of cell-cell junctions containing cadherins are formed in epithelial
cells and are known to express equal levels of both N-Cadherin which is a type I cad-
herin and VE cadherin which is a type II cadherin (Wheelock and Johnson, 2003).
VE-cadherin is thought to localise to the junctions and N-Cadherin localises on the
surface of the cell (Navarro et al., 1998). Although the role of N-Cadherin is not fully
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understood in endothelial cells it is known that it does not form part of the endothelial
cell junction complex (Wheelock and Johnson, 2003). VE-cadherin however does form
part of this complex along with β-catenin, plakoglobin and p120 catenin that then con-
nect to the actin cytoskeleton and form typical adherens junctions (Lampugnani et al.,
1995). Endothelial cells also have junctions that connect to the cytoskeleton, however
the filaments are made up of vimentin rather than keratin. Endothelial cells do not
contain desmosomal cadherin so the VE-cadherin is restricted to α-catenin and actin
interactions (Kowalczyk et al., 1998).
During early vertebrate development, polarised assembly of junctional proteins at
the apical surface of the cell is essential (Yeaman et al., 1999). Epithelial cells maintain
their polarity by the sorting of apical and basolateral proteins into various vesicles in the
TGN, the proteins are then targeted to their specific membrane compartments (Whee-
lock and Johnson, 2003). Cell polarity is established at the very early stages of devel-
opment and this polarity is mediated by E-Cadherin. For polarisation to occur within
the cell proper localisation of a number of proteins in a number of different cell types is
needed. These include cadherins, scaffolding proteins and signalling molecules (see
Figure 1.7, page 39) (Ohno, 2001).
E-Cadherin is the most studied of the cadherin family in tumourigenesis due to the
high levels expressed in epithelial cells, which are the origin of most cancers. In vitro
and in vivo studies have proven that if you inhibit the activity of E-Cadherin normal
epithelial cells change into invasive cells, and overexpression of E-Cadherin converts
invasive cells to non-invasive cells (Perl et al., 1998). It is well established that E-
Cadherin functions as a tumour suppressor with many studies describing and proving
this in great detail (Ghadimi et al., 1999; Wheelock et al., 2001; Perret et al., 2002).
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Expression of N-Cadherin also causes epithelial cells (squamous and breast cells)
to become more motile and more invasive in vitro and more metastatic in vivo (Nieman
et al., 1999; Hazan et al., 2000). It has also been shown that the effect of N-Cadherin
on motility is mediated through the FGF receptor signalling pathway (Nieman et al.,
1999). N-Cadherin is thought to directly interact with FGF receptor 1 and prevent the
receptor from being internalised therefore increasing the receptor on the cell surface
and enhancing downstream signalling (Cavallaro et al., 2001). N-Cadherin also inter-
acts with FGF receptor 4 mediated by N-CAM, which is a cell-cell adhesion molecule
(Suyama et al., 2002). Thus expression of N-Cadherin by tumour cells can influence
cellular behaviour via ligand-dependent and ligand-independent interactions with FGF
receptor (Hulit et al., 2007).
Epithelial to mesenchymal transitions occur when epithelial cells are converted into
fibroblast-like motile cells, which is regularly observed during normal development.
Similar actions are seen through the stages of carcinogenesis. Decreased expres-
sion of E-Cadherin is a hallmark for epithelial-mesenchymal transitions (Perret et al.,
2002).
Cadherin function and expression has major effects on the cell phenotype and be-
haviour and expression levels are essential in development not only to form cell-cell
junctions but to mediate cell signalling events and cell sorting that regulates develop-
ment (Wheelock and Johnson, 2003).
1.12 ADAM proteases
Proteases are proteolytic enzymes, which play essential roles in a number of different
biological processes, and are linked with a large number of pathological conditions,
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one of which being cancer (López-Otín and Overall, 2002). The complete number of
proteases produced by the human body comprises at least 569. These are grouped
into five different classes: 194 metalloproteases, and 176 serine, 150 cysteine, 28 thre-
onine and 21 aspartic proteases (López-Otín and Matrisian, 2007).
Proteases have been identified to contribute to all stages of tumour progression.
Both intracellular and extracellular proteases can function as signalling molecules in a
number of different cellular processes including proliferation, adhesion, migration, an-
giogenesis, and apoptosis with many of them being essential in cancer biology (Ege-
blad and Werb, 2002; Borgoño and Diamandis, 2004).
A Disintegrin And Metalloprotease (ADAM)s are a family of extracellular metallopro-
teases. which have functions in cell adhesion, and proteolysis of a diverse range of cell
surface receptors and signalling molecules (Wolfsberg et al., 1995). To date 40 fam-
ily members have been identified in the mammalian genome. Out of the 40 ADAM
genes identified only 12 of them encode for proteolytically active proteases (Reiss
et al., 2005). The biological processes in which ADAMs are known to be involved in-
clude sperm-egg interactions, cell migration, axon guidance, muscle development and
immunity (Huxley-Jones et al., 2007). The most well known role for ADAMs is the acti-
vation of preforms of a number of growth factors and cytokines and also the shedding
of the extracellular domains of growth factor receptors and adhesion molecules (Duffy
et al., 2011). The ectodomain shedding of a number of substrates is combined with the
cleavage by regulated intramembrane proteolysis (RIP) which generates signals that
target the nucleus with the primary signal being the Notch signal (Reiss et al., 2005).
It is thought that ADAMs are synthesised in the rough ER and are matured in a late
Golgi compartment (Feng et al., 2000; Kang et al., 2002). This process involves gly-
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cosylation and the removal of the prodomain through furin from the ADAM precursor
molecule (Endres et al., 2003). Recent studies suggest that isolated prodomains of
ADAMs may inhibit both active and mature forms of the enzymes (Moss et al., 2007).
When most of the ADAMs are in the steady state they are localised to the Golgi and
also to the plasma membrane (Gutwein et al., 2003). Although there are many details
known about the physiological events that are mediated by the activation of various
ADAMs very little is known about the intracellular localisation and the transport of these
proteins (Reiss and Saftig, 2009).
The disintegrin domain of ADAMs could possibly be involved in cell-cell adhesion
processes (White, 2003). The cytoplasmic tail has been implicated in the inside-out
signalling, the control of maturation and subcellular localisation and outside-in regu-
lation of cell signalling (Seals and Courtneidge, 2003). The cytoplasmic domain is
proposed to mediate ADAM function either by regulating catalytic activity through the
coupling of ADAM activity to signalling or trafficking the protein to the correct loca-
tion within the cell (Tanaka et al., 2004). ADAM mediated ectodomain shedding has
emerged as a vital method to reduce the selective proteins from the surface of the cell
and also to inactivate receptors (Hattori et al., 2000).
ADAMs are known to apply many effects on cell migration and cell adhesion (Reiss
and Saftig, 2009). Although they have their own adhesive capacity, for example inte-
grin binding, they also modify cell signalling pathways that are essential for migration
guidance, for example ephrin signalling (Reiss et al., 2006). The proteolysis of Cell
Adhesion Molecules (CAM) mediated by ADAMs is an essential mechanism for cell
migration during development, inflammatory diseases and tumour metastasis (Reiss
et al., 2006).
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Many CAMs such as cadherins are released in soluble forms in vivo and in vitro.
ADAM10 facilitates cleavage of the cadherin members that mediate Ca2+ dependent
cell-cell adhesion. The cadherins in particular that are processed by ADAM10 are N-
Cadherin and E-Cadherin (Schulz et al., 2008). The release of the extracellular domain
contains the homophilic binding site and is majorly important for the regulation of cell
adhesion, cell migration and cell signalling (Maretzky et al., 2005).
ADAMs have emerged recently as the key metalloproteinases that are involved in
the release of the EGFR ligands and in EGFR activation (Sahin and Blobel, 2007).
ADAM17 is known as an essential sheddase for Haemoglobin (HB), Tumour Growth
Factor (TGF)β, Epidermal Growth Factor (EGF) and epiregulin whilst ADAM10 is known
to be involved in the shedding of EGF and betacellulin (Sahin et al., 2004). ADAM10
shedding is mediated by calcium influx, phorbol esters activate ADAM17 shedding of
EGFR ligands, however another essential mechanism of ADAM-dependent EGFR acti-
vation is transactivation by G Protein-Coupled Receptors (GPCR) (Ohtsu et al., 2006).
There are a number of GPCR agonists that include thrombin and endothelin-1 (ET-1)
that are known to transactivate EGFR signalling. Very little is known about the ADAM
activation by G-protein derived signalling molecules (Ohtsu et al., 2006).
There are several ADAMs involved in cancer and are thought to enhance malignant
tumour growth due to the activation of EGFR thus stimulating cell proliferation (Kenny
and Bissell, 2007). ADAMs can also induce the epithelial-mesenchymal transition by
cleaving E-Cadherin, which also causes increased cell proliferation and increased ma-
lignant tumour growth (Maretzky et al., 2005).
ADAMs are differentially expressed in a number of different diseases including can-
cer and atherosclerosis (Turk, 2006). Therefore ADAM proteases have now been used
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as biomarkers for early diagnostics and also for prognostic markers to allow the ap-
propriate selection of therapy (Duffy et al., 2011). Therapeutics targeting ADAM10 and
ADAM17 have already appeared to have anti-cancer effects and are in clinical trials
(Duffy et al., 2011).
It is now well established that ADAM-mediated ectodomain shedding is essential to
regulate cell-cell interaction and cell-cell communication. If the shedding is misregu-
lated then diseases occur like autoimmune and cardiovascular malfunctions, infection
and cancer. Therefore ADAMs have now become attractive targets for therapies. How-
ever further research is needed to fully understand the regulation and control of ADAM
activity, ADAM redundancy in substrate processing, the structure and the interaction of
ADAMs with the proteins that regulate the ectodomain shedding. There is also more
research required on how the cellular localisation of ADAMs is regulated and how this
localisation is linked to their proteolytic functions (Reiss and Saftig, 2009).
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1.13 Aim of the study
Cell migration is an underlying process important for faithful development and immune
response. Dysfunction of any of the tightly regulated steps within this process can
have detrimental consequences causing metastasis in cancer. The precise intracel-
lular pathways and mechanisms underlying this migratory process are still unknown.
However it is clear that Rab GTPases and their GDP-GTP exchange factors (GEFs)
are critical in specifying membrane domains for vesicle trafficking during cell polarisa-
tion and migration. The aim of this project was to begin to elucidate these pathways by
identifying the Rab GTPases and their candidate regulators that are required for cell
migration in A549 lung cancer cells in vitro, and assign the specific cargo molecules
that are passed through the underlying membrane trafficking pathways and the order
in which the different Rabs act.
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2 Results
2.1 Rab GTPases required for cell migration in vitro
Cell migration is important for the generation of tissues, wound repair and immune sys-
tem function (Fletcher and Rappoport, 2010). It is fundamental in contributing towards
both development and disease. To identify which Rab GTPases control the trafficking
pathways that are involved in cell migration in vitro a scratch wound migration assay
was designed. Along with the scratch wound assay the cells were depleted of all known
human Rab GTPases using siRNA. Dharmacon SMART-pool on-target plus duplexes
were chosen to eliminate any off target effects. Due to the concerns that some closely
related Rabs can be redundant these particular Rabs were combined in one pool for
the purpose of this screen.
2.2 Human Rab GTPase screen using siRNA in a scratch wound
assay
A549 lung epithelial cells were grown up to make a confluent monolayer in a plastic
12 or 24 well dish. This monolayer creates a sheet of cells that are connected to one
another by cell-cell adherens junctions. To create a wound in this monolayer, a P200
plastic Gilson tip was used to scratch the wound and allow the cells from the sheet to
migrate into it. Migration of the cells is associated with cell polarisation that directs the
cells in the correct direction allowing the wound to heal. In order for the cells to move,
loss of adherens junctions is needed to allow the migrating cell to become detached
from its neighbours. Once the wound is healed and the cells stop migrating then these
adherens junctions reform.
The A549 cells were siRNA treated with the Rab GTPase library for 72 hours prior
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to the wounding. Once the wound was crafted, the cells were left for 30 minutes to re-
cover before being imaged using a live cell microscope. The wound was imaged every
5 minutes for 16 hours. After 16 hours of imaging a video of the wound healing was
created using the software Metamorph. Using this software the migration of the cells
was measured (Figure 2.1, page 51). This data revealed that depletion of the major-
ity of the Rabs screened resulted in reduced migration when compared to the negative
control (Figure 2.2, page 52). Due to this result it was decided to focus on the Rabs that
caused the most acute migration defects, because many Rabs are expected to have
indirect effects on cell migration by altering Golgi and endosome function. Therefore,
only conditions showing a change greater than one standard deviation from the mean
were considered as a result of a direct effect on cell migration. This was illustrated
by a red dotted line on the graph that indicated the median and the blue shaded area
indicates plus or minus one of the standard deviation (Figure 2.2, page 52). All findings
below the lower blue shaded area was classed as a severe migration defect.
Figure 2.1: Workflow of scratch wound assay. A549 cells in 24-well plates were treated with
siRNA duplexes targeting the human Rab GTPases family. After 72 hours, the cell
monolayers were wounded using a P200 tip, and then after a 30 minute recovery
period imaged using a 10x objective on a live cell microscope for 16 hours and
videos were collected.
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Figure 2.2: Rab14 is required for cell migration in vitro. A549 cells in 24-well plates were treated with siRNA duplexes targeting
the human Rab GTPase family. Similar Rabs were pooled into one duplex, see legend to bar graph, due to concerns
that they may be functionally redundant. After 72 hours, the cell monolayers were wounded, and then after a 30 minute
recovery period imaged for 16 hours. The distance migrated by the wound front after 16 hours is plotted in the bar graph.
Error bars indicate the standard deviation (n=3). The red dotted line indicates the median distance migrated, and the light
blue-grey shading outlines the boundaries of the standard deviation for all conditions.
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2.3 Rab11 subfamily is required for A549 cell migration.
In order to ensure that the Rab GTPases from the library are being depleted efficiently,
cells were treated with the target siRNA duplex for the same amount of time used in the
screen and compared to lysate that had been treated with a control GL2 siRNA duplex.
The cells were then lysed using SDS-PAGE sample buffer and loaded on a gel before
being western blotted and probed for the Rabs indicated in the figure (Figure 2.3, page
53). To ensure the lysates were equally loaded, tubulin was used as a loading control.
Figure 2.3: Western blot controls for the Rab siRNA migration screen. Cells were treated
with siRNA control duplex (-) or siRNA duplexes for the Rab GTPases (+), as shown
in the figure. After 72 hours, the cells were lysed in SDS-PAGE sample buffer, and
then western blotted as indicated in the figure. Tubulin was used as a loading
control.
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Using the criteria described above Rab4, Rab11, Rab15 and Rab14 show the most
severe migration defects out of the screen. Rab14 depleted cells appeared most im-
paired with cells remaining in a sheet over the 16 hours of imaging and only marginally
spreading into the wound over this time (Figure 2.4, page 55, Movie 1 and 2). Still
images were created from the movies at fixed time points of 0 hours, 4 hours, 8 hours,
12 hours and 16 hours in order to compare migration effects in the different Rab deple-
tions within the cells (Figure 2.4, page 55).
These results are consistent with previous studies that have shown that Rab4 and
Rab11 are involved in cell migration by controlling the trafficking of various cargo in-
cluding integrins and the adherens molecule E-cadherin (Roberts et al., 2001b; Lock
and Stow, 2005). Rab4 and Rab11 depleted cells migrated very slowly away from the
confluent sheet of cells and over the 16 hours the wound remained open (Figure 2.4,
page 55, Movie 1). Interestingly, Rab4 and Rab11 along with Rab14 fall into the same
Rab11 subfamily. The Rab11 subfamily has been associated with endocytic recycling
in many studies (Ullrich et al., 1996; Yamamoto et al., 2010). Due to all three being
positive for migration defects in this particular screen it is very unlikely that these re-
sults are due to off target effects or redundant functions, suggesting that all three Rabs
play a fundamental role in the regulation of the transport of specific cargo molecules in
cell migration.
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Figure 2.4: Rab14 is required for cell migration in vitro. A549 cells in 24-well plates were treated with siRNA duplexes targeting
the human Rab GTPase family. Similar Rabs were pooled, see legend to bar graph, due to concerns that they may be
functionally redundant. After 72 hours, the cell monolayers were wounded, and then after a 30 minute recovery period
imaged for 16 hours. Brightfield images from control, Rab14, Rab4, and Rab11 depleted cells are shown at 0, 4, 8, 12,
and 16 hours. The dotted red lines mark the edges of the wound at each time point. The scale bars indicate 50 µm.
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2.4 What pathways required for cell migration are regulated by
Rab GTPases?
In order to further define the trafficking pathways that are required for cells to migrate,
the effects of depleting the known and candidate GEFs were examined. Recent stud-
ies suggest that the DENN (differentially expressed in normal and neoplasia) domain
proteins make up the largest family of proteins that are known to be Rab GEFS (Allaire
et al., 2010; Levivier et al., 2001; Sato et al., 2008; Yoshimura et al., 2010). To date,
however no GEF has been found for any member of the Rab11 subfamily and although
the DENN domain family has been tested there have been no candidates confirmed.
Our laboratory has identified a small group of proteins containing DENN-related do-
mains. These proteins are known as FAM116A, FAM116B, FAM45A, Avl9 and KIA1147
(see Figure 1.4, page 27). Although all of these proteins contain domains that are sim-
ilar to the DENN domain proteins, FAM116A and FAM116B contain the highest degree
of sequence similarity to the DENN domain and thus the FAM116 proteins have been
referred to as DENND6 (Marat et al., 2011).
2.5 DENN-related proteins FAM116 and Avl9 are required for cell
migration.
To test if any of the DENN domain or DENN-related proteins are necessary for A549
cell migration, they were depleted with siRNA SMART-pool duplexes from Dharmacon
silencing the target DENN or DENN-related gene. The same scratch wound assay
that was described in detail earlier for the Rab screen was then performed (Figure 2.5,
page 57 and Movie 3).
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Figure 2.5: The DENN related proteins FAM116 and Avl9 are required for cell migration
in vitro. A549 cells in 24-well plates were treated with siRNA duplexes targeting
the human DENN and DENN-related proteins. After 72 hours, the cell monolayers
were wounded, and then after a 30 minute recovery period imaged for 16 hours.
The distance migrated by the wound front after 16 hours is plotted in the bar graph.
Error bars indicate the standard deviation (n=3). The red dotted line indicates the
median distance migrated, and the light blue-grey shading outlines the boundaries
of the standard deviation for all conditions.
In order to ensure that the DENN and DENN-related proteins were depleted effi-
ciently, cells were treated with the target siRNA duplex for the same amount of time
used in the screen and compared to lysate that had been treated with a control GL2
siRNA duplex. The cells were then lysed using SDS-PAGE sample buffer and loaded
on a gel before being western blotted and probed for the DENN or DENN-related pro-
tein indicated in the figure (Figure 2.6, page 58). To ensure the lysates were equally
loaded, tubulin was used as a loading control.
The scratch wound assay showed that the cells depleted with FAM116A, FAM116B
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Figure 2.6: Western blot controls for the Rab GEF siRNA migration screen Cells were
treated with siRNA control duplex (-) or siRNA duplexes for the DENN-related pro-
teins (+), as shown in the figure. After 72 hours, the cells were lysed in SDS-PAGE
sample buffer, and then western blotted as indicated in the figure. Tubulin was used
as a loading control.
and Avl9 had the most significant migration defects (Figure 2.7, page 59 and Movie 3).
The migration defects seen with the DENN-related depleted cells were very similar to
that seen when the Rab11 subfamily (Rab4, Rab11 and Rab14) was depleted.
FAM116A depleted cells moved as a sheet and not as individual cells as seen in
the negative control, and over the 16 hours of imaging the wound remained open and
the sheet of cells only spread into the wounded space very slightly (Figure 2.7, page
59 and Movie 3). Avl9 depleted cells also showed a migration defect although not as
severe as that seen with FAM116A depletion. The cells still failed to close the wound
over the 16 hours and the migration of the cells was somewhat slower than in the
negative control (Figure 2.7, page 59 and Movie 3).
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Figure 2.7: The DENN related proteins FAM116 and Avl9 are required for cell migration in vitro. A549 cells in 24-well plates
were treated with siRNA duplexes targeting the human DENN and DENN-related proteins described in Figure 1.4, page
27. After 72 hours, the cell monolayers were wounded, and then after a 30 minute recovery period imaged for 16 hours.
Brightfield images from control, FAM116A, and Avl9 depleted cells are shown at 0, 4, 8, 12, and 16 hours. The scale bars
indicate 50 µm.
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2.6 FAM116A and Rab14 depleted cells show similar migration
defects.
Due to the FAM116A depleted cells showing a very severe migration defect like that
seen with Rab14, a comparison was made between cells depleted of the Rab and
DENN-related proteins that caused the most significant defects from both the screens.
The distance the cells migrated over time was compared over the two screens; this
comparison indicated the cells depleted with FAM116A showed a very similar migration
pattern to the cells depleted with Rab14. It was also clear that the migration defect seen
with Avl9 depleted cells looked comparable to the defect of Rab4 and Rab11 depleted
cells (Figure 2.8, page 60). Analysing both the Rab and DENN wound assays made it
clear that the DENN-related proteins FAM116A and Avl9 could be candidates for being
Rab GEFs and are required for normal cell migration events to take place in A549 cells.
This could possibly be due to FAM116A and Avl9 controlling the regulation of members
of the Rab11 subfamily.
Figure 2.8: The DENN related proteins FAM116 and Avl9 are required for cell migration
in vitro. A549 cells in 24-well plates were treated with siRNA duplexes targeting
Rab4, Rab11, Rab14, FAM116A, and Avl9. After 72 hours, the cell monolayers
were wounded, and then after a 30 minute recovery period imaged for 16 hours.
The distance migrated by the wound front is plotted over time in the graph.
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2.7 FAM116A and FAM116B proteins show specific GEF activity
towards Rab14.
Given the previous data demonstrating that depletion of the DENN-related proteins,
FAM116 and Avl9, leads to cell migration defects with characteristics similar to those
observed with the depletion of the Rab11 subfamily GTPases, the roles of FAM116
and Avl9 were investigated in greater detail. GDP-GTP exchange factor (GEF) assays
were performed by Dr. Yoshimura using recombinant proteins produced in E.coli ex-
pression systems to identify potential target Rab GTPases of these two putative GEF,
DENN-related proteins (Figure 2.9, page 62).
Although it was not possible to find a target Rab GTPase for Avl9 using the GDP
releasing assay despite many attempts, the assay was successful for FAM116A and
FAM116B, which showed specific activity towards Rab14. FAM116B was screened
against the entire Rab GTPase library and only showed high specific activity towards
Rab14 and to a lesser extent towards Rab35. No activity was measured against
any other members of the Rab11 subfamily (Figure 2.9, page 62). FAM116A when
screened against the Rab11 subfamily was only active towards Rab14 (Figure 2.9,
page 62). The results of this assay, along with the findings from the migration screens
provide strong evidence suggesting that the DENN-related proteins FAM116A and
FAM116B are physiological GEFs for the Rab GTPase Rab14.
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Figure 2.9: FAM116 proteins have Rab14 GEF activity Human FAM116A and FAM116B were tested against a representative panel
of human Rab proteins using the GDP-releasing assay. Briefly, 10 µg of each GST-tagged Rab to be tested was incubated
in 50 mM HEPES-NaOH pH 6.8, 0.1 mg/ml BSA, 125 µM EDTA, 10 µM Mg-GDP, and 5 µCi [3H]-GDP (10 mCi/ml; 5000
Ci/mmol) in a total volume of 200 µl for 15 minutes at 30◦C to load the Rab with the radioactive GDP probe. For standard
GDP-releasing GEF assays 100 µl of the loading reaction was then mixed with 10 µl 10 mM Mg-GTP, 10 nM His6-tagged
FAM116A purified from bacteria or a buffer control, and adjusted to 120 µl final volume with assay buffer. The GEF
reaction occurred for 20 minutes at 30◦C. After this, 2.5 µl were taken for a specific activity measurement, the remainder
was split into two tubes, then incubated with 500 µl ice-cold assay buffer containing 1 mM MgCl2, and 20 µl packed
glutathione-sepharose for 60 minutes at 4◦C to separate Rab-GDP complexes from free ‘released’ GDP. After washing
3 times with 500 µl ice-cold assay buffer the sepharose was transferred to a vial containing 4 ml scintillation fluid and
counted. The amount of nucleotide exchange was calculated in pmoles GDP-released (Linford et al., 2012).
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2.8 Rab14 requires FAM116 for the recruitment to recycling
endosomes.
Rab GEFs are thought to play an essential role in the activation of a specific Rab at the
surface of the membrane. If the Rab GEF function is removed or lost it is anticipated
that the localisation of the Rab will be altered. To test this hypothesis with FAM116
and Rab14, HeLa cells were either depleted with the control siRNA GL2 or with the
siRNA duplex FAM116A and transfected with eGFP-Rab14. The HeLa cells were then
imaged every 20 seconds using the live cell imaging system. Imaging was carried out
together with Dr Nunes-Bastos (Figure 2.10, page 64).
In the control cells eGFP-Rab14 was observed as small punctae that were slow
moving and gathering around the periphery of the cell (Figure 2.10, page 64). However,
when the FAM116A depleted cells were imaged, the localisation of the eGFP-Rab14
was altered extremely. Instead of small punctae structures at the periphery of the cell
like seen in the control cells, the eGFP-Rab14 in the depleted cells accumulated in
large ring like structures that were close to the nucleus (Figure 2.10, page 64).
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Figure 2.10: FAM116 is required for the recruitment of Rab14 to recycling endosomes HeLa cells were treated with control or
FAM116A siRNA duplexes for 48 hours, and then transfected with eGFP-Rab14 expression constructs. After a further 24
hours, the cells were imaged every 20 seconds using a spinning disk confocal microscope at 37◦C in 5% CO2. Exposure
times were 10-33 msec at 3% laser power for 488 nm probes. A maximum intensity projection of the eGFP signal in the
entire cell volume is shown (Linford et al., 2012).
64
2 RESULTS
2.9 eGFP-Rab14 cells are transferrin receptor positive when
FAM116A is depleted.
To investigate whether the large ring like structures that are present are transferrin re-
ceptor positive in the HeLa cells, they were depleted with FAM116A siRNA or GL2 as a
control and overexpressed with eGFP-Rab14, fixed with paraformaldehyde (PFA) and
stained with the transferrin receptor antibody. The clusters of enlarged ring like struc-
tures close to nucleus seen in the FAM116A depleted cells were positive for transferrin
receptor (Figure 2.11, page 65); this result is consistent with previous studies that have
reported that microtubule-dependent trafficking to the surface of the cell is promoted
by Rab14 (Ueno et al., 2011). However, when the other members of the Rab11 sub-
family were investigated by the depletion of FAM116A and overexpressed with either
Rab4 or Rab11, the localisation was not altered when compared to the control. These
findings confirm that FAM116 proteins have specific GEF activity towards Rab14 cells
in vitro and that the removal of FAM116A results in the mis-localisation of eGFP-Rab14
in HeLa cells.
Figure 2.11: Transferrin recycles through a Rab14 positive compartment HeLa cells ex-
pressing eGFP-Rab14 were treated with control or FAM116A siRNA duplexes
for 72 hours, fixed, and then stained for the transferrin receptor and DAPI. The
enlarged area shows the overlap between Rab14 and transferrin receptor in
FAM116A depleted cells.
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2.10 Transferrin passes through a FAM116A positive
compartment.
To identify where FAM116 acts within the cell, eGFP-FAM116A was expressed in HeLa
cells and the cells were then stained with various markers for a number of different cel-
lular organelles. The different markers included EEA1, which stains early endosomes,
transferrin receptor staining recycling endosomes, Lysosome Associated Membrane
Protein 1 (LAMP1) staining lysosomes, M6PR staining trans-Golgi and late endosomes
and cis-Golgi Matrix Protein (GM130), which stains the Golgi apparatus.
The expression of FAM116A resulted in FAM116A being localised to fine membrane
tubules on the periphery of the cell that overlapped with the staining of transferrin
receptor, a recycling endosome marker (Figure 2.12, page 67). This indicates that
FAM116 acts on recycling endosomes within the cell. The localisation of FAM116A
did not overlap with any of the markers for early endosomes, late endosomes or the
Golgi apparatus (Figure 2.12, page 67). When Avl9 was expressed in the same way
as FAM116A and stained for identical markers, there was some overlap with transfer-
rin receptor, and there was no overlap with the early endosome marker EEA1 (Figure
2.12, page 67).
Although Avl9 expression overlapped with the staining of transferrin receptor it did not
cause the same tubulation effect that the expression of FAM116A had on the recycling
endosome marker. This result is consistent with the idea that both Avl9 and FAM116A
may act on the same pathway but they specifically act on different GTPases within the
cell.
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Figure 2.12: Transferrin passes through a FAM116 positive compartment HeLa cells expressing eGFP-FAM116A or eGFP-Avl9
were fixed, and then stained with antibodies to transferrin receptor (TfR; recycling endosomes), EEA1, lysosomal acidic
membrane protein 1 (LAMP1; lysosomes), mannose-6-phosphate receptor (M6PR; trans-Golgi and late endosomes),
and the 130 kDa Golgi matrix protein (GM130; Golgi apparatus). Scale bars indicate 10 µm in all panels.
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2.11 Transferrin passes through FAM116A positive compartments
in live cells.
To identify whether FAM116A localises to an endocytic recycling positive compartment,
a transferrin uptake was performed on cells expressing eGFP-FAM116A by incubating
HeLa cells in uptake medium containing transferrin tagged with a red fluorescent dye
on ice for 60 minutes before placing them in warm serum containing medium and im-
mediately imaging using the live cell imaging system (Figure 2.13, page 69 and Movie
4).
The transferrin that was bound to the receptor had a staining that was diffuse with
finely stained punctae that were present on the surface of the cell. After 6 minutes
these small punctate structures quickly merged into larger punctate structures that are
predicted to be early endosomes. These structures can be seen by the red signal in
the figure (Figure 2.13, page 69 and Movie 4).
The expressed FAM116A was localised on a tubular compartment that was dynamic.
There was also staining present throughout the cytoplasm of the cell, which can be
seen by the green signal in the figure (Figure 2.13, page 69 and Movie 4). The trans-
ferrin passed through recycling endosomes from 12-24 minutes and it was between
these time points that both the red and green signals overlapped and turned yellow on
the tubular compartments of FAM116A marked with arrows on the figure (Figure 2.13,
page 69 and Movie 4). The yellow signal was lost after 30 minutes and after 60 minutes
the red transferrin signal was lost when the transferrin as expected was recycled back
to the surface of the cell (Figure 2.13, page 69).
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Figure 2.13: Transferrin passes through a FAM116 positive compartment. HeLa cells expressing eGFP-FAM116A were used for
live cell imaging of transferrin uptake assays at 37◦C in 5% CO2. Exposure times were 10-33 msec at 3% laser power
for 488 nm and 555 nm probes. Maximum intensity projection images of the entire cell volume are shown for the time
points indicated. Arrows mark regions over co-localisation at 15-24 minutes. The scale bar indicates 10 µm in all panels
(Linford et al., 2012).
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2.12 Transferrin passes through Rab14 positive compartments in
live cells.
The transferrin uptake experiment described above was also carried out with expres-
sion of eGFP-Rab14 instead of the Rab GEF FAM116A. This resulted in very similar
overlap with transferrin to that seen with the FAM116A overexpression. The transfer-
rin passed through recycling endosomes from 12-24 minutes and between these time
points the red and green signals overlapped and turned yellow on the large punctate
structures of Rab14 marked with arrows on the figure (Figure 2.14, page 71). The
yellow signal was lost after 30 minutes and after 60 minutes the red transferrin signal
was lost when the transferrin as expected was recycled back to the surface of the cell
(Figure 2.14, page 71). Both of these findings support the understanding that both
Rab14 and FAM116A localise to an endocytic compartment that is part of the transfer-
rin recycling pathway.
2.13 Rab14 and FAM116 function at an intermediate step of the
transferrin recycling pathway.
In order to measure the transport of both epidermal growth factor (EGF) and transferrin
to identify which stage of the endocytic pathway is regulated by Rab14 and FAM116,
uptake assays were carried out. Transferrin tagged with a red fluorescent dye and
EGF that was tagged with a green fluorescent dye were used for this assay. HeLa cells
were depleted of Rab14, FAM116A or GL2 for the negative control for 72 hours and
serum starved for the final 16 hours before being incubated on ice with the EGF and
transferrin in uptake medium for 60 minutes. After the 60 minutes the cells were quickly
washed in ice cold PBS to remove any unbound EGF or transferrin and placed in warm
serum containing medium and incubated at 37◦C for various time points (0, 15, 30, 45,
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Figure 2.14: Transferrin passes through a Rab14 positive compartment Transferrin uptake assays were performed using HeLa
cells transfected with eGFP-Rab14. Tf and eGFP-Rab14 were imaged every minute using a spinning disk confocal
microscope at 37◦C in 5% CO2. Exposure times were 10-33 msec at 3% laser power for 488 nm and 555 nm probes
(Linford et al., 2012).
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60 minutes), before being fixed with PFA. Once the cells were fixed they were then
stained for the recycling endosome marker transferrin receptor. The cells were then
imaged using a fixed cell fluorescent microscope (Figure 2.15, page 73, Figure 2.16,
page 74 and Figure 2.17, page 75).
This uptake assay revealed no effect on the uptake and the transport of EGF in all
the conditions studied, indicating that the trafficking pathway to early endosomes, late
endosomes and to lysosomes is not perturbed when Rab14 or FAM116 is depleted
from the cells (Figure 2.15, page 73, Figure 2.16, page 74 and Figure 2.17, page 75).
However, examination of the transferrin uptake assays and the transferrin receptor
staining in the Rab14 and FAM116A depleted cells revealed a five-fold increase of the
transferrin and transferrin receptor staining at all time points when compared to the
control. The endocytosed transferrin accumulates in large punctate structures in the
Rab14 and FAM116A depleted cells (Figure 2.15, page 73, Figure 2.16, page 74 and
Figure 2.17, page 75), and the recycling of the transferrin was severely delayed in these
cells when compared to the control. This delay was especially noticeable at the time
points 45 and 60 minutes, when most of the endocytosed transferrin in the control cells
had disappeared back to the cell surface.
Due to the signal being so high in the Rab14 and FAM116A depleted cells the images
shown in the figure had to be captured using different exposure times. In the control
cells the exposure time used was 250 msec and in the Rab14 and FAM116A depleted
cells this was reduced 5 fold to 50 msec (Figure 2.15, page 73, Figure 2.16, page 74
and Figure 2.17, page 75).
Using these exposure times the amount of cell-associated EGF and transferrin was
72
2 RESULTS
Figure 2.15: Rab14 and FAM116 act on the transferrin endocytic recycling pathway HeLa
cells were treated with control siRNA duplexes for 72 hours. The cells were then
used for combined transferrin and EGF uptake assays. Samples were fixed at 0,
15, 30, 45, and 60 minutes, and then stained with antibodies to the transferrin
receptor and DAPI. The scale bar indicates 10 µm.
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Figure 2.16: Rab14 and FAM116 act on the transferrin endocytic recycling pathway HeLa
cells were treated with Rab14 siRNA duplex for 72 hours. The cells were then
used for combined transferrin and EGF uptake assays. Samples were fixed at 0,
15, 30, 45, and 60 minutes, and then stained with antibodies to the transferrin
receptor and DAPI. The scale bar indicates 10 µm.
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Figure 2.17: Rab14 and FAM116 act on the transferrin endocytic recycling pathway HeLa
cells were treated with FAM116A siRNA duplex for 72 hours. The cells were then
used for combined transferrin and EGF uptake assays. Samples were fixed at 0,
15, 30, 45, and 60 minutes, and then stained with antibodies to the transferrin
receptor and DAPI. The scale bar indicates 10 µm.
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quantitated using the software ImageJ for the control, Rab14 and FAM116A depleted
cells and was plotted in a bar chart to compare all three conditions (Figure 2.18, page
76).
Figure 2.18: Rab14 and FAM116 act on the transferrin endocytic recycling pathway The
amount of cell-associated EGF and transferrin was measured using ImageJ for
both control and Rab14 depleted cells, and is plotted in the bar charts. Exposure
times were 250 msec for transferrin in the control samples, and 50 msec in the
Rab14 and FAM116A depleted samples. This was not corrected for in the bar
graph. Errors bars indicate the standard deviation (n=5).
To investigate whether the increased signal of transferrin receptor seen in the Rab14
and FAM116 depleted cells was due to increased levels of the receptor or just the
change of localisation, a western blot was performed. HeLa cells were treated with con-
trol, Rab4, Rab11, Rab14 or FAM116A siRNA duplex for 72 hours, then serum starved
for 16 hours to match the identical conditions used in the uptake assays. The cells were
then lysed using SDS-PAGE sample buffer and western blotted as indicated in Figure
2.19 (page 77). The western blot result confirmed that the increased signal seen in the
uptake assay was due to elevated levels of the recycling endosome marker transferrin
receptor and not just the result of altered localisation. A Golgi marker GM130 and a
lysosome marker LAMP1 were also probed but the levels of these organelle markers
were unchanged throughout the different conditions. Tubulin was used to ensure the
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levels of protein loaded for the different samples remained the same so a comparison
could be made (Figure 2.19, page 77).
Figure 2.19: Rab14 and FAM116 act on the transferrin endocytic recycling pathway HeLa
cells were treated with control, Rab4, Rab11, Rab14, and FAM116A siRNA du-
plexes for 72 hours, then serum starved for 16 hours to match the conditions used
for transferrin uptake experiments. The cells were then lysed in SDS-PAGE sam-
ple buffer, 10 µg of protein was loaded and western blotted with antibodies raised
against Transferrin receptor, GM130 and LAMP1. Tubulin was used as a loading
control.
2.14 Transferrin recycles through a Rab14 positive compartment
in live cells.
To confirm that transferrin recycles through a Rab14 compartment in live cells, the
same transferrin uptake was carried out as described above on cells depleted of Rab14
(GL2 was used as a control), but instead of the cells being fixed prior to imaging they
were directly imaged from time point 0 and using the live cell spinning disc microscope
the cells were imaged every minute at 37◦C. This result confirmed the previous finding
that the endocytosed transferrin accumulates in large punctate structures in the Rab14
depleted cells (Figure 2.20, page 78 and Movie 5), and the recycling of the transfer-
rin was severely delayed in the Rab14 depleted cells when compared to the control.
This delay was especially noticeable at the time point 45 minutes, when most of the
endocytosed transferrin in the control cells has disappeared.
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Figure 2.20: Transferrin recycles through a Rab14 positive compartment Transferrin uptake assays were performed using HeLa
cells treated with control or Rab14 siRNA duplexes for 72 hours. Tf was imaged every minute using a spinning disk
confocal microscope at 37◦C in 5% CO2. Exposure times were 10-33 msec at 3% laser power for 555 nm probes. Scale
bars indicate 10 µm in all panels.
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2.15 Rab4, Rab5, Rab11 and Rab14 all define membrane domains
within the endocytic-recycling pathway.
Rab5, Rab4 and Rab11 have all been shown in previous studies to define separate
membrane domains within the endocytic recycling pathway (Sonnichsen et al., 2000).
The results in this study confirm that Rab14 also defines a distinct membrane do-
main within this pathway, so to place the various Rabs in the order that they control
the endocytic recycling pathway, an experiment to measure the co-localisation of the
eGFP-tagged Rab and transferrin was carried out together with Dr Nunes-Bastos.
HeLa cells expressing eGFP-Rab5, Rab4, Rab11 or Rab14 were incubated with the
tagged transferrin as described above and the transferrin uptake was imaged using the
spinning disc confocal microscope (Figure 2.21, page 80). The co-localisation of both
the Rab and the transferrin were calculated using Volocity 5 (n=5). The Pearson cor-
relation coefficients were plotted against time and the error bars on the graph indicate
standard error of the mean (Figure 2.22, page 81).
As predicted, Rab5 defined the earliest stages of the recycling pathway followed
then by Rab4 that was found to localise with the transferrin at both early and late
stages (Figure 2.21, page 80 and Figure 2.22, page 81). Rab14 showed maximum
co-localisation with transferrin at intermediate time points from 20-30 minutes (Figure
2.21, page 80 and Figure 2.22, page 81). This is consistent with the co-localisation
found when FAM116A and endocytosed transferrin overlapped (Figure 2.13, page 69
and Movie 4). Rab11 then defined the later compartments of the pathway as previously
shown (Sonnichsen et al., 2000).
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Figure 2.21: Rab14 defines an intermediate recycling compartment HeLa cells expressing eGFP-Rab GTPases as indicated were
used for live cell imaging of transferrin uptake assays at 37◦C in 5% CO2. Exposure times were 10-33 msec at 3% laser
power for 488 nm and 555 nm probes. Maximum intensity projection images of the entire cell volume are shown for the
time points indicated. Arrows mark regions over co-localisation. The scale bar indicates 10 µm in all panels (Linford
et al., 2012).
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Figure 2.22: Rab14 defines an intermediate recycling compartment Co-localisation of the eGFP-Rab GTPases and transferrin
were calculated using Volocity 5 (n=5). Pearson correlation coefficients are plotted against time, and error bars indicate
the standard error of the mean (Linford et al., 2012).
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2.16 Rab4, Rab11 and Rab14 define different compartments within
the endocytic recycling pathway.
To make a direct comparison of the localisation of the Rabs, to identify if all of them de-
fine a compartment within the endocytic recycling pathway, HeLa cells co-expressing
eGFP-Rab14 and either mCherry-Rab4 or Rab11 were fixed and stained with antibod-
ies to transferrin receptor (Figure 2.23, page 82). This result confirmed the previous
finding that Rab14 defines an intermediate stage in the endocytic recycling pathway
which follows Rab5 and Rab4 but that is prior to Rab11. These recent findings im-
ply that a deficiency in the endocytic recycling pathway reinforces the migration defect
caused by the depletion of Rab14 and FAM116A in A549 cells.
Figure 2.23: Rab14 defines an intermediate recycling compartment. HeLa cells co-
expressing eGFP-Rab14 and either mCherry-Rab4 or Rab11 were fixed and
stained with antibodies to transferrin receptor. The scale bar indicates 10 µm
in all panels (Linford et al., 2012).
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2.17 Polarisation of cells depleted of Rab14 and FAM116A cells
remains normal.
The data presented so far show that Rab14 defines an intermediate compartment on
the endocytic recycling pathway, with Rab4 defining an early stage and Rab11 defin-
ing a late stage of the pathway. Many studies have shown that both Rab4 and Rab11
are involved in trafficking of integrins that are needed for polarisation of the cell during
cell migration in vitro and in vivo. However, no studies have confirmed that Rab14 is
involved of the trafficking of either of these cargo molecules.
Polarisation of the cell is mediated by efficient integrin trafficking (Caswell and Nor-
man, 2006). Therefore, to analyse whether Rab14 and FAM116A are required for
integrin trafficking and therefore polarisation, A549 cells were depleted of Rab14 or
FAM116A for 72 hours and a scratch wound assay was carried out on a monolayer
of cells. The cells were then fixed at various time points (0, 4, 8 and 16 hours) and
stained with a Golgi marker GM130 and a centriolar marker pericentrin (Figure 2.24,
page 84). When cells are polarised the Golgi and the centrosome are located within
the front segment of the cell.
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Figure 2.24: Analysis of Golgi and centrosome polarisation in Rab14 and FAM116 de-
pleted cells. A549 cells treated with control, Rab14, or FAM116A siRNA for 72
hours were scratch wounded and then left for 0, 4, 8, and 16 hours as indicated.
The cells were fixed, and then stained with antibodies to the Golgi marker GM130,
and the centriolar marker pericentrin. DNA was stained with DAPI. The scale bar
is 10 µm. Cell polarisation towards the wound was assessed by drawing a cir-
cle centred over the nucleus, with a 120◦ segment facing the wound. Cells were
polarised towards the wound, if the Golgi and centrosome were located in this
segment. Images are oriented so the wound is to the right.
Rab14 and FAM116A depleted cells had normal polarisation of the centrosome and
Golgi apparatus when compared to the control suggesting that these cells do not fail
to polarise and eliminating this as the cause for the migration defect. Golgi and cen-
trosome polarisation was measured in 100 cells for control, Rab14 and FAM116A de-
pleted cells (Figure 2.25, page 85). This confirmed that there was no real difference in
the Rab14 and FAM116A depleted cells when compared to the control.
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Figure 2.25: Analysis of Golgi and centrosome polarisation in Rab14 and FAM116 de-
pleted cells. Cell polarisation at 0 and 4 hours is plotted in the bar graph. Bars
indicate the standard error from the mean (n=3).
2.18 N-Cadherin accumulates at cell-cell junctions in Rab14 and
FAM116A depleted A549 cells.
Due to Rab14 and FAM116A depleted cells not having a defect in polarisation, staining
and western blot analysis of various markers known to be involved in cell migration
were analysed. A549 cells were treated with control, Rab4, Rab11, Rab14 or FAM116A
siRNA duplexes for 72 hours. The cells were lysed in SDS-PAGE sample buffer and
then western blotted and probed for a number of antibodies indicated in Figure 2.26
(page 86). The levels of β-catenin, E-cadherin, vimentin and actin all remained similar
in the depleted cells when compared to the control suggesting that the cells are not un-
dergoing a transition from epithelial to a mesenchymal state or vice versa. The levels
of the integrin β1, the Golgi marker GM130 and the lysosomal marker LAMP1 were all
similar in every condition tested (Figure 2.26, page 86). The western blot did however
reveal that the level of N-Cadherin was increased in the cells depleted of Rab14 and
FAM116A. Due to this increase the localisation of N-Cadherin was therefore investi-
gated.
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Figure 2.26: Abnormal adherens junctions in Rab14 and FAM116 depleted cells A549
cells were treated with control, Rab4, Rab11, Rab14, FAM116A, and Avl9 siRNA
duplexes for 72 hours. The cells were lysed in SDS-PAGE sample buffer and
10 µg of protein was loaded onto a gel. Lysates were Western blotted with anti-
bodies against N-Cadherin, β-Catenin, E-Cadherin, β1-Integrin, GM130, LAMP1,
Vimentin and actin. Tubulin was used as a loading control.
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To look at the localisation of N-Cadherin in A549 cells, the cells were treated with
siRNA against GL2, Rab14 or FAM116A for 72 hours, fixed with PFA and stained with
an N-Cadherin antibody. In the control cells the levels of N-Cadherin were low but
the cell-cell adherens junctions were stained very clearly when longer exposures were
taken. However in the Rab14 and FAM116A depleted cells the levels of N-Cadherin
were considerably increased when compared to the control and the cell-cell junctions
were very clearly defined but were much thicker and more fibrous looking than the
junctions seen in the control cells (Figure 2.27, page 87). Due to the increase in levels
a much lower exposure time was used for microscopy of the Rab14 and FAM116A de-
pleted cells and a higher exposure for the control cells.
Figure 2.27: Abnormal adherens junctions in Rab14 and FAM116 depleted cells A549
cells were treated with control, Rab14, and FAM116A siRNA duplexes for 72
hours, fixed, and then stained with DAPI and antibodies to N-Cadherin. Low ex-
posure equals 50 msec and high exposure equals 250 msec.
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The increased level of N-Cadherin seen in the Rab14 and FAM116A depleted cells
suggest that the migration defect seen in these cells could be due to defective regula-
tion of the cell-cell adherens junctions in A549 cells. To explore this idea, A549 cells
were depleted of Rab4, Rab11, Rab14, FAM116A or Avl9 and GL2 siRNA was used as
a control. The scratch wound assay described earlier was performed. The cells were
fixed at 0, 4, 8 and 16 hours and then stained with an N-Cadherin antibody (Figure
2.28, page 89).
The results from this assay showed that at 0 hours the cell-cell adherens junctions
in the control, Rab4, Rab11 and Avl9 depleted cells were defined but this staining was
lost as the cells started to migrate at time point 4-8 hours and at 16 hours the signal
had disappeared. However, in the cells depleted of Rab14 and FAM116A the level of
N-Cadherin at the cell-cell junctions was severely increased at 0 hours and this defined
staining was retained over time. At 16 hours the staining in the Rab14 and FAM116A
depleted cells was still the same level of that seen at 0 hours and the cells fail to
separate from the edge of the sheet, and are not able to break down the N-Cadherin
cell-cell junctions and therefore are not able to migrate over the 16 hours of the assay
(Figure 2.28, page 89).
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Figure 2.28: Abnormal adherens junctions in Rab14 and FAM116 depleted cells A549
cells were treated with control, Rab4, Rab11, Rab14, FAM116A, and Avl9 siRNA
duplexes for 72 hours. The cell monolayers were then scratched, samples fixed at
0, 4, 8, and 16 hours, and then stained with DAPI and antibodies to N-Cadherin.
Images are oriented so the wound is to the right. Scale bar indicates 10 µm in all
images.
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2.19 Rab14 and FAM116A depleted cells have a migration defect
that is rescued by N-Cadherin silencing.
The previous result suggests that cell-cell adherens junctions cannot be remodelled
in the absence of the Rab14 and FAM116A recycling pathway and therefore the cells
cannot move from the wound edge of a monolayer, which results in no or severely re-
duced cell migration.
To analyse whether the cell-cell remodelling defect is N-Cadherin specific, A549 cells
were depleted with Rab14 or FAM116A and N-Cadherin, E-cadherin or FGFR2 siRNA
duplexes. FGFR2 was used in this case, as previous studies have linked FGFR2 to
N-Cadherin function in some migration events (Cavallaro and Dejana, 2011). The
cells were fixed with PFA and stained with N-Cadherin to see whether the level of
N-Cadherin in the depleted cells is rescued (Figure 2.29, page 91).
This result confirms that the level of N-Cadherin can be reduced in the Rab14 and
FAM116A depleted cells (Figure 2.29, page 91). N-Cadherin levels are unaltered in
E-Cadherin or FGFR2 double-depleted cells. Due to the western blot data and im-
munofluorescent (IF) images confirming that the double siRNA is efficient in all cases
it was then important to establish whether N-Cadherin depletion rescues the migration
defect seen in the cells depleted of Rab14 and FAM116A. Therefore a scratch wound
assay was carried out.
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Figure 2.29: N-Cadherin depletion rescues the migration defect in Rab14 and FAM116 de-
pleted cells. A549 cells were treated with control, Rab14, FAM116A, N-Cadherin,
E-cadherin, and FGFR2 siRNA duplexes alone or in the combinations indicated
for 72 hours. Fixed, and then stained with DAPI and antibodies to N-Cadherin.
Scale bar indicates 10 µm.
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A western blot was performed to ensure that the double siRNA silencing was effi-
cient. A549 cells were depleted with Rab14 or FAM116A and N-Cadherin, E-cadherin
or FGFR2 siRNA for 72 hours and lysed with SDS-PAGE sample buffer and then west-
ern blotted and probed with the antibodies stated in Figure 2.30 (page 92). The western
blot result showed that the silencing of both genes is efficient in all the combinations
tested and the levels of β-catenin remained unchanged in all conditions. Tubulin was
used as a loading control to ensure the same level of protein was loaded in all samples.
Figure 2.30: N-Cadherin depletion rescues the migration defect in Rab14 and FAM116 de-
pleted cells. A549 cells were treated with control, Rab14, FAM116A, N-Cadherin,
E-cadherin, and FGFR2 siRNA duplexes alone or in the combinations indicated
for 72 hours. The cells were lysed, and 10 µg of lysate were then Western blotted
for N-Cadherin, E-cadherin, β-catenin or tubulin as a loading control.
A549 cells were depleted of Rab14, FAM116A, N-Cadherin, E-cadherin or FGFR2
alone or in a combination for 72 hours, the monolayer of cells was then scratched with a
tip and imaged on the live cell microscope for 16 hours. The distance the cells migrated
was plotted on a bar graph with the error bars indicating the standard error of the mean
(Figure 2.31, page 93).
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Figure 2.31: N-Cadherin depletion rescues the migration defect in Rab14 and FAM116 de-
pleted cells. A549 cells were treated with control, Rab14, FAM116A, N-Cadherin,
E-cadherin, and FGFR2 siRNA duplexes alone or in the combinations indicated
for 72 hours. The cell monolayers were then scratched and imaged for 16 hours.
Cell migration was measured and is plotted on the graph with error bars to show
the standard error of the mean.
The results from the scratch wound assay revealed that the N-Cadherin depletion
did rescue the migration defect when depleted with Rab14 or FAM116A (Figure 2.32,
page 94). However, if the cells were depleted of Rab14 or FAM116A and E-cadherin
or FGFR2 the migration defect was not rescued and the distance the cells migrated
was very similar to that of just the single depletion of Rab14 or FAM116A (Figure 2.32,
page 94), indicating that E-cadherin or FGFR2 have no obvious effect on cell migration
in A549 cells. This result also confirms that the migration defect seen with depletion of
Rab14 or FAM116A is N-Cadherin specific and suggests that the N-Cadherin cell-cell
junctions cannot be remodelled in the absence of the Rab14 or FAM116A endocytic
recycling pathway.
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Figure 2.32: N-Cadherin depletion rescues the migration defect in Rab14 and FAM116
depleted cells. Images are shown from the 0 and 16 hours time points for the
Rab14 and FAM116A depleted cells in the presence and absence of N-Cadherin
siRNA. Scale bar indicates 50 µm.
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2.20 Calcium chelation rescues migration defects in Rab14 and
FAM116A depleted cells.
In order to identify whether alterations in cadherin junctions cause the cell migration
defect, a simple method using a calcium-chelating agent was used to disrupt these
junctions. The chelating agent EDTA was titrated using the scratch wound assay to
enable a low enough concentration for the cells to remain adhered to the dish and to
allow normal migration but a high enough concentration to disrupt the junctions effi-
ciently (Figure 2.33, page 95).
Figure 2.33: Calcium chelation rescues the migration defect of Rab14 and FAM116 de-
pleted cells. EDTA was added to confluent monolayers of A549 cells to a final
concentration of 25, 50, 100, 200, 300, 400, 500, 600 µM, or 1, 1.25, 2.5, 5 mM.
The cells were then scratched to create a wound, left for 30 minutes to recover,
and then imaged for 16 hours. Cell migration was measured and is plotted on the
graph as a function of EDTA concentration. At 2.5 and 5 mM EDTA cell numbers
were reduced due to adhesion defects. Error bars show the standard error of the
mean.
From analysing the titration of the EDTA a 1mM concentration of EDTA was then
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used to carry out a wound heal assay. A549 cells were depleted of Rab4, Rab11,
Rab14 or FAM116A (GL2 was used as a control) for 72 hours before a final concentra-
tion of 1mM EDTA was added to the medium. The cells were then scratched using a
P200 tip and placed on the live cell imaging microscope for 16 hours and images were
taken every 5 min (Figure 2.34, page 97 and Movie 6).
The addition of 1mM EDTA to the cells depleted of Rab14 or FAM116A suppressed
the cell migration defect confirming that it is due to the cells not being able to remodel
the junctions effectively. However, the cell migration defect seen with the cells depleted
with Rab4, Rab11 or Avl9 were not altered at all by the calcium chelation (Figure 2.34,
page 97).
The distance the cells migrated once depleted for 72 hours and with the addition of
1mM EDTA was measured and the distances were plotted on a bar graph. This ex-
periment was repeated three times with the error bars indicating the standard error of
the mean. The results are made clear from the graph revealing that without calcium
chelation the Rab14 and FAM116A depleted cells have a severe migration defect and
yet with the addition of 1mM EDTA in the medium the adherens junctions are chelated
and the migration defect was rescued quite dramatically. However even with the addi-
tion of the EDTA into the medium, cells depleted of Rab4, Rab11 or Avl9 did not rescue
the migration defect (Figure 2.35, page 98), suggesting that the migration defect these
cells have is not related to the remodelling of adherens junctions.
To check whether the levels of N-Cadherin were altered during cell migration with
the addition of 1mM EDTA, A549 cells were depleted of Rab14 or FAM116A (GL2 was
used as a control) for 72 hours, then 1mM EDTA was added to the medium prior to
a scratch being formed in the monolayer. The cells were then fixed with PFA at the
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Figure 2.34: Calcium chelation rescues the migration defect of Rab14 and FAM116 de-
pleted cells. EDTA was added to a confluent monolayer of A549 cells to a final
concentration of 1 mM. The cells were then scratched to create a wound, left for
30 min to recover, then imaged for 16 hours. Images are shown from the 0 and 16
hours time points for the Rab14 and FAM116 depleted cells. Scale bar indicates
50 µm.
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Figure 2.35: Calcium chelation rescues the migration defect of Rab14 and FAM116 de-
pleted cells. A549 cells were treated with control, Rab4, Rab11, Rab14,
FAM116A and Avl9 siRNA duplexes for 72 hr. The cell monolayers were then
scratched and imaged for 16 hr. Cell migration was measured in the presence or
absence of 1mM EDTA and is plotted on the graph with error bars to show the
standard error of the mean (n = 3).
time points 0, 4, 8 and 16 hours, then stained with an N-Cadherin antibody. In the
control cells the levels of N-Cadherin decreased at the edge of the wound as the cells
migrate and this was seen in the presence or absence of the EDTA. However, in the
Rab14 and FAM116A depleted cells the N-Cadherin levels remain high throughout the
16 hours and the levels on the edge of the wound did not decrease and the wound
remained unhealed. The levels of N-Cadherin in the presence of EDTA in the Rab14
and FAM116A depleted cells decreased at the wound edge like that seen in the control
cells and the cells then migrated into the wound over the 16 hours (Figure 2.36, page
99). Together, the results from the live cell and fixed cell experiments showed that
the increased levels of N-Cadherin at the cell surface and increased cell-cell junction
formation seen in Rab14 and FAM116A depleted cells are the primary cause of the
migration defect and this can be rescued by calcium chelation using 1mM EDTA.
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Figure 2.36: Reduced cell surface N-Cadherin in Rab14 and FAM116 depleted cells fol-
lowing calcium chelation. EDTA was added to a confluent monolayer of A549
cells and they were treated with control, Rab14, or FAM116A siRNA duplexes for
72 hours. The cell monolayers were scratched, samples fixed at 0, 4, 8, and 16
hours, and then stained with DAPI and antibodies to N-Cadherin. Images are ori-
ented so the wound is to the right. Images from the 0 and 16 hour time points are
shown. Scale bar indicates 10 µm in all images.
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2.21 ADAM9 and ADAM10 are responsible for N-Cadherin
shedding, which Rab14 and FAM116A regulate.
To understand what is controlling the levels of N-Cadherin at the cell surface in A549
cells a number of proteases were screened. A family of transmembrane proteases of
the disintegrin and metalloprotease domain (ADAM) family regulate the levels of many
cell-surface proteins including cadherins. ADAMs are known to cleave the extracellu-
lar domain of the target and this releases it from the membrane; this process is often
called shedding. The increased levels of N-Cadherin seen with Rab14 and FAM116A
depleted cells could therefore be due to a defect of the shedding at the cell surface and
this defect could be related to ADAM family proteases.
To analyse this idea, A549 cells were depleted of Rab4, Rab11, Rab14, FAM116A
and Avl9 for 72 hours and serum starved for 16 hours. The medium was then TCA
precipitated and the cells lysed using SDS-PAGE sample buffer. The medium and the
lysate were then loaded on a gel, western blotted and probed for N-Cadherin (Figure
2.37, page 101). This result showed that the cells depleted of Rab14 and FAM116A
had reduced shedding of N-Cadherin into the medium, which results in increased levels
of N-Cadherin in the lysate. The levels seen in the cells depleted of Rab4, Rab11 and
Avl9 were unaltered when compared to the control. This same method was also used
to screen a library of catalytically active ADAM proteases, in order to identify if any of
the family members are responsible for the shedding of N-Cadherin (Figure 2.37, page
101).
This result showed that the level of N-Cadherin was reduced in the cells depleted
of Rab14, FAM116A, ADAM9 and ADAM10 in the medium and the lysate showed in-
creased levels, indicating that the shedding of N-Cadherin is reduced in these depleted
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Figure 2.37: Rab14 and FAM116 regulate the localisation of ADAM10 and shedding of
N-Cadherin A549 cells were treated with Rab, Rab GEF, and ADAM protease
specific siRNA duplexes as indicated for 72 hours. After 72 hours the cells were
washed in three times in serum free medium, and left in serum-free medium for
24 hours. Proteins in the medium were then recovered by TCA precipitation, and
equivalent aliquots of the cell lysate and medium Western blotted for N-Cadherin,
or tubulin as a loading control.
samples. The cells depleted of all other Rabs, Rab GEFs and ADAMs showed similar
levels of that seen in the control samples suggesting that they do not have a role in
the shedding of N-Cadherin at the cell surface (Figure 2.37, page 101 and Figure 2.38,
page 102).
To quantitate this result and make it clear as to what members of the ADAM family
had a role in the shedding of N-Cadherin, the western blot experiment was repeated
twice and from these two experiments the level of N-Cadherin shed into the medium
was calculated using ImageJ software; a tubulin blot was used as a loading control. The
calculations were then plotted in a bar graph and from the bar graph it is very clear that
only cells depleted of Rab14, FAM116A, ADAM9 and ADAM10 show reduced levels
of N-Cadherin shedding and increased levels of N-Cadherin at the cell surface (Figure
2.37, page 101 and Figure 2.38, page 102).
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Figure 2.38: Rab14 and FAM116 regulate the localisation of ADAM10 and shedding of
N-Cadherin A549 cells were treated with Rab, Rab GEF, and ADAM protease
specific siRNA duplexes as indicated for 72 hours. After 72 hours the cells were
washed in three times in serum free medium, and left in serum-free medium for
24 hours. Proteins in the medium were then recovered by TCA precipitation, and
equivalent aliquots of the cell lysate and medium Western blotted for N-Cadherin,
or tubulin as a loading control. The amount of shed N-Cadherin was calculated
for two independent experiments and is plotted in the bar graph.
To identify if the same ADAM family members are involved in cell migration a scratch
wound assay as described above was carried out. A549 cells were depleted of Rab14,
ADAM8, ADAM9 and ADAM10 for 72 hours, then the monolayer of cells was scratched
with a P200 tip and the cells were fixed with PFA at time points 0, 4, 8 and 16 hours and
stained with N-Cadherin (Figure 2.39, page 103). The levels of N-Cadherin remained
high at the cell-cell junctions throughout the 16 hours in the cells depleted of Rab14 as
expected and therefore the cells did not migrate. This was also the case for the cells
depleted of ADAM9 and ADAM10. The N-Cadherin levels at cell-cell junctions were
much higher than that seen in the control at timepoint 0 and this signal remained high
at the wound edge and the cells showed the same defect in migration as that seen with
Rab14 and FAM116A. The cells depleted of ADAM8 had similar levels of N-Cadherin
to that seen in the control and migrated normally over the 16 hours (Figure 2.39, page
103).
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Figure 2.39: Rab14 and FAM116 regulate the localisation of ADAM10 and shedding of
N-Cadherin A549 cells were treated with control, Rab14, ADAM8, ADAM9, and
ADAM10 siRNA duplexes for 72 hours. The cell monolayers were then scratched,
samples fixed at 0, 4, 8, and 16 hours, and then stained with DAPI and antibod-
ies to N-Cadherin. Images are oriented so the wound is to the right. Scale bar
indicates 10 µm in all images. The distance migrated is shown with a standard
deviation (n=3).
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The data from the western blot and the migration assay suggests that the increased
levels of N-Cadherin seen in the Rab14, FAM116A, ADAM9 and ADAM10 depleted
cells are due to altered trafficking of ADAM9 and ADAM10 to the surface of the cell,
which could explain the defect in migration and the increased levels of N-Cadherin seen
in Rab14 and FAM116A depleted A549 cells.
To test this hypothesis the localisation of ADAM10 was imaged in HeLa cells depleted
with Rab14 and FAM116A siRNA for 72 hours and serum starved for 16 hours. The
cells were then incubated on ice with transferrin tagged with red fluorescence for 60
min and placed in warm serum containing medium. The cells were then fixed at time
point 30 minutes and stained with an antibody for ADAM10 (Figure 2.40, page 104).
ADAM9 could not be tested any further, since no suitable antibody was available.
Figure 2.40: Rab14 and FAM116 regulate the localisation of ADAM10 and shedding of N-
Cadherin Cells treated as above were used for transferrin uptake assays, then
after 30 minutes fixed and stained with ADAM10 antibodies.
104
2 RESULTS
The results from this assay showed that the localisation of ADAM10 was very similar
to that seen for the transferrin after 30 minutes incubation in warm serum containing
medium. The control cells showed localisation as small punctate structures on the pe-
riphery of the cell; however the localisation of ADAM10 in the Rab14 and FAM116A
depleted cells was drastically altered to large punctate structures inside the cell like
that seen with transferrin.
These results suggest that ADAM10 is recycled through the cell via a Rab14 and
FAM116A compartment in the endocytic recycling pathway and without Rab14 and its
GEF FAM116A, ADAM10 cannot recycle back to the cell surface and therefore accu-
mulates in recycling endosomes within the cell.
To confirm this hypothesis the localisation of ADAM10 was compared on the cell
surface and internally by the use of an ADAM10 antibody. HeLa cells were depleted
with Rab14 or FAM116A siRNA for 72 hours and then fixed with PFA and stained with
the ADAM10 antibody and a fluorescent secondary antibody labelled with 488 (green
channel). The cells were then permeabilised and stained again with the same ADAM10
antibody and a secondary antibody labelled with 555 (red channel) (see schematic)
(Figure 2.41, page 106).
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Figure 2.41: Rab14 and FAM116 regulate ADAM10 localisation and N-Cadherin shedding
HeLA cells were treated with control, Rab14, FAM116 siRNA duplexes for 72
hours. The cells were then fixed and stained with ADAM specific antibodies per-
meabilised and stained again with the same ADAM antibody.
This result revealed that in the control cells the ADAM10 staining was mostly on
the cell surface and very little staining was found inside the cell. However, the cells
depleted of Rab14 or FAM116A have no or very little staining on the cell surface and
high levels of ADAM10 staining inside the cell on enlarged punctate structures. To
quantitate these results, 200 cells from each condition were counted and the number
of cells stained with ADAM10 on the cell surface was plotted on a bar graph (Figure
2.42, page 107). This experiment was repeated three times and the error bars indicate
the standard error of the mean. This quantitation confirms that the intensity of ADAM10
cell surface staining is reduced in the Rab14 and FAM116A depleted cells compared
to the control (Figure 2.42, page 107).
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Figure 2.42: Rab14 and FAM116 regulate ADAM10 localisation and N-Cadherin shedding
HeLa cells were treated with control, Rab14, FAM116 siRNA duplexes for 72
hours. The cells were then fixed and stained with ADAM specific antibodies per-
meabilised and stained again with the same ADAM antibody. Cell surface levels of
ADAM was measured and plotted on the graph with error bars indicating standard
error of the mean (n=3).
Together these results confirm that Rab14 and its GEF FAM116A are novel com-
ponents of the endocytic-recycling pathway. The results also reveal that Rab14 and
FAM116A define a trafficking pathway that is essential for the regulation of N-Cadherin
by ADAM proteases (ADAM9 and ADAM10) and in turn for the control of cell-cell junc-
tions.
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3 Discussion
3.1 Rab14 and its GEF FAM116 are required for cell migration in
vitro.
To identify the trafficking pathways required for cell migration in vitro a simple, repro-
ducible and effective scratch wound assay was developed. Screening an siRNA library
targeting the known Rab GTPases identified that Rab4, Rab11 and Rab14 depleted
cells showed a severe migration defect when compared to the control cells over 16
hours of imaging. The most acute migration defect was seen after loss of Rab14,
where the wound remained open throughout the 16-hour experiment and the cells just
remained as a monolayer sheet and only spread into the wound marginally. In previ-
ous studies cell migration defects have been linked to the cells having a polarisation
defect of the Golgi and the cytoskeleton. However, when the polarisation was tested
in the Rab14 depleted cells the Golgi and the cytoskeleton appeared normal and was
directed towards the migrating end of the cell thus eliminating polarisation as being a
factor in these cells.
Rab4 and Rab11 depleted cells were also identified in the screen to show a migra-
tion defect and previous studies have proven that Rab4, Rab11 and Rab25 have roles
associated with the endocytic recycling pathway (Ullrich et al., 1996; Yamamoto et al.,
2010). The cells depleted of Rab4 or Rab11 migrated very slowly into the wound cre-
ated, and over the 16 hours this wound was only healed very slightly when compared
to the control. The migration defect seen in this screen is also consistent with the pre-
vious studies suggesting that Rab4 and Rab11 are required in migration and for the
trafficking of various cargo molecules involving integrins and E-Cadherin.
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Rab5 is proven to be essential to block endocytosis of different cargo molecules such
as the EGF receptor (Fuchs et al., 2007) and so it was expected that Rab5 depleted
cells would have created a more severe migration defect in the scratch wound assay.
However, this was not the case. The reason for this result could have been due to the
siRNA procedure as the three Rab5 isoforms had to be simultaneously depleted, which
reduces the efficiency for each individual isoform. Therefore, the efficiency could have
been too low to create a severe migration defect.
The same scratch wound assay was carried out on the DENN and DENN-related
proteins to find a candidate Rab GEF for the Rab11 subfamily GTPases Rab4, Rab11
and Rab14. The most severe migration defect seen within this group was with the
DENN-related proteins FAM116A, FAM116B and Avl9. The migration pattern of the
cells depleted of FAM116A was very similar to that seen in the Rab14 depleted cells so
a comparison was made of the distance migrated over time. This result indicated that
FAM116A and Rab14 did follow the same pattern of migration. This result along with
a GEF assay confirmed that the DENN-related Rab GEFs FAM116A and FAM116B
function during cell migration by regulating the GTPase Rab14.
3.2 N-Cadherin shedding is regulated by ADAM9 and ADAM10.
The results presented in this study confirm that Rab14, which is a member of the
Rab11-related GTPase and its GEF FAM116A and FAM116B play an essential part
in the cell migration of A549 cells by regulating the levels of N-Cadherin on the cell
surface. This result was confirmed by western blotting that showed the levels of N-
Cadherin in the cell were increased in cells depleted of Rab14 or FAM116A and im-
munofluorescence analysis also showed that the levels of N-Cadherin were increased
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at the cell-cell junctions suggesting that these cells are unable to remodel the cell-cell
adherens junctions and these junctions link the cells together at the wound edge and
without being able to remodel these junctions, the cells are unable to migrate.
To confirm that the defect of regulating the N-Cadherin levels at the cell surface in
Rab14 and FAM116A depleted cells was specific, the adherens junctions were dis-
rupted in two separate ways: by silencing the specific cadherins using a Dharmacon
siRNA on-target plus siRNA or by disrupting the junctions using EDTA.
Since it is well known that cell-cell junctions require the presence of extracellular cal-
cium, a simple way to disrupt the junctions is calcium chelation. In order to disrupt the
junctions a calcium-chelating agent EDTA was used. Adding 1mM final concentration
of EDTA to the cells created the chelation of cell-cell adherens junctions. This addi-
tion actually rescued the migration phenotype seen after loss of Rab14 and FAM116A
confirming that the defect in migration is due to the cells being unable to reform the cell-
cell junctions. This result was specific to Rab14 and FAM116A as the cells depleted
of Rab4, Rab11 and Avl9 still could not migrate in the presence of calcium chelation,
suggesting that the migration defect in these depleted cells is not linked to reformation
of cell-cell junctions that are calcium dependent.
To establish whether the failure of remodelling the junctions in A549 cells was cad-
herin specific the cells were depleted of Rab14 or FAM116A along with N-Cadherin, E-
Cadherin or FGFR2. FGFR2 was used as it has been previously linked to N-Cadherin
function in cell migration (Cavallaro et al., 2001; Suyama et al., 2002; Cavallaro and
Dejana, 2011), and so was targeted along with N- and E-Cadherin.
A549 cells depleted of Rab14 or FAM116A resulted in the level of N-Cadherin being
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dramatically increased at the cell-cell junction when compared to control cells. How-
ever the levels of E-Cadherin and FGFR2 did not change. The increased levels of
N-Cadherin identified in the Rab14 and FAM116A depleted cells was rescued when N-
Cadherin was also depleted from the cells using a double siRNA. However, when the
cells were depleted of Rab14 or FAM116A and E-Cadherin or FGFR2, the N-Cadherin
levels remained high and the migration defect continued. This data confirms that the
cells depleted of Rab14 and FAM116A could not reform N-Cadherin specific cell-cell
junctions and without reforming these junctions the cells cannot migrate. The levels of
E-Cadherin, β-catenin, vimentin and actin were unaltered in the Rab14 and FAM116A
depleted cells when compared to the control suggesting that these cells are not expe-
riencing an epithelial to mesenchymal change or vice versa.
N-Cadherin has been shown to directly interact with FGFR and to be involved in
signalling events that are essential during some cell migration and metastasis events
(Cavallaro et al., 2001; Williams et al., 2001; Suyama et al., 2002; Hulit et al., 2007;
Cavallaro and Dejana, 2011). Interestingly, during early embryonic development Rab14
has been shown to be involved in the trafficking of FGFR2 (Ueno et al., 2011). How-
ever, using the conditions in this study FGFR2 did not appear to be involved in the
migration of A549 cells and did not seem to explain the defect seen in the Rab14 and
FAM116A depleted cells suggesting that FGFR2 does not partake in the role of regu-
lating N-Cadherin in A549 cells in culture. However, this does not rule out a role in vivo
during development when extracellular signalling processes are likely to be crucial for
controlling cell migration events and cell-cell function formation.
A Disintegrin And Metalloproteinase (ADAM) family of transmembrane proteases are
known to regulate the levels of many cell surface proteins including the Cadherin fam-
ily. ADAMs release the extracellular domain of proteins from their target by cleaving
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the domain; this is often called shedding (Reiss et al., 2005). The increased levels that
are identified in A549 cells depleted of Rab14 and FAM116A in this study showed a
decreased level of shedding occurring on the cell surface that was due to altered recy-
cling of some of the ADAM family proteases.
The increased levels of N-Cadherin on the cell surface seen after loss of Rab14 and
FAM116A are confirmed in this study to be a result of altered recycling of two ADAM
family transmembrane proteases (Figure 3.1, page 113). Two members of the ADAM
family were found to be specific to N-Cadherin levels on the cell surface in A549 cells,
and these two members are ADAM9 and ADAM10. When ADAM9 and ADAM10 were
depleted from the cells the level of N-Cadherin was increased on the cell surface with
the cell-cell junctions being thick and fibrous like that seen in Rab14 and FAM116A
depleted cells.
When the ADAM family members were depleted and tested for migration using the
scratch wound assay it was also ADAM9 and ADAM10 that showed the most severe mi-
gration defect, very similar to that seen in Rab14 and FAM116A depleted cells. ADAM8
was used as a control for this family and the cells depleted of ADAM8 had normal levels
of N-Cadherin at the cell surface and normal migration when compared to the control
cells.
ADAM10 has been shown to directly control the cleavage of cadherins and in par-
ticular N-Cadherin and E-cadherin and thereby ADAM10 controls the levels of these
cadherins on the cell surface (Maretzky et al., 2005; Reiss et al., 2005). This process
has been proven to be critical in the regulation of cell adhesion, cell migration and cell
signalling (Maretzky et al., 2005) (Figure 3.1, page 113).
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Figure 3.1: ADAM10 is recycled via the endocytic recycling pathway. Rab14 and its GEF
FAM116A therefore define an endocytic recycling pathway needed for ADAM10
protease trafficking and regulation of cell-cell junctions.
In this study ADAM10 was shown to accumulate in a transferrin-positive compart-
ment in cells that are depleted of Rab14 and FAM116A and is shown to be reduced
on the cell surface when compared to control cells. This accumulation of ADAM10
inside the cell upon loss of Rab14 and FAM116A results in reduced shedding thus in-
creased levels of N-Cadherin on the cell surface at cell-cell junctions (Figure 3.1, page
113). Other studies have also shown that ADAM9 and ADAM10 regulate the shedding
of other ligands including collagen XVII, and interestingly it was reported that ADAM9
may act by processing ADAM10 (Tousseyn et al., 2009).
Exactly how N-Cadherin and E-Cadherin are separated by such a mechanism re-
mains unclear, but the results in this study suggest that further regulation contributions
are required. Interestingly, recent data has shown that E-Cadherin and ephrin B re-
ceptor interact with one another and the processing is controlled by ADAM10 (Solanas
et al., 2011), so it could be possible that there are slightly different mechanisms that
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enable independent different cadherin subtypes to be individually regulated.
3.3 The endocytic recycling network is defined by multiple Rabs
Rab4 and Rab11 are known to be required for the trafficking of integrins and E-Cadherin.
Rab4 and Rab11 depleted cells in this study displayed a migration defect in A549 cells
when a scratch wound assay was performed. Interestingly, the Rab that showed the
most severe migration defect in this study was Rab14, and Rab14 is also part of the
Rab11 subfamily and all members of this family have been associated with the endo-
cytic recycling pathway (Ullrich et al., 1996; Yamamoto et al., 2010). The results from
this study signify that the different Rabs within the endocytic recycling pathway all reg-
ulate very specific cargo molecules.
The results from the EGF uptake confirmed that the uptake and transport of EGF was
not affected when HeLa cells were depleted of Rab4, Rab11, Rab14 and FAM116A
suggesting that the trafficking pathway to early endosomes, late endosomes and lyso-
somes are not altered in the absence of the Rab11 subfamily and the GEF of Rab14.
However, the results in the transferrin uptake revealed a five-fold increase in the inten-
sity of staining in all time points when the cells were depleted of Rab14 or FAM116A.
Additionally the endocytosed transferrin accumulated in large punctate structures and
the recycling of transferrin was acutely delayed when compared to the control. The
time points of 30 and 45 minutes were the most obvious as the Rab14 and FAM116A
depleted cells still had strong staining in the recycling endosomes indicating endocy-
tosed transferrin could not be efficiently recycled back to the cell surface like seen in
the control cells, where the staining had disappeared at these time points.
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The level of transferrin receptor was also increased five-fold in the cells depleted of
Rab14 and FAM116A. A western blot confirmed that the levels were increased and
the intensity of staining was not due to altered localisation. The increased transferrin
receptor levels suggest that the cells depleted of Rab14 or FAM116A are fundamen-
tally starved of iron, and therefore try to compensate by upregulating the levels of the
receptor. These findings confirm an endocytic trafficking defect and more specifically a
defect in the endocytic recycling pathway, and reinforce the cell migration defect caused
by the depletion of Rab14 or FAM116A in A549 cells.
Cell-surface recycling of a number of various membrane proteins to different domains
within the plasma membrane are independently regulated by cells. So far, Rab11 has
been the most studied Rab in endocytic recycling research (Tzaban et al., 2009). The
Rab11 function however, cannot explain the behaviour of all molecules that are recy-
cled through this pathway completely. This becomes obvious when studying polarised
epithelial cells, where Rab11 is known to be required for the recycling to the basolateral
surface only (Tzaban et al., 2009).
There is further evidence to suggest that Rab14 is required for the trafficking to the
apical surface (Kitt et al., 2008). This fits with the idea that the various Rabs within the
endocytic recycling pathway regulate different cargo molecules that recycle to different
areas of the cell surface. The findings and the behaviour seen by the cargo molecules
being recycled are very difficult to explain in terms of a similar linear transport pathway.
It is also known that both apical and basolateral endocytic recycling pathways form
an intersecting system in polarised epithelial cells (Odorizzi et al., 1996; Gibson et al.,
1998).
It is well understood that Rab5, Rab4 and Rab11 all define discrete membrane do-
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mains within the endocytic recycling pathway (Sonnichsen et al., 2000). This study
confirms that Rab14 also defines a distinct membrane domain within this pathway. The
results put the different Rabs in the order that they act in and it was revealed that Rab5
defines the early stages of the endocytic pathway and Rab11 defines the later stages,
Rab4 was found on both early and late stages as shown in previous studies (Sonnich-
sen et al., 2000). Rab14 and its GEF FAM116A were found to act on intermediate
compartments of the endocytic recycling pathway (Figure 3.2, page 116).
When the localisation of transferrin was compared with Rab14 maximum co-localisation
was seen between the times 20 and 30 minutes. This was the same time points at
which transferrin was found to co-localise mostly with FAM116A confirming that both
Rab14 and its GEF FAM116A both regulate the same section of the endocytic recy-
cling pathway (Figure 3.2, page 116).
Figure 3.2: Rab14 defines an intermediate step in the endocytic recycling pathway. Rab4,
Rab11, and Rab14 and its GEF FAM116A localize to and act on an intermediate
compartment of the transferrin recycling pathway that acts prior to Rab11 and after
Rab5 and Rab4.
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The results from this study suggest that depending on which cargo molecule is get-
ting recycled through the endocytic pathway different Rabs are regulated to get the
molecule recycled to correct place. This might not be as simple as one might have orig-
inally thought and more work is needed to understand how particular cargo molecules
follow different yet simple linear sequences of the different membrane compartments
involved in this pathway.
3.4 Rab GEF families
An essential factor required for the function of GTPases is the necessity for activation
at the surface of a specific membrane (Pfeffer and Aivazian, 2004). This is achieved by
specific guanine-nucleotide exchange factors (GEFs) that promote the release of GDP
and binding of GTP (Barr and Lambright, 2010). The GEFs that are known to date
fall into discrete families defined by a number of conserved, but structurally unrelated
protein domains and protein complexes (Figure 3.3, page 118) (Barr and Lambright,
2010). Recent studies have shown that the (DENN) domain proteins, which are known
to be differentially expressed in normal tissues and neoplasia, form a large family of
Rab GEFs (Levivier et al., 2001; Sato et al., 2008; Allaire et al., 2010; Yoshimura et al.,
2010) (Figure 3.3, page 118). Although a large number of Rabs have now been asso-
ciated with their candidate GEFs, there have been none reported to act on the Rab11
subfamily.
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Figure 3.3: DENN domain proteins form a large family within human cells. A schematic di-
agram illustrating the human DENN and DENN-related proteins with the upstream
(u-DENN), core DENN and downstream (d-DENN) regions indicated. Additional
domains that are likely to be of relevance for DENN targeting or regulation are also
colour coded (Yoshimura et al., 2010; Linford et al., 2012).
There has been some evidence in previous studies suggesting that budding yeast
Avl9 is in fact not a Rab GEF. However, there is no data at present on the specificity of
any of the other DENN-related proteins.
Previous studies show that the core DENN proteins have particular Rab activity (Sato
et al., 2008; Allaire et al., 2010; Yoshimura et al., 2010) and the structural basis for the
Rab GEF activity is fully explained (Wu et al., 2011). The DENND1 subfamily is the
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most understood and is known to regulate Rab35. Both DENND1 and Rab35 act on
the endocytic pathway. It is required for receptor recycling of yolk protein in C.elegans.
In mammals it is required for recycling of MHC-I and the uptake of shiga toxin, which is
a causative agent of shigellosis (Allaire et al., 2010).
The results presented in this study reveal that the DENN-related protein FAM116 is
the GEF for the Rab GTPase Rab14 and so extends the list of known GEFs by adding
the DENN-related group of proteins to the list. FAM116A and FAM116B proteins are in
fact the most closely related to the DENN domain proteins and have also been named
DENND6A and DENND6B (Figure 3.3, page 118) (Marat et al., 2011).
Further results from this study provided the evidence that the Rab GEF FAM116A
regulates Rab14 activation on the surface of the membrane. This was shown when
HeLa cells were expressed with GFP-Rab14 and were depleted of FAM116A. In the
control cells the localisation of Rab14 was observed as small punctate structures that
gathered at the periphery of the cell with some additional signal spreading through
the cytoplasm. However, when FAM116A was depleted from the cell the localisation
of the GFP-Rab14 was drastically altered. Rab14 was found accumulating in large
ring-like structures that are adjacent to the nucleus. When these ring-like structures
were stained for transferrin receptor they co-localised suggesting these structures are
transferrin receptor positive. Interestingly, this clustering of transferrin receptor positive
structures adjacent to the nucleus is consistent with a report revealing that Rab14 pro-
motes microtubule-dependent trafficking to the surface of the cell (Ueno et al., 2011).
When Rab4 and Rab11 were expressed with the depletion FAM116A the localisation
did not change suggesting that FAM116A is the GEF specific for Rab14.
It remains unclear as to whether the remaining DENN-related proteins Avl9, FAM45A
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and KIAA1147 are Rab GEFs. Avl9 has been described in budding yeast as a secre-
tion mutant, showing synthetic lethality with the dynamin Vps1 and with the clathrin
adaptor complex 1 subunit and Apl2 (Harsay and Schekman, 2007). There have been
studies suggesting that the Ras superfamily member Gtr2 was the target GTPase for
Avl9, although these studies lack direct biochemical evidence for GEF activity (Zhang
et al., 2010). The migration defect seen with the Avl9 depletion in this study suggests
that the mammalian Avl9 could indeed be a GEF for one the Rab11 subfamily members
Rab4 or Rab11. However, despite many attempts, it has not been possible to show any
biochemical GEF activity towards either Rab4 or Rab11. There is a possibility that Avl9
requires an extra subunit in order to have activity. This is true for the GEF complexes
Mon1-CCZ1 and Ric1-Rgp1 (Barr and Lambright, 2010).
The question as to whether Avl9 is a Rab4 or a Rab11 GEF or whether it is a Rab
GEF at all still remains to be answered and further studies are required. The other
DENN-related proteins FAM45A and KIA1147 did not show any migration defects when
depleted from A549 cells so do not appear to be Rab4 or Rab11 GEFs and might not
even show GEF activity towards any of the Rab GTPase members. There are a num-
ber of Rabs that still lack any known GEF activity, these include Rab2 that is found
on the Golgi and secretory granules, Rab18 that is found on lipid droplets and Rab30,
Rab33a, Rab33b and Rab43 that are all involved in Golgi function. Even with the ad-
vances in the understanding of Rab activation and Rab GEF function, extensive work is
still required in order to find all the Rab regulators and uncover their cellular functions.
By identifying the GEF regulator for Rab14 and by being able to describe its cellular
function, this study is one very important step closer towards this goal.
In summary, this study explains in detail that Rab14 and its GEF FAM116A regulate
the trafficking of ADAM10 in the endocytic recycling pathway, and therefore control the
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level of N-Cadherin shedding at the cell surface. The defect in the remodelling of the
N-Cadherin junctions then inhibits cell migration and cell motility in A549 cells.
3.5 Future work
In this work, we have made a progress towards a more complete understanding of
the Rabs required for cell migration, and the trafficking events they control. However,
many questions remain. Rabs have specific effector proteins, although some effectors
do bind multiple Rabs at different sites. Many effector proteins have been identified
for a number of Rab GTPases and even some for the Rab11 subfamily. Rab4 pro-
motes the recycling of αVβ3 integrin and cell migration through the RUN and FYVE
domain effector protein RUFY1 (Roberts et al., 2001a) and Rab11 and its effector pro-
tein Rab-coupling protein (RCP) activates αVβ3 integrin and promotes delivery to the
tip of the pseudohyphae during cell migration (Caswell et al., 2007). There are only
a few effector proteins identified for Rab14. Studies by Yamamoto et al. as well as
my initial yeast two hybrid screens and pull down assays identified RUFY1/RabIP4 as
a Rab14 and Rab4 effector protein (Yamamoto et al., 2010). Another Rab14 effector
might be KIF16B (Ueno et al., 2011). Due to the results in this study showing that the
trafficking of ADAM10 is facilitated by just Rab14 and is totally independent of Rab4
then the effector protein RUFY1 cannot be the only effector protein for Rab14, and it
also suggests that the effector proteins that are involved in the transport of ADAM10
and Rab14 dependent cell migration have not yet been identified.
Finding Rab14 specific binding proteins could start to answer the question that has
arisen in this study: Why in this wound heal assay is only N-Cadherin and not E-
Cadherin or FGFR affected by the depletion of Rab14 and its GEF FAM116A? Both
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have been shown in previous studies to be shed by the protease ADAM10 (Solanas
et al., 2011). Finally, there are links between Rab14 and the regulation of Golgi to en-
dosome transport and also the transport of endosome to phagosome fusion so further
work is definitely needed to address how all of these Rab14 roles are independently
regulated and how in turn do they integrate with one another.
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4 Materials and Methods
4.1 Materials
4.1.1 Reagents
All reagents were obtained by Sigma Aldrich (Dorset, UK), Fisher Scientific (Loughborough UK)
or VWR (Leicestershire UK) unless stated otherwise.
4.1.2 Equipment
Table 4.1: Equipment
Equipment Manufacturer and Model
Refrigerated Benchtop Centrifuge Eppendorf centrifuge 5417R
Benchtop Centrifuge Eppendorf centrifuge 5417C
Heating block and thermomixer Eppendorf Thermomix compact
Centrifuge Beckman Coulter
Cell culture hoods Heraeus HeraSafe
Cell culture incubators Heraeus HeraCell
Film developer Kodak X-OMAT 2000 Processor
High pressure cell homogeniser Avastin Emulsiflex C5
Incubators Heraeus Function Line
PCR machine Eppendorf Mastercycler Personal
Magnetic stirrer IKA RET basic IKAMAG
Gel system Bio-Rad Protean
Gel power pack Bio-Rad power pack
Gel drier Bio-Rad 583
pH meter Beckman Coulter 350
Semi dry blotter BioRad Trans-blot SD
Continued on next page
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Equipment Manufacturer and Model
Wet transfer blotter Premium Genie Blotter
Shakers Infors HT multitron standard
Vortex IKA MS3 basic
Centrifuge rotors Beckman coulter JA17
Beckman coulter JLA 8.1000
Waterbath Haake DC10
Fixed cell microscope Standard upright microscope equipped with a
CoolSNAP HQ2 camera (Roper Scientific)
Live cell Microscope Olympus IX81-ZDC with a CoolSNAP HQ2
camera (Roper Scientific)
Spinning disc live cell microscope Ultraview Vox spinning disk confocal system
(Perkin Elmer)
4.1.3 Solutions
The compositions of all buffers used within the chapter are described in the table below. Water
was the standard solvent used unless otherwise stated.
Table 4.2: Solutions
Buffer Composition
Blocking buffer for western blot 5% milk powder in PBS , 0.2% (w/v) Tween-20
Buffer S 10 mM K2HPO4 pH 7.2, 10 mM EDTA, 50 mM
β-mercaptoethanol, 50 µg/ml zymolase
DNA loading dye (6x) 0.25% (w/v) bromophenol blue, 40% (w/v) su-
crose in TE
Continued on next page
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Buffer Composition
IMAC 20,50,200 20 mM Tris-HCl pH8.0, 300 mM NaCl, (20, 50,
200) mM Imidazole
Laemmli Buffer (3x) For 100 ml: 2.3 g Tris base, 9.0 g SDS, 30 ml
glycerol, Adjust pH to 6.8 with HCl, adjust vol-
ume to 90 ml with dH2O, 50 mg bromophenol
blue, add 10% β-mercaptoethanol prior to use
LB (Agar) 10 g/l Bacto-tryptone, 5 g/l Bacto-yeast extract,
10 g/l NaCl, (plus 15 g/l Agar)
LB (Broth) 10 g/l Bacto-tryptone, 5 g/l Bacto-yeast extract,
10 g/l NaCl
Lisorb 100 mM Lithium acetate, 10 mM Tris-HCl pH
8.0, 1 mM EDTA pH 8.0, 1 M sorbitol, filter ster-
ilise
Mammalian cell lysis buffer 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1%
(w/v) Triton X-100
Mowiol 2.4 g Mowiol 4-88 added to 6 g analytical grade
glycerol while stirring, 6 ml of ddH2O added and
left for 2 hours at room temperature, 12 ml of
0.2 M Tris-HCl pH 8.5 added while stirring for
10 minutes at 50◦C , the solution was clarified
by centrifugation at 3000 x g for 15 minutes and
stored at -20◦C
Phosphate-Buffered Saline (PBS) 8 g/l NaCl, 0.2 g/l KCl, 1.44 g/l Na2HPO4, 0.24
g/l KH2PO4 (pH 7.4)
Ponceau 0.2% Ponceau red in 1% acetic acid
SDS-PAGE separating buffer 181.72 g/l Tris base, 4 g/l SDS
Continued on next page
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Buffer Composition
SDS-PAGE stacking buffer 60.6 g/l Tris base, 4 g/l SDS
SDS-PAGE running buffer 30.2 g/l Tris base, 188 g/l glycine, 10 g/l SDS
TAE buffer (50x) For 1 l: 242.4 g Tris base, 57.2 ml glacial acetic
acid, 50mM EDTA pH 8.0
TE buffer 10 mM Tris-HCl pH 8.0, 1 mM EDTA
Transfer buffer (wet transfer) 14.4 g Glycine, 3.03 g Tris, 800 ml Water and
200 ml methanol
Transfer buffer (semi-dry transfer) 90 ml 1x SDS-PAGE running buffer, 10 ml
methanol
Tris-Buffered Saline (TBS) (dialysis buffer) 50 mM Tris, 150 mM NaCl, 2mM DTT
4.1.4 siRNA oligonucleotides
Small interfering RiboNucleic Acid (siRNA) oligonucleotides that were used were obtained as
preconfigured SMART- pools by Dharmacon or individual oligos designed by Qiagen. The small
interfering Ribonucleic Acid (siRNA) oligonucleotides used in the course of this work are listed
in the table below.
Table 4.3: siRNA oligonucleotides
Target Gene Target sequence Company
GL2 (Control) CGUACGCGGAAUACUUCGAUU Dharmacon
DennD1A TCCTGGCAGATTACACGACAA Qiagen
DennD1B CATCGTGATTATCTCGAGCAA Qiagen
DennD2A CCGGCACAAGTCCCTCAACAT Qiagen
DennD2B CACGGAGCTGGTGGCACTAAA Qiagen
Continued on next page
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Target Gene Target sequence Company
DennD2C CTGGGTCAGCACTTTATTACA Qiagen
DennD2D CCGCCGATTTGTGAAGAAGTT Qiagen
DennD3 CGACGGTTTAGTTCTGATAAA Qiagen
DennD4A CACGTTCTGCAAGTCGACAA Qiagen
DennD4B CTGGTGGATTACTTCGTGGTA Qiagen
DennD4C CACAGTTTAGGCAGCCGCTTA Qiagen
MTMR5 GACGCCTGTGTTCCACAATTA Qiagen
MTMR13 CTCGCTTGATCAGCTCTCCAA Qiagen
MADD CACACCGTCCACTGAATTCAA Qiagen
DennD5A CAGCATGTCTATGTCCCTATT Qiagen
DennD5B ACACTCGGATTGATAAGATAA Qiagen
Rab1A (SMART-Pool) L-008283-00-0005 Dharmacon
Rab1B (SMART-pool) L-008958-00-0005 Dharmacon
Rab2A (SMART-pool) L-010533-00-0005 Dharmacon
Rab2B (SMART-pool) L-010370-02-0005 Dharmacon
Rab3A (SMART-pool) L-009668-00-0005 Dharmacon
Rab3B (SMART-pool) L-008825-00-0005 Dharmacon
Rab3C (SMART-pool) L-008520-00-0005 Dharmacon
Rab3D (SMART-pool) L-010822-00-0005 Dharmacon
Rab4A (SMART-pool) L-008539-00-0005 Dharmacon
Rab4B (SMART-pool) L-008780-00-0005 Dharmacon
Rab5A (SMART-pool) L-004009-00-0005 Dharmacon
Rab5B (SMART-pool) L-004010-00-0005 Dharmacon
Rab5C (SMART-pool) L-004011-00-0005 Dharmacon
Rab6A (SMART-pool) L-008975-00-0005 Dharmacon
Rab6B (SMART-pool) L-008548-00-0005 Dharmacon
Continued on next page
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Target Gene Target sequence Company
Rab7 (SMART-pool) L-010388-00-0005 Dharmacon
Rab7L (SMART-pool) L-010556-00-0005 Dharmacon
Rab8A (SMART-pool) L-003905-00-0005 Dharmacon
Rab8B (SMART-pool) L-008744-00-0005 Dharmacon
Rab9A (SMART-pool) L-004177-00-0005 Dharmacon
Rab9B (SMART-pool) L-010055-00-0005 Dharmacon
Rab10 (SMART-pool) L-010823-00-0005 Dharmacon
Rab11A(SMART-pool) L-004726-00-0005 Dharmacon
Rab11B(SMART-pool) L-004727-00-0005 Dharmacon
Rab12 (SMART-pool) L-023375-01-0005 Dharmacon
Rab13 (SMART-pool) L-008389-00-0005 Dharmacon
Rab14 (SMART-pool) L-009934-00-0005 Dharmacon
Rab15 (SMART-pool) L-031564-01-0005 Dharmacon
Rab17 (SMART-pool) L-006474-00-0005 Dharmacon
Rab18 (SMART-pool) L-010824-00-0005 Dharmacon
Rab19B(SMART-pool) L-028859-01-0005 Dharmacon
Rab20 (SMART-pool) L-008317-00-0005 Dharmacon
Rab21 (SMART-pool) L-009450-00-0005 Dharmacon
Rab22A(SMART-pool) L-019214-00-0005 Dharmacon
Rab22B(SMART-pool) L-010065-00-0005 Dharmacon
Rab23 (SMART-pool) L-009789-00-0005 Dharmacon
Rab24 (SMART-pool) L-008828-01-0005 Dharmacon
Rab25 (SMART-pool) L-010366-00-0005 Dharmacon
Rab26 (SMART-pool) L-008793-00-0005 Dharmacon
Rab27A(SMART-pool) L-004667-00-0005 Dharmacon
Rab27B(SMART-pool) L-004668-00-0005 Dharmacon
Continued on next page
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Target Gene Target sequence Company
Rab28 (SMART-pool) L-008582-00-0005 Dharmacon
Rab30 (SMART-pool) L-008269-00-0005 Dharmacon
Rab32 (SMART-pool) L-009920-00-0005 Dharmacon
Rab33A(SMART-pool) L-009668-00-0005 Dharmacon
Rab33B(SMART-pool) L-008909-00-0005 Dharmacon
Rab34 (SMART-pool) L-009735-00-0005 Dharmacon
Rab35 (SMART-pool) L-009781-00-0005 Dharmacon
Rab36 (SMART-pool) L-009553-00-0005 Dharmacon
Rab37 (SMART-pool) L-008933-01-0005 Dharmacon
Rab38 (SMART-pool) L-004177-00-0005 Dharmacon
Rab39 (SMART-pool) L-026511-01-0005 Dharmacon
Rab40A(SMART-pool) L-008924-00-0005 Dharmacon
Rab40B(SMART-pool) L-008353-00-0005 Dharmacon
Rab40C(SMART-pool) L-010368-00-0005 Dharmacon
Rab41 (SMART-pool) L-031575-01-0005 Dharmacon
Rab43 (SMART-pool) L-028161-01-0005 Dharmacon
Fam116A(SMART-pool) L-016505-00-0005 Dharmacon
Fam116B(SMART-pool) L-032332-02-0005 Dharmacon
Avl9 (SMART-pool) L-025311-01-0005 Dharmacon
FAM45A (SMART-pool) L-032004-02-0005 Dharmacon
KIAA1147 (SMART-pool) L-005758-00-0005 Dharmacon
N-Cadherin (SMART-pool) L-011605-00-0005 Dharmacon
E-Cadherin (SMART-pool) L-003877-00-0005 Dharmacon
FGFR2 (SMART-pool) L-003132-00-0005 Dharmacon
ADAM8 (SMART-pool) L-004502-01-0005 Dharmacon
ADAM9 (SMART-pool) L-004504-00-0005 Dharmacon
Continued on next page
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Target Gene Target sequence Company
ADAM10 (SMART-pool) L-004503-00-0005 Dharmacon
ADAM12 (SMART-pool) L-005118-00-0005 Dharmacon
ADAM15 (SMART-pool) L-004505-00-0005 Dharmacon
ADAM17 (SMART-pool) L-003453-00-0005 Dharmacon
ADAM19 (SMART-pool) L-005757-00-0005 Dharmacon
ADAM20 (SMART-pool) L-004523-00-0005 Dharmacon
ADAM21 (SMART-pool) L-004524-00-0005 Dharmacon
ADAM28 (SMART-pool) L-005758-00-0005 Dharmacon
ADAM30 (SMART-pool) L-005759-00-0005 Dharmacon
ADAM33 (SMART-pool) L-004525-00-0005 Dharmacon
ADAMDEC1(SMART-pool) L-005760-00-0005 Dharmacon
4.1.5 Antibodies
The antibodies used in the course of this work are listed in the tables below, along with their
typical dilutions used for western blotting (WB) and Immunofluorescence (IF). The species
indicated are M= Mouse, S= Sheep Rt= Rat and Rb=Rabbit
4.1.5.1 Primary antibodies
Table 4.4: Primary antibodies
Antibody name Antigen WB IF Company
M α Tubulin Clone DM1A 1:3000 1:1000 Sigma-Aldrich
M α EEA1 Human EEA1 1:100 1:50 BD Bioscience
R α EEA1 Human EEA1 1:1000 1:250 Cell Signalling
Continued on next page
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Antibody name Antigen WB IF Company
Clone 2411
S α GM130 His-Rat GM130 1:1000 1:1000 Barr Laboratory
M α GM130 Human GM130 1:1000 1:1000 BD Bioscience
M α Lamp1 Human Lamp1 1:1000 1:1000 Developmental Studies
Hybridoma Bank, Uni-
versity of Iowa
S α TGN46 Human TGN46 1:1000 1:1000 Serotec
M α TfR Human TfR 1:1000 1:1000 Chemicon
R α TfR Human TfR 1:1000 1:1000 Millipore
CI-MPR Human MPR 1:1000 1:1000 Abcam
Clone 2G11
R α Pericentrin Human Pericentrin 1:5000 1:5000 Abcam
R α E-Cadherin Human E-Cadherin 1:1000 1:1000 Epitomics
S α N-Cadherin Human N-Cadherin 1:1000 1:2000 R&D systems
R α β-Catenin Human β-Catenin 1:1000 1:1000 Cell Signalling
M α β1 Integrin Human β1 1:1000 —— Serotec
Clone 9EG7
M α β1 Integrin Human β1 1:1000 —— BD Bioscience
Clone 9EG7
Rt α β1 Integrin Human β1 1:1000 —— Millipore
S α GFP His-GFP 1:2000 —— Barr laboratory
M α Myc c-myc, Clone 9E10 1:1000 1:1000 Cancer Research
R α Myc c-myc —– 1:1000 Santa Cruz
S α Golgin-97 Human Golgin-97 1:500 1:500 Barr laboratory
aa589-769
R α Golgin-160 Human Golgin-160 1:1000 1:1000 Barr laboratory
Continued on next page
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Antibody name Antigen WB IF Company
M α sec31 Human Sec31 —— 1:1000 BD Biosciences
M α βCop7 Human CopII —— 1:1000 BD Biosciences
4.1.5.2 Secondary antibodies
Table 4.5: Secondary antibodies
Antibody Species Antigen WB IF Company
HRP-α-S Donkey Sheep IgG 1:1000 —— Jackson Labs
HRP-α-R Donkey Rabbit IgG 1:1000 —— Jackson Labs
HRP-α-M Donkey Mouse IgG 1:1000 —— Jackson Labs
HRP-α-G Donkey Goat IgG 1:1000 —— Jackson Labs
Alexa-488 Donkey Mouse IgG —– 1:1000 Molecular Probes
Alexa-488 Donkey Sheep IgG —– 1:1000 Molecular probes
Alexa-488 Donkey Rabbit IgG —– 1:1000 Molecular Probes
Alexa-555 Donkey Mouse IgG —– 1:1000 Molecular Probes
Alexa-555 Donkey Sheep IgG —– 1:1000 Molecular Probes
Alexa-555 Donkey Rabbit IgG —– 1:1000 Molecular Probes
Alexa-567 Donkey Mouse IgG —– 1:1000 Molecular Probes
Alexa-567 Donkey Sheep IgG —– 1:1000 Molecular Probes
Alexa-567 Donkey Rabbit IgG —– 1:1000 Molecular Probes
Alexa-647 Donkey Mouse IgG —– 1:1000 Molecular Probes
Alexa-647 Donkey Sheep IgG —– 1:1000 Molecular Probes
Alexa-647 Donkey Rabbit IgG —– 1:1000 Molecular Probes
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4.2 DNA methods
Enzymes for DNA modification were obtained from New England Biolabs (NEB) (Ipswich, MA,
USA) Promega (Madison, WI, USA) or Invitrogen (Carlsbad, CA, USA). All were used according
to the supplier instructions.
4.2.1 ’Shortway’ Cloning System
A standard cloning strategy, referred to as the ‘Shortway’ system, was used when generating
constructs, in order to make all inserts compatible with a wide range of different vectors. This
involved generating inserts with a BamHI, BglII, or BclI site at the 5’ end and a SalI or XhoI site
at the 3’ end. The overhanging ATC of the BamHI/ BglII/ BclI site was designed to be in frame
with the start codon of the insert.
GGG ATC CCC ATG (BamHI)
GAG ATC TC ATG (BglII)
GTG ATC ACC ATG (BclI)
The restriction site is bold and the start codon is in italics. These restriction sites were added
by PCR. The insert was TA-TOPO cloned into the vector pCRIITOPO (Invitrogen, Carlsbad,
CA, USA). Constructs were sequenced in pCRIITOPO and then subcloned into the following
vectors.
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4.2.2 Compatible Vectors
Bacterial expression:
His-tagging (N-term) pQE32 BamHI-SalI
GST-tagging (N-term) pFAT2 BamHI-XhoI
MBP-tagging (N-term) pMalTEV-His
with His-tag (C-term) pMalTEV-His BamHI-SalI
Mammalian expression:
GFP-tagging (N-term) pEGFP-C2 BglII-SalI
GFP-tagging (C-term) pEGFP-N3 BglII-SalII
Myc-tagging (N-term) pcDNA3.1/MycA BamHI-XhoI
If a DNA stretch of interest contained internal XhoI and SalI sites it was cloned using 3’ BamHI
/ BglII / BclI sites, and inserted into singly cut vectors using the indicated 5’ end cutting en-
zyme. The vectors were treated with alkaline phosphatase for 15 min at 37◦C prior to loading
on agarose gels. When all restriction sites required for ‘shortway-cloning’ were found in the
DNA stretch of interest, it was cloned, and one of the internal restriction sites was removed by
a silent site directed mutagenesis.
4.2.3 Restriction digests and agarose gel electrophoresis of DNA
Analytical restriction digests were carried out in a total volume of 20µl using 0.5µl of each
enzyme in the appropriate buffer to digest approximately 500 ng of DNA. Digests were carried
out for 1.5 hours at the indicated temperature. The whole reaction was mixed with 4 µl DNA
loading buffer and loaded for electrophoresis onto an agarose gel of concentrations between
0.5% and 2% depending on the expected size of the DNA fragments. To pour gels agarose of
the desired concentration was dissolved in 1 x TAE by heating. Ethidium bromide was added to
a concentration of 0.8 µg/ml for visualisation. The gel was run in 1 x TAE at a constant voltage
of 80 V for 45 minutes. DNA was visualized on a UV transilluminator. Preparative restriction
digests were performed using 2.5 µg DNA. Vector DNA was treated with alkaline phosphatase
at 37◦C for 15 minutes by the addition of 1 µl enzyme to the digestion mix prior to loading on the
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gel. After electrophoresis, appropriate bands were excised using a scalpel blade and purified
using a gel extraction kit (Qiagen) according to the manufacturer’s instructions.
4.2.4 Cloning digested DNA fragments
Ligations were performed in a total volume of 20µl using 1µl of T4 DNA ligase (NEB) in 1x ligase
buffer (NEB). 100 ng of vector DNA was used along with enough insert DNA to make a 3:1 molar
ratio of insert to vector DNA. Ligations were incubated for 2 hours at room temperature before
transformation of bacteria with 10 µl ligation product.
4.2.5 PCR and cloning of PCR products
Oligonucleotides for PCR reactions were obtained from Metabion (Martinsried, Germany) pre-
dissolved to 100 µM. For all PCR reactions a GeneAmp PCR System 2400 thermocycler
(Perkin-Elmer, Waltham, MA, USA) or a Benchtop Cycler (Eppendorf) was used. Reactions
were carried out in a total volume of 50 µl and contained 1 x polymerase reaction buffer, 1.25
µM forward and reverse primers, 0.25 mM dNTPs, and 1µl (2.5 U) Pfu turbo polymerase (Strata-
gene, La Jolla, CA, USA) or 1 µl (1 U) KOD hot start polymerase (Novagen, Madison, WI, USA).
As a template either 10ng plasmid DNA, 5µl marathon-ready cDNA library (Clontech, Palo Alto,
CA, USA) or a HeLa cDNA library (see 5.3.5) was used.
For Pfu polymerase the following scheme was used:
- 2 min 95◦ C 15sec 95◦C
- 25 cycles of: 30 sec 55◦C
2 min / kb of DNA to be amplified 68◦C
- 2 min / kb of DNA to be amplified 68◦C
- Cooling to 4◦C
For KOD polymerase normally the following scheme was used:
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- 2 min 95◦C 15sec 95◦C
- 25 cycles of: 30 sec 60◦C
30sec / kb of DNA to be amplified 72◦C
- 30sec / kb of DNA to be amplified 72◦C
- Cooling to 4◦C
Dependent on the DNA stretch of interest elongation times and temperatures were altered.
PCR products were then analysed by agarose gel electrophoresis.
For cloning from cDNA libraries, a nested approach was used. A first round of PCR was per-
formed as described using primers matching sequences in the 3’ UTR and in the 5’UTR. The
product of this first round of PCR was purified using a PCR nucleotide removal kit (Qiagen,
Hilden) according to the manufacturer’s instructions. 5 µl of the purified PCR product were
used in a second round of PCR. This time primers matching to the 3‘ and the 5‘ end of the
ORF were used. The product of this second round of PCR was then analysed and purified by
agarose gel electrophoresis.
Following gel extraction of PCR products using a Gel extraction kit (Qiagen, Hilden) according
to the manufacturer’s instructions, Adenosine overhangs were added to the ends of the PCR
product by incubation with 1 µl Taq polymerase (Promega, Madison, WI, USA) at 72◦C for 30
minutes in the presence of 1x polymerase buffer and 0.25 mM dNTPs in a total volume of 50 µl.
The product was inserted into the pCRIITOPO vector using the TA-TOPO cloning system (Invit-
rogen, Carlsbad, CA, USA). 2 µl of TA- tailed PCR product was incubated with 0.5 µl TA-TOPO
cloning mix for 5 minutes at room temperature. If the standard method was not successful 0.5
µl of salt mix was added and the mix was incubated for 30 minutes at room temperature. The
entire mix was then used for transformation of TOP10 bacteria.
4.2.6 DNA sequencing
All insert DNA generated by PCR was sequenced commercially by Source Bioscience (Oxford,
UK).
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4.3 Bacterial methods
4.3.1 Growth and maintainence of E.coli
Bacteria were grown at 37◦C in Luria Bertani (LB) medium containing an appropriate antibiotics
for selection, either 100 µg/ml ampicillin, 50 µg/ml kanamycin, or 34 µg/ml chloramphenicol.
Short-term storage was on LB-agar plates plus antibiotic at 4◦C.
Table 4.6: Bacterial strains
Strain Genotype Use
XL1-Blue F’::Tn10 proA+B+ lacIq ∆(lacZ)M15/ recA1endA1
gyrA96 (NaIr) thi hsdR17 (rK-mK+) glnV44 relA1
lac
General cloning pur-
poses
BL21 (DE3)* F-ompT gal [dcm] [lon] hsdSB rB- mB-; an E.coli
B strain with DE3, a λ prophage carrying the T7
RNA polymerase gene
Recombinant protein
expression
JM109* F’ traD36 proA+B+ lacIq ∆(lacZ)M15/
∆(lacproAB) glnV44 e14- gyrA96 recA1
relA1endA1 thi hsdR17
Recombinant protein
expression
TOP10 F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15
∆lacX74 recA1 deoR araD139 ∆(ara-leu)7697
galU galK rpsL (StrR) endA1 nupG
TA cloning for PCR
products
GM1263 F- ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44
galK2 galT22 mcrA dcm-6 hisG4 rfbD1 rpsL136
dam13::Tn9 xylA5 mtl-1 thi-1 mcrB1 hsdR2
Non-methylated DNA
for digestion with
Dam/ Dcm- sensitive
enzymes
*BL21(DE3) and JM109 strains carrying the pRIL plasmid (Stratagene) were used for recom-
binant protein expression. This plasmid encodes the tRNA genes for rare arginine, isoleucine,
137
4 MATERIALS AND METHODS
and leucine codons and conveys chloramphenicol resistance.
4.3.2 Preparation and transformation of chemically competent bacteria
To prepare chemically competent E. coli, a single colony was picked from a fresh plate and
used to inoculate 50 ml of LB (with selection, if necessary) and grown overnight at 37◦C while
shaking. 1 ml of overnight culture was then used to inoculate 100 ml of fresh LB and the cells
were grown at 37◦C until an OD600 of 0.5. The culture was then chilled on ice for 15 minutes
before being transferred to a sterile centrifuge tube and centrifuged at 3000 x g for 10 minutes at
4◦C. The supernatant was discarded and the cell pellet resuspended in 0.4 total culture volume
of TfbI (30 mM KOAc, 100 mM RbCl2, 10 mM CaCl2, 50 mM MnCl2, 15% (v/v) glycerol, pH
adjusted to 5.8 with dilute acetic acid). The cells were incubated on ice for 15 minutes and then
pelleted as before. The cell pellet was then resuspended in 0.04 volumes TfbII (10 mM MOPS,
75 mM CaCl2, 10 mM RbCl2, 15% (v/v) glycerol, pH adjusted to 6.5 with dilute NaOH). After
storing on ice for 15 minutes, the cells were aliquoted into 50 µl aliquots in sterile Eppendorf
tubes, frozen in liquid nitrogen, and stored at -80◦C until needed.
For transformation, aliquots were thawed on ice before adding the DNA. In general, 10 µl of
a ligation reaction was used for transformation of 50 µl competent bacteria, or 1 µl of plasmid
DNA (approx. 200 ng). Cells and DNA were mixed and left on ice for 20 minutes before being
heat-shocked in a 42◦C water bath for 90 seconds. Cells were placed back on ice for 2 minutes
before the addition of 250 µl LB lacking antibiotics. The cells were allowed to recover for 60
minutes at 37◦C with shaking before being plated on LB-agar plates containing an appropriate
selection antibiotic. All 250 µl of a ligation transformation were plated while only 50 µl of a
plasmid transformation was plated. Plates were then incubated overnight at 37◦C.
4.3.3 Plasmid DNA preparation from bacteria
Plasmid DNA was prepared using either miniprep or maxiprep kits (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. Minipreps were prepared from 1.5 ml, maxipreps
from 250 ml of overnight cultures grown in LB containing selective antibiotics at 37◦C.
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4.3.4 Purification of 6x His-tagged protein from bacteria
A single colony was picked from a fresh plate of transformed E. coli and used to inoculate
25 ml of LB plus selective antibiotics and grown overnight at 37◦C with shaking. 10 ml of
the overnight culture was then used to inoculate 1 l of fresh LB plus antibiotics and grown at
37◦C until an OD600 of 0.5 - 0.6 was reached. Depending upon the protein being expressed,
cultures were shifted to 18 ◦C for 30 minutes before being induced with 0.5 mM Isopropyl β-D-
thiogalactoside (IPTG) from a 1 M stock or induced immediately at 37◦C. Cultures were then left
for either 3 hours (37◦C) or overnight (18◦C). Bacteria were then harvested by centrifugation
at 3000x g for 15 minutes at 4◦C and cell pellets were frozen on dry ice for 20 minutes. For
protein purification, cell pellets were thawed and resuspended by the addition of 20 ml IMAC5
buffer containing protease inhibitor tablets and 0.1% Triton X-100 (TX-100) per litre of original
culture. The resuspended bacteria pellet was the homogenised using a chilled Emulsiflex C5
high-pressure homogeniser (Avestin Europe GmbH, Mannheim). The lysate was passed about
10 times through the homogeniser until the DNA was sheared and the lysate became much
less viscous. The lysate was then centrifuged at 28000 rpm for 30 minutes at 4◦C in an SW28
rotor in a Beckman Optima LE-80K Ultracentrifuge (Beckman, USA) to pellet the cell debris.
The cleared lysate supernatant was transferred into a clean Falcon tube. 0.5 ml of Nickel
Nitriloacetic Acid (Ni-NTA) agarose (Qiagen) per litre of original culture, washed in the same
buffer, was added to the cleared lysate and the tube was rotated for 2 hours at 4◦C to allow
protein binding to occur. The resin was then pelleted by centrifugation at 1000 x g for 5 minutes
at 4◦C and washed in 2 x 30 ml of IMAC20 containing 0.1 % TX-100. The resin was then
washed in a further 30 ml of IMAC20 without TX100 and bound protein was eluted by the
addition of IMAC200. The eluate was collected in 1 ml fractions. After SDS-PAGE analysis
of 10 µl of these fractions, peak fractions containing recombinant protein were pooled and
dialysed overnight at 4◦C TBS containing 2mM DTT. The recombinant protein was aliquoted,
quickly frozen in liquid nitrogen and stored at -80◦C. After quickly thawing the protein at 37◦C
with shaking the concentration was determined using a standard Bradford assay.
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4.4 Protein methods
4.4.1 SDS PAGE and coomassie staining
Small (8 x 6.5 x 0.075 cm) SDS polyacrylamide gels were prepared. These consisted of a
resolving, or upper gel and a stacking or upper gel. First the lower gel was cast in wide range
of percentages dependent on the molecular size of the protein of interest.
Table 4.7: Composition of SDS polyacrylamide gels
Gel (%) 4 5 6 7 7.5 10 12 12.5 15
Separating buffer (4x) 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
AMBA (37.5:1) 1.3 1.7 2.0 2.3 2.5 3.3 4.0 4.2 5.0
Distilled water 6.2 5.8 5.5 5.2 5.0 4.2 3.5 3.3 2.5
To polymerise the minigel 10 µl TEMED and 100µl of 10% (w/v) APS were added and the gel
was carefully overlaid with water. After the lower gel was fully polymerized the overlaying water
was aspirated and an upper gel was cast on top.
Table 4.8: Composition of stacking gels
Gel (%) 3 3.5 4 4.5
Stacking buffer (4x) 2.5 2.5 2.5 2.5
AMBA (37.5:1) 1.0 1.2 1.3 1.5
Distilled water 6.5 6.3 6.2 6.0
To polymerise the minigel, 10µl TEMED and 100µl of 10% (w/v) APS were added. A comb was
inserted immediately avoiding air bubbles.
Samples were prepared in SDS-PAGE sample buffer and boiled for 5 minutes at 95◦C. Gels
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were run in a BioRad Mini-PROTEAN 3 gel chamber (BioRad, Germany) in SDS-PAGE running
buffer at 180V, 30 mA per minigel. Protein gels were stained by immersion in 0.01 % Coomassie
Brilliant Blue R-250 in 50 % methanol, 10 % acetic acid for 20 minutes, while shaking. Gels
were destained in 20 % isopropanol, 20 % acetic acid.
4.4.2 Western blotting
Proteins run on SDS-gels were transferred to 45 µm Hybond-C Extra Nitrocellulose (Amersham-
Pharmacia, UK) by semi-dry blotting in transfer buffer (1x SDS-PAGE running buffer plus 10 %
methanol) using a Trans-Blot SD Transfer Cell (BioRad, Germany) at 15 V, 300 mA, for 45 min-
utes. Blots were then blocked in milk-PBS for 1 hour before addition of the primary antibody.
Blots were usually incubated with the primary antibody in milk-PBS for 1 hour at room temper-
ature before being washed 3 x 5 minutes in PBST. Secondary antibodies linked to horseradish
peroxidase were subsequently incubated with the blot for 1 hour before the blots were washed
for a further 3 x 5 minutes in PBST. Bound antibodies were then detected by chemilumines-
cence using ECL Western blot detection reagents (Amersham- Pharmacia, UK) according to
the manufacturer’s instructions, exposed to Kodak X-Omat XAR-5 film for an appropriate length
of time and developed in a Kodak X-OMAT 2000 Processor.
4.4.3 Determination of protein concentration
Protein concentrations were determined using the BioRad Protein Assay kit (BioRad, Ger-
many), a modified version of the Bradford Assay. The dye reagent was diluted 1:5 in water
and 1 ml 1x reagent was used per assay point. Known concentrations of bovine serum albu-
min (BSA) were used to generate a standard curve. The samples were mixed well with the
dye reagent, and transfered to disposable cuvettes for measurement of the OD595 in an Ultro-
spec 3000 Pro spectrophotometer (Amersham-Pharmacia). The concentration of the protein
samples was calculated according to the BSA standard curve.
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4.4.4 Protein precipitation with TCA
From large volumes proteins were precipitated using trichloroacetic acid (TCA) for loading on
SDS-PAGE gels. Sodium deoxycholate was added to a final concentration of 0.02 % and the
sample vortexed. Next TCA was added to a final concentration of 12 %, the sample vortexed,
and left on ice for 30 minutes. Precipitated proteins were then recovered by centrifugation at
20000 x g for 20 minutes at 4◦C. The supernatant was discarded and the pellet washed with ice-
cold acetone before being centrifuged for a further 10 minutes. The supernatant was discarded
and the pellet resuspended in an appropriate amount of 1.5x SDSPAGE sample buffer with
addition of 1 M Tris-HCl pH 8.0, to adjust the pH of the sample if necessary.
4.4.5 Antibody generation and production
Polyclonal antibodies were generated by immunisation of sheep with recombinant protein in
collaboration with Dr Maggie Chambers in Scottish National Blood Service (Penicuik, Scot-
land). Sheep were immunised initially subcutaneously with 250 µg antigen mixed with Freund’s
complete adjuvant followed by four intramuscular boosts with 250 µg antigen mixed with Fre-
und’s incomplete adjuvant. All test bleeds including the final bleed were tested on Western Blot
for their ability to recognise recombinant antigen and the endogenous protein in cell extracts.
Specific antibodies were purified from the bleed out via affinity chromatography.
In order to exclude antibodies against the tag- protein (MBP, GST, 6xHis) used to purify of orig-
inal recombinant antigen, the tag- protein alone was coupled to Affigel-15 (BioRad, Germany).
4 ml of Affigel-15 beads were washed once with water to remove the isopropanol storage so-
lution and added to 4 ml protein solution of 1 mg/ml recombinant tag protein. After 2 hours of
incubation with shaking at 4◦C, the gel was spun for 2 minutes at 1000x g. Thereafter it was
washed three times with 15 ml PBS, once with 15 ml of 0.2 M glycine pH 2.8 and again three
times with 15 ml PBS to remove any uncoupled protein.
For purification of the antibody 15 ml of serum was filtered and incubated with 1 ml of the affinity
matrix coupled to about 1 mg tag- protein rolling for 90 minutes at 4◦C. After this, the slurry was
pelleted by centrifugation for 2 minutes at 1000x g. The supernatant contained the antigen-
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specific antibodies. Tag protein- specific antibodies remained bound to the matrix. The super-
natant was then incubated rolling for 90 minutes at 4◦C with another equally prepared affinity
matrix coupled to approx. 1 mg antigen to purify the antigen specific antibodies. After this, the
slurry was pelleted by centrifugation for 2 minutes at 1000x g. Following three washes with 15
ml PBS, bound antibodies were eluted using 0.2 M glycine pH 2.8 and collected as 1 ml frac-
tions into Eppendorf tubes containing 200 µl 1M Tris-HCl pH 8.0. Samples were immediately
mixed to neutralise the acidic pH and stored on ice. After SDS-PAGE analysis antibody peak
fractions were pooled, dialysed overnight against PBS, aliquoted and stored at -80◦C or kept
at 4◦C for immediate use.
4.5 Mammalian cell culture
4.5.1 Cell culture
HeLa, A549 and HEK293T cells were cultured at 37◦C and 5 % CO2 atmosphere in Dulbeccos
Modified Eagle Medium (DMEM) containing 10 % fetal calf serum, 100 U/ml penicillin and 100
µg/ml streptomycin (GIBCO, Invitrogen, Carlsbad, CA, USA).
4.5.2 Wound heal assay
A549 cells were plated out at a density of 12,000 cells per well in a 12 or 24 well plate. They
were left to settle for 24 hours before siRNA treatment for 72 hours. The cells were grown to
a confluent monolayer which was scratched with a P200 gilson diamond tip (Gilson, UK) to
create the wound. For live cell microscopy the cells were cultured in CO2 independent medium
(GIBCO, Invitrogen, Carlsbad, CA, USA) and for fixed cell microscopy the cells were cultured
in DMEM as described above.
4.5.3 Transient transfection of mammalian cells
HeLa cells were transiently transfected with plasmid DNA constructs using the lipid-based
transfection reagent LT1 (Geneflow, UK) or the equivalent FuGene HD (Roche, Germany).
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For a 24-hour transfection about 50,000 cells per well of a 6-well plate were seeded 24 hours
prior to the transfection. Per single well of a 6-well plate 1 µg plasmid DNA was used with 3
µl FuGene6 or LT1 diluted in 100 µl OptiMEM medium (Invitrogen, Carlsbad, CA, USA). Af-
ter gentle mixing and complex formation for 25 minutes at room temperature the mixture was
added drop-wise to the cells. Usually the transfection was left for 24 hours.
4.5.4 RNA interference of mammalian cells
In order to selectively knockdown the expression levels of particular proteins, small interfering
RNA duplexes (siRNAs) were transfected into Hela cells. Either 21 nucleotide siRNA duplexes
with a 3’ overhang of two nucleotides were designed or pre-designed SMART Pools by Dhar-
macon Inc. were used. The lyophilised and pre-annealed siRNA duplexes were diluted to a
stock solution of 100 µM and aliquots were stored at -80◦C. HeLa cells were seeded 24 hours
prior to transfection to a density of about 25,000 cells per well of a 6-well plate for a typical 72
hours siRNA time course. For transfection the lipid-based transfection reagent Oligofectamine
(Invitrogen, Carlsbad, CA, USA) was used. For a single well of a 6-well plate 3 µl Oligofec-
tamine and 3 µl of 20 µM siRNA duplex were added to 200 µl OptiMEM medium (Invitrogen,
Carlsbad, CA, USA) in a RNAse-free Eppendorf tube. The mixture was mixed gently and left
for 25 minutes at room temperature. The mixture was then added drop-wise to the cells.
4.6 Mammalian cell methods
4.6.1 Immunofluorescence
For IF cells were cultured on ethanol-flamed coverslips in 6-well plates. For PFA fixation, 3 %
paraformaldehyde was prepared by dissolving 3 g paraformaldehyde in 100 ml PBS at 80◦C in
a fume hood. 10 µl 1 M CaCl2 and 10 µl 1 M MgCl2 were added while stirring before the so-
lution was allowed to cool to room temperature and pH adjusted to 7.4. The solution was then
vacuum-filtered through a 0.45 µm filter and 15 ml aliquots were stored at -20◦C. The coverslips
were fixed in 3% paraformaldehyde for 15 minutes and were then washed once in 2 ml quench
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solution (50 mM NH4Cl in PBS made freshly prior to use) before incubation in a further 2 ml
quench solution for 10 minutes. The coverslips were then washed in 3 x 2ml PBS. If the cells
were to be permeabilised, they were incubated for 5 minutes in permeabilisation solution (0.2%
TX-100 in PBS) before washing in 3 x 2ml PBS.
For methanol fixation, the coverslips were washed twice in PBS. Per well 2ml of - 20◦C
methanol was added, and the 6-well plate was incubated at -20◦C for 5 minutes. Subsequently
the coverslips were washed in room temperature PBS twice.
For antibody labelling, primary antibodies were diluted appropriately in PBS. A strip of parafilm
was placed on a flat surface and 50 µl drops of the antibody solution were placed on the strip.
Coverslips with fixed cells were then transferred, cell face down, onto the antibody drops. The
coverslips were then covered with a moist, dark chamber and left for 1 hour at room temper-
ature. After this incubation the coverslips were returned to the wells and washed in 3 x 2ml
PBS. The same procedure as before was followed for incubation with secondary antibodies
conjugated to appropriate fluorophores. After washing in PBS for the final time, coverslips were
mounted onto clean microscope slides by placing them, cell face down, onto a 10 µl drop of
Mowiol mounting medium. The mounting medium used usually contained 1 µg/ml DAPI stain.
The coverslips were then left overnight at room temperature to allow the Mowiol to dry.
4.6.2 Cell extracts
In order to detach cells from the cell culture dishes, HeLa cells were treated with PBS containing
1 mM EDTA for 15 minutes at 37◦C, then gently pipetted off from the cell culture dishes into
clean plastic vials and centrifuged for 5 minutes at 400 g. Total cell extracts were prepared from
cell pellets by addition of ice-cold mammalian lysis buffer containing 1 tablet of complete mini
protease inhibitor (Roche, Mannheim, Germany) per 10 ml solution and pipetting up and down
several times. After 20 minutes incubation on ice the lysate was cleared by centrifugation at
20000 g at 4◦C for 15 minutes.
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4.7 Yeast methods
4.7.1 Strains, growth and media
The S.cerevisiae strain PJ69-4A was used for all two-hybrid experiments, the genotype of which
is:
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆, LYS2::GAL1UASGAL1TATA-
HIS3, GAL2UAS-GAL2TATA-ADE2, MEL1 met2::GAL7-lacZ
Yeast were grown in either YPDA or SC dropout media selecting for appropriate plasmids at
30◦C. Short-term storage was on agar plates at 4◦C. YPDA medium consisted of 20g/l peptone
(Difco/Becton-Dickinson), 10 g/l yeast extract (Difco), and 20g/l glucose (plus 20 g/l Bacto-agar
for YPDA-agar). The medium was then sterilised in an autoclave and, after cooling to approxi-
mately 55 ◦C, 6 ml 0.2 % sterile filtered adenine hemisulphate was added.
Synthetic complete (SC) dropout medium was prepared as follows: Amino acid base (-His/-Trp/-
Leu/-Ura) was prepared by mixing 20 g alanine, arginine, asparagine, aspartic acid, cysteine,
glutamine, glutamic acid, glycine, inositol, isoleucine, lysine, methionine, phenylalanine, pro-
line, serine, threonine, tyrosine, and valine with 5 g adenine and 2 g paraaminobenzoic acid.
To prepare dropout mixes, 36.7 g of amino acid base was mixed with either 2 g histidine, 4
g leucine, 2 g tryptophan, or 2 g uracil, as appropriate to form the correct dropout mix. The
SC dropout medium was autoclaved and after cooling to approximately 55 ◦C, 6 ml 0.2 % ster-
ile filtered adenine hemisulphate was added, unless the dropout medium should be without
adenine.
4.7.2 Yeast transformation (Frozen cell method)
To prepare frozen competent yeast cells, several colonies were picked from a freshly grown
plate and grown overnight in YPDA or in SC -Trp for bait strains at 30 ◦C with shaking. The
overnight culture was diluted to an OD600 of 0.15 in fresh medium and grown at 30 ◦C to an
OD600 of 0.5 - 0.6 (1.2 - 1.5 x 107 cells). The cells were then harvested at 3000 rpm for 2 min-
utes at room temperature in a Heraeus centrifuge. The cells were washed in one half culture
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volume sterile water and spun as before. The cells were then resuspended in 1/8th culture vol-
ume of LiSorb and incubated for 5 minutes at room temperature before being spun as before.
The cell pellet was resuspended in 600 µl LiSorb per 100 ml original culture. Single stranded
carrier DNA was added (10µl /100µl yeast of 10 mg/ml Gibco salmon sperm DNA, heat-treated
at 95 ◦C for 5 minutes). After aliquoting the cells were kept at -80◦C.
To transform frozen competent yeast, the cells were thawed at room temperature. Per transfor-
mation 10 µl of cells were used. About 100ng of plasmid DNA were added to the cells, followed
by 150 µl LiPEG and 17,5 µl DMSO. The mixture was vortexed and incubated for 15 minutes
at room temperature before heat-shocking for 15 minutes in a 42 ◦C waterbath. The cells were
then pelleted at 400xg in a microfuge, the supernatant was removed, and the cells were resus-
pended in 200 µl sterile water. 100 µl were then plated onto appropriate selective plates and
grown at 30 ◦C.
In the case of directed yeast two-hybrid experiments, transformed cells were originally grown
on SC-Leu/-Trp plates to select for both the bait and prey plasmids. After 2 - 3 days growth,
colonies were picked and restreaked onto SC-Leu/-Trp and SC-QDO (SCLeu/- Trp/-His/-Ade)
plates to assess the two-hybrid interaction.
4.7.3 Plasmid DNA minipreps from yeast cells
To prepare plasmid DNA from yeast cells a matchhead-sized ball of cells scraped from a fresh
plate into 1 ml water was pelleted at 400 g in a microfuge. The cell pellet was resuspended
in 500 µl buffer S. The cells were then incubated at 37 ◦C for at least 1 hour. Afterwards 100
µl lysis buffer was added, vortexed, and the lysate incubated at 65 ◦C for at least 30 minutes
until the mixture cleared. 166 µl 3 M KOAc pH 5.5 was then added to stop the lysis reaction.
The tubes were inverted to mix, and incubated on ice for 10 minutes. After centrifugation at
20000x g in a microfuge at 4◦C for 15 minutes the supernatant was transferred to a clean
Eppendorf tube. 800 µl cold ethanol was added and the tubes were inverted to mix. Following
incubation on ice for 10 minutes the reaction was spun as before for a further 10 minutes. The
supernatant was removed and the pellet washed in 1 ml 70% ethanol. The pellet was allowed
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to air dry before resuspending in 40 µl sterile water.
4.7.4 Yeast two-hybrid screening
To screen human a cDNA library for potential interactors of a protein of interest, the protein
was cloned into the pFBT9 vector. Next a competent bait strain containing this construct was
generated using SC -Trp media as selection.
To determine the efficiency of transformation in the newly generated bait strain it was trans-
formed using a cDNA library in pACT2 generated from human testis. It was then plated in
different dilutions on SC -Leu/-Trp to select for co-transfected yeast. The efficiency was cal-
culated as [(number of colonies x volume of suspension (µl)]/plated volume (µl) x dilution x
amount of library DNA (µg). With this information a defined 1 million clones could be screened.
After transformation of the bait strain with sufficient cDNA library to ensure 1 million screened
clones, the yeast was plated on 15 cm dishes on SC QDO to select for interaction. Plates were
left at 30◦C for up to seven days, before DNA was purified from the yeast. The DNA was then
transformed for amplification in E. coli using electroporation and subsequently purified. These
plasmids were then re- transformed into the bait strain as in PJ 694A together with an empty
pFBT9 plasmid. Using, both PJ 694A and pFBT9 as empty vector controls, real positives could
be distinguished from false positives and were then sequenced and identified using the Basic
Local Alignment Search Tool BLAST (http://www.ncbi.nlm.nih.gov/blast/).
4.8 Microscopy
4.8.1 Fixed cell microscopy
Fixed samples on glass slides were imaged using a 60x 1.35 NA oil immersion objective on a
standard upright microscope equipped with a CoolSNAP HQ2 camera (Roper Scientific) under
the control of Metamorph 7.5 software. Images were cropped in Adobe Photoshop CS3 or
ImageJ and placed into Illustrator CS3 without performing any other contrast adjustments of
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image manipulations to produce the figures.
4.8.2 Live cell microscopy
A549 cells were grown to 100% confluency in a 6 well plate a wound was scratched through
the middle using a P200 gilson tip and imaged for 16 hours using a 10x 0.25 NA objective on
an Olympus IX81-ZDC live cell imaging system equipped with a CoolSNAP HQ2 camera under
the control of Metamorph 7.5 software. Video images were then cropped using ImageJ and still
images were placed into Illustrator CS3 without performing any other contrast adjustments of
image manipulation to produce the figures.
Fluorescence imaging was performed at 37◦C in 5% CO2 using the 60x 1.42 NA oil immersion
objective of an Ultraview Vox spinning disc confocal system (Perkin Elmer). Image stacks of 25-
35 planes spaced 0.5-0.7 µm were taken. Exposure times were 10-33 msec at 3% laser power
for both 488 nm and 555 nm probes. Maximum intensity projection images of the fluorescent
channels were cropped in NIH ImageJ and placed into Adobe Illustrator CS3 to produce the
figures. Intensity and colocalisation measurements were performed on the full 3D dataset using
the volume quantitation and object tracking tools of Volocity 5 (Perkin Elmer).
4.9 Cellular and biochemical assays
4.9.1 Transferrin uptake assays
Transferrin coupled to Texas Red (100xstock, 5 mg/ml) (Molecular Probes, Karlsruhe) was
stored as stock solutions in PBS at -20◦C. For uptake assays, HeLa cells plated on glass
coverslips at a density of 50,000 cells/well of a six-well plate were washed three times with
serum-free growth medium 36 h after plating, and then incubated in serum-free growth medium
for 15-16 h at 37 ◦C and 5% CO2. Coverslips were washed three times in ice-cold PBS, and
placed on 40 µl drops of uptake medium (DMEM, 2% [wt/vol] bovine serum albumin, 20mM
HEPES NaOH (pH 7.5) and 50 µg/ml transferrin on an ice-cold metal plate covered in Parafilm
(Pechiney Plastic Packaging, Menasha, WI). After 1 h incubation, the coverslips were washed
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three times in ice-cold PBS to remove excess ligand. One coverslip was fixed to give the total
bound ligand, and the remaining coverslips were transferred to a six-well plate containing pre-
warmed growth medium and incubated at 37◦C and 5% CO2. At the time points of interest,
coverslips were fixed and processed for IF microscopy.
4.9.2 EGF uptake assay
EGF coupled to Green Fluorescent Protein (GFP) (40xstock, 200 µg/ml) (Molecular Probes,
Karlsruhe) were stored as stock solutions in PBS at -20◦C. For uptake assays, HeLa cells
plated on glass coverslips at a density of 50,000 cells/well of a six-well plate were washed
three times with serum-free growth medium 36 h after plating, and then incubated in serum-
free growth medium for 15-16 h at 37◦C and 5% CO2. Coverslips were washed three times in
ice-cold PBS, and placed on 40 µl drops of uptake medium (DME, 2% [wt/vol] bovine serum
albumin, 20mM HEPES NaOH (pH 7.5) and 5 µg/ml EGF on an ice-cold metal plate covered
in Parafilm (Pechiney Plastic Packaging, Menasha, WI). After 1 h incubation, the coverslips
were washed three times in ice-cold PBS to remove excess ligand. One coverslip was fixed
to give the total bound ligand, and the remaining coverslips were transferred to a six-well plate
containing pre-warmed growth medium and incubated at 37◦C and 5% CO2. At the time points
of interest, coverslips were fixed and processed for immuno fluorescence microscopy.
4.9.3 GDP release assay
Human FAM116A and FAM116B were tested against a representative panel of human Rab
proteins using the GDP-releasing assay. 10 µg of each GST-tagged Rab to be tested was
incubated in 50 mM HEPES-NaOH pH 6.8, 0.1 mg/ml BSA, 125 µM EDTA, 10 µM Mg-GDP,
and 5 µCi [3H]-GDP (10 mCi/ml; 5000 Ci/mmol) in a total volume of 200 µl for 15 minutes at
30◦C to load the Rab with the radioactive GDP probe. For standard GDP-releasing GEF assays
100 µl of the loading reaction was then mixed with 10 µl 10 mM Mg-GTP, 10 nM His6-tagged
FAM116A purified from bacteria or a buffer control, and adjusted to 120 µl final volume with
assay buffer. The GEF reaction occurred for 20 minutes at 30◦C. After this, 2.5 µl were taken
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for a specific activity measurement, the remainder was split into two tubes, then incubated with
500 µl ice-cold assay buffer containing 1 mM MgCl2, and 20 µl packed glutathione-sepharose
for 60 minutes at 4◦C to separate Rab-GDP complexes from free ‘released’ GDP. After washing
3 times with 500 µl ice-cold assay buffer the sepharose was transferred to a vial containing 4
ml scintillation fluid and counted. The amount of nucleotide exchange was calculated in pmoles
GDP-released.
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5.1 Summary of the Rab GTPase family
Figure 5.1: Phylogenetic tree of Rab GTPases. Evolutionary tree representing the relation-
ship of the distinct Rab families that were potentially present in the last eukaryotic
common ancestor (Klöpper et al., 2012).
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Table 5.1: Rab GTPases A table to summarise the Rab GTPase, the intracellular localisation,
the trafficking pathway that it regulates, the effector proteins and any diseases in
which the Rab is involved. Colours correspond to groups in phylogenetic tree (see
Figure 5.1, page 173). Table modified from Hutagalung and Novick, 2011
Rab Localisation Membrane Effector Proteins Disease
Protein Trafficking Pathways
Rab1a
Rab1b
ER to Golgi ER to Golgi and Intra-Golgi P115, GM130, giantin, golgin-84, Gcc185,
MICAL-1, JRAB, OCRL1, INPP5B, cog6,
GBF1, Iporin
Parkinson’s dis-
ease
Rab35 PM, endosome RE to plasma membrane,
actin assembly
MICAL family, OCRL1, fascin, Centaurin β2 Unknown
Rab33a Golgi, dense-core
vesicles
Autophagosome formation ATG16L, GM130, rabaptin-5, rabex-5 Unknown
Rab33b Golgi
Rab19 Golgi Unknown D-AKAP2, ddGCC88, dGolgin97 Unknown
Rab43 ER, Golgi ER to Golgi, Shiga toxin
transport
Unknown Unknown
Rab30 ER, Golgi Unknown Cog4, Golga4/p230, dGCC88, dGolgin97,
dGolgin245
Unknown
Rab8a
Rab8b
Cell membrane,
vesicles, primary
cilia
Exocytosis, TGN/RE to
plasma membrane
Rabphilin, MICAL family, JRAB/MICAL-L2,
TRIP8b, FIP-2, optineurin, otoferlin, RIM1,
RIM2, Noc2, OCRL1, Sro7, cenexin3;
Bardet-Biedel
syndrome,
Huntington’s
disease
Rab13 Cell/tight junctions,
TGN, RE
TGN/RE to plasma mem-
brane
MICAL family, JRAB/MICAL-L2, protein ki-
nase A, INPP5B, OCRL1
Neurological
disease
Rab12 Golgi, secretory
vesicles
Exocytosis Rab interacting lysosomal protein-like 1 Unknown
Rab15 Early/sorting endo-
some, RE
Sorting endosome/RE to
plasma membrane
MICAL family, JRAB/MICAL-L2 Unknown
Rab10 Golgi, basolateral
sorting endosomes,
GLUT4 vesicles
Exocytosis, TGN/RE to
plasma membrane
Rim1, MICAL family, JRAB/MICAL-L2 Pneumonia
Rab3a
Rab3b
Rab3c
Rab3d
Secretory vesicles,
plasma membrane
Exocytosis, neurotransmit-
ter release
rabin3, RIM1α, RIM2α, granuphilin, Noc2,
Munc18-1, rabphilin, INPP5B, SNAP-29,
synapsin, polymeric IgA receptor, Gas8,
Zwint-1, OCRL1
Warburg Mi-
cro/Martsolf
syndromes
(Rab3GAP)
Rab26 Secretory granules Exocytosis RIM1 Unknown
Rab37 Secretory granules Exocytosis RIM1 Unknown
Continued on next page
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Rab Localisation Membrane Effector Proteins Disease
Protein Trafficking Pathways
Rab27a
Rab27b
Melanosomes Exocytosis Slp1-5, Slac2-a, Slac2-b, granuphilin,
MyRIP, Rim2, Rabphilin, Noc2, Munc13-4,
Golga4/p230
Griscelli syn-
drome Griscelli
syndrome
Rab34 Golgi,
macropinosomes
Intra-Golgi transport, peri-
Golgi positioning of lyso-
some
Hmunc13, RILP, RILP-L1 Unknown
Rab36 Golgi Unknown Caspase-1 Unknown
Rab45 Perinuclear region Unknown Unknown Unknown
Rab44a Unknown Unknown Unknown Unknown
Rab44b Unknown Unknown Unknown Unknown
Rab18 Golgi, lipid droplets Lipid droplet formation Unknown Unknown
Rab40a
Rab40b
Rab40c
Rab40d
Golgi, RE Endosome/intracellular
transport
Elongin B/C, Cullin5, D-AKAP2, RILP-L1,
RME-8
Unknown
Rab5a
Rab5b
Rab5c
PM, CCVs, early
endosome
Early endosome fusion EEA1, Rabaptin-5/5β, Rabex-5,
Rabenosyn-5, INPP5B, OCRL1, PI3 ki-
nases, Rabankyrin-5, APPL1, APPL2,
Huntingtin-HAP40, caveolin-1, angiotensin II
type 1A receptor, Rabip4’
Parkinson’s dis-
ease
Rab17 RE Transcytosis Unknown Unknown
Rab21 Early endosome Endosomal transport α-Integrin subunit Unknown
Rab22a Early endosome Endosomal transport, pro-
tein recycling to plasma
membrane
Rabex-5, EEA1, rabenosyn-5, RAD51,
INPP5B, OCRL1, rKIAA1055
Unknown
Rab22b TGN, endosome M6P receptor transport to
endosome
OCRL1 Unknown
Rab24 ER Autophagosome formation COOH-terminal binding protein 1 Unknown
Rab20 Golgi, endosome Apical membrane recy-
cling
INPP5E Unknown
Rab7a
Rab7b
Late endosomes,
lysosomes/vacuole,
melanosomes,
phagosomes
Late endosome to lyso-
some
Vps 35/29/26 complex, Rabring7, protea-
some alpha-subunit PSMA7, Vps34/p150
PI3-kinase complex, oxysterol binding pro-
tein related protein 1, RILP
Charcot-Marie-
Tooth
Rab9a
Rab9b
Late endosomes Endosome to TGN TIP47, INPP5B, GCC185, PI3P PIKfyve ki-
nase associated protein p40, NdeI, HPS4
Unknown
Continued on next page
175
5 APPENDIX
Rab Localisation Membrane Effector Proteins Disease
Protein Trafficking Pathways
Rab23 PM, endosome Protein recycling/transport
to plasma membrane
Unknown Carpenter syn-
drome
Rab32
Rab38
Melanosomes TGN to melanosomes Varp/Ankrd27 Hermansky-
Pudlak syn-
drome
Rab7L1 Unknown Unknown Unknown Unknown
Rab2a
Rab2b
ER, ER-Golgi
intermediate com-
partment, Golgi
ER to Golgi INPP5B, golgin-45, RIC-19, PKC
iota/lambda, GM130, GAPDH, Drosophila
melanogaster germ cell-less homolog 1,
GARI, Fam71f2, Fam71b
Unknown
Rab39a
Rab39b
Golgi Unknown Caspase-1 Unknown
Rab42 Unknown Unknown Unknown Unknown
Rab4a
Rab4b
Early endosome Protein recycling/transport
to plasma membrane
CD2AP, D-AKAP2, Rabip4, Rabip4’,
Rabaptin-5α, Rabaptin-5, Syntaxin 4,
Dynein LIC-1, Rab coupling protein,
Rabenosyn-5
Unknown
Rab11a
Rab11b
Golgi, RE, early en-
dosomes
TGN/RE to plasma mem-
brane
Sec15, Rab11-FIP1 to FIP5, myosin Vb, PI4-
kinase β, rabphilin-11, Rab6 interacting pro-
tein 1, Rabin3/Sec2,
Huntington’s
disease
Rab25 RE RE (apical) to plasma
membrane
Integrin β-1 subunit, FIP2, Rip11 Epithelial can-
cers
Rab14 Golgi, early endo-
some, GLUT4 vesi-
cles
TGN/RE to plasma mem-
brane; apical membrane
targeting
FIP2, RCP, Rip11, D-AKAP2 Unknown
Rab6a
Rab6b
Rab6c
Golgi Endosome to Golgi, intra-
Golgi transport, Golgi to
ER
Rab6 interacting protein 1/2A/2B, Cog6, ki-
nesin Rab6-KIFL, GCC185, giantin, OCRL1,
ELKS, INPP5B, golgin SCYL1BP1, golgin-
97, golgin-245, hVps52, dynein light chain
DYNLRB1, p150 subunit of dynein/dynactin
complex, mint3 adaptor protein, Bicaudal-
D1/2, VFT complex, golgin Sgm1;
Gerodermia os-
teodysplastica
Rab41 Golgi Unknown Cog6, Golga4/p230, D-AKAP2 Unknown
Rab28 Unknown Unknown Unknown Unknown
RabL4 Unknown Unknown Unknown Unknown
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5.2 Publication 1
Rab14 and its exchange factor FAM116 link endocytic recycling and adherens junction
stability in migrating cells.
Andrea Linford, Shin-ichiro Yoshimura, Ricardo Nunes Bastos, Lars Langemeyer, An-
dreas Gerondopoulos, Daniel J Rigden, Francis A Barr.
Rab GTPases define the vesicle trafficking pathways underpinning cell polarization
and migration. Here, we find that Rab4, Rab11, and Rab14 and the candidate Rab
GDP-GTP exchange factors (GEFs) FAM116A and Avl9 are required for cell migration.
Rab14 and its GEF FAM116A localize to and act on an intermediate compartment
of the transferrin-recycling pathway prior to Rab11 and after Rab5 and Rab4. This
Rab14 intermediate recycling compartment has specific functions in migrating cells
discrete from early and recycling endosomes. Rab14-depleted cells show increased
N-cadherin levels at junctional complexes and cannot resolve cell-cell junctions. This
is due to decreased shedding of cell-surface N-cadherin by the ADAM family protease
ADAM10/Kuzbanian. In FAM116A- and Rab14-depleted cells, ADAM10 accumulates
in a transferrin-positive endocytic compartment, and the cell-surface level of ADAM10 is
correspondingly reduced. FAM116 and Rab14 therefore define an endocytic recycling
pathway needed for ADAM protease trafficking and regulation of cell-cell junctions. -
Dev Cell (2012) vol. 22 (5) pp. 952-66
http://www.sciencedirect.com/science/article/pii/S1534580712001876
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SUMMARY
Rab GTPases define the vesicle trafficking pathways
underpinning cell polarization and migration. Here,
we find that Rab4, Rab11, and Rab14 and the candi-
date Rab GDP-GTP exchange factors (GEFs)
FAM116A and AVL9 are required for cell migration.
Rab14 and its GEF FAM116A localize to and act
on an intermediate compartment of the transferrin-
recycling pathway prior to Rab11 and after Rab5
and Rab4. This Rab14 intermediate recycling
compartment has specific functions in migrating
cells discrete from early and recycling endosomes.
Rab14-depleted cells show increased N-cadherin
levels at junctional complexes and cannot resolve
cell-cell junctions. This is due to decreased shedding
of cell-surface N-cadherin by the ADAM family
protease ADAM10/Kuzbanian. In FAM116A- and
Rab14-depleted cells, ADAM10 accumulates in a
transferrin-positive endocytic compartment, and
the cell-surface level of ADAM10 is correspondingly
reduced. FAM116 and Rab14 therefore define an
endocytic recycling pathway needed for ADAM pro-
tease trafficking and regulation of cell-cell junctions.
INTRODUCTION
Cell migration and polarization are underpinned by a complex
network of cellular trafficking pathways, which transport a variety
of different membrane proteins required for sensing extracellular
cues, as well as the creation and remodeling of cell adhesions
and cell-cell junctions (Baum and Georgiou, 2011; Caswell
et al., 2009; Huttenlocher, 2005; Mellman and Nelson, 2008;
Ulrich and Heisenberg, 2009). In addition to their physiological
functions during development, altered cell polarization and
increased cell migration are also found in disease states, such
as cancer, or in response to physical wounds, which require
coordinated changes in cell polarization, proliferation, and cell
migration if the damage is to be repaired (Caswell et al., 2009;
Mellman and Nelson, 2008).
In recent years, Rab-GTPase-directed endocytic trafficking
pathways have begun to emerge as key transport events
required for remodelling of cell adhesion and cellular junctions,
as well as cell polarization and migration (Baum and Georgiou,
2011; Caswell et al., 2009). Rab5-dependent endocytic transport
of E- and N-cadherins is important for controlling cell-cell
adhesions during vertebrate gastrulation and brain development
(Kawauchi et al., 2010; Ulrich et al., 2005), as well as receptor
trafficking during the accompanying signaling events (Assaker
et al., 2010; Je´kely et al., 2005). The Rab5-related GTPase
Rab21 also functions in b1-integrin trafficking and cell invasion
(Hooper et al., 2010; Mai et al., 2011; Pellinen et al., 2006). Trans-
port of signaling receptors required for proper axonal guidance
requires Rab27 (Arimura et al., 2009). Best understood are prob-
ably the Rab11 family of GTPases, Rab4, Rab11, and Rab25 that
play key roles in the transport of different integrin complexes in
migrating cells (Caswell et al., 2007, 2009), E-cadherin trafficking
during adherens junction formation (Le et al., 1999; Lock and
Stow, 2005), and in cell polarization during asymmetric cell divi-
sions (Emery et al., 2005). Rab11 family GTPases are typically
associated with different stages of the endocytic recycling
pathway (de Renzis et al., 2002; So¨nnichsen et al., 2000; Ullrich
et al., 1996), for which the transferrin receptor is themost studied
cargo.
Although endocytic recycling is often viewed as a single
pathway, this may not be the case, because specific Rabs are
associated with the trafficking of different cargo molecules to
discrete regions of the cell surface. Accordingly, Rab11 and its
effector, the Rab-coupling protein (RCP), promote a5b1-integrin
recycling (Caswell et al., 2008), whereas Rab25 makes direct
contact to the cytoplasmic tail of a5b1-integrin and promotes
its delivery to the tips of elongated pseudohyphae during inva-
sive cell migration in three-dimensional (3D) matrices (Caswell
et al., 2007). Rab4 promotes the recycling of aVb3-integrin and
cell migration through the RUN (RPIP8/UNIC-14, NESCA)
and FYVE (FAB1/YOTB/VAC1/EEA1) domain effector protein
RUFY1 (Roberts et al., 2001; Vukmirica et al., 2006). Rab14,
the final member of the Rab11 subfamily has not been directly
linked to cell migration events or the traffic of a specific cargo,
although it is known to interact with both RCP and RUFY1 (Kelly
et al., 2010; Yamamoto et al., 2010) andwas identified in the pro-
teome of endosomes isolated from migrating cells together with
Rab5, Rab7, and Rab11 (Howes et al., 2010).
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A crucial component of Rab function is the requirement for
activation at a specific membrane surface (Pfeffer and Aivazian,
2004; Zerial and McBride, 2001). This is achieved by specific
guanine nucleotide exchange factors (GEFs) that promote the
release of GDP and binding of GTP (Barr and Lambright,
2010). The known Rab GEFs typically fall into discrete families
defined by a number of conserved, yet structurally unrelated
protein domains and protein complexes (Barr and Lambright,
2010; Wu et al., 2011). However, to date, none of these GEF
families has been definitively shown to act on the Rab11
GTPases, Rab4, Rab11, Rab14, and Rab25 or to play an essen-
tial role in processes controlled by these GTPases. We therefore
set out to identify candidate Rab-RabGEF pathways required for
cell migration in vitro and assign the underlying membrane
trafficking pathways and order they act in.
RESULTS
Rabs Required for Cell Migration In Vitro
Confluent monolayers of A549 lung epithelial cells, grown to
create a single sheet of cells linked by adherens junctions,
were scratched using a plastic pipette tip. This creates a wound
or break in the cell monolayer into which the adjacent cells can
migrate. The migration event is associated with cell polarization
in the direction of the wound and loss of junctions with neigh-
boring cells. Once the wound has closed, the cells reform
a confluent sheet-like monolayer. To identify trafficking path-
ways required for cell migration in vitro, this scratch-wound cell
migration assay was combined with siRNA depletion of human
Rab GTPases (Figure 1). Because of concerns that some closely
related Rabs may be redundant, these were combined into one
pool for the purposes of the screen. Measurements of cell migra-
tion after 16 hr revealed that depletion of most Rabs resulted in
reduced cell migration relative to the negative control (Figure 1A).
It was therefore decided to focus on the most severe migration
defects, defined as at least one standard deviation under the
median migration distance (Figure 1A, dotted red line marks
the median, shaded light blue-gray area the standard deviation;
Movie S1 available online). Using these criteria, Rab4, Rab11,
Rab14, and Rab15 were found to have a migration defect.
Rab14-depleted cells remained as a sheet and only spread
slightly into the wounded area (Figure 1B andMovie S2). Consis-
tent with previous studies showing that Rab4 and Rab11 are
required for integrin and E-cadherin trafficking, Rab4- and
Rab11-depleted cells migrated more slowly away from the
edge of the cell sheet and failed to close the wound after 16 hr
(Figure 1B). Interestingly, Rab4, Rab11, and Rab14 fall into the
sameRab11 subfamily and have all been implicated in endocytic
recycling (Ullrich et al., 1996; Yamamoto et al., 2010). However,
because all three were identified in this screen, it is unlikely that
they have redundant functions, suggesting that they regulate the
transport of specific cargomolecules. Simultaneous depletion of
the three Rab5 isoforms resulted in a 50% reduction in migration
relative to the control; however, this was slightly above the
threshold used (Figure 1A). This is possibly a false negative due
to incomplete depletion of all three forms of Rab5, which is
needed to block endocytosis of cargo, such as the EGF receptor
(Fuchs et al., 2007). Rab15 was also identified in this screen, but
this was not investigated further at this time.
Rab Regulatory Pathways Required for Cell Migration
In Vitro
To further define the trafficking pathways involved in cell migra-
tion, the effects of depleting known and candidate Rab GEFs
were investigated. At present, the cellular GEFs for Rab4,
Rab11, and Rab14 are unknown. Recent evidence shows that
the differentially expressed in normal and neoplasia (DENN)
domain proteins form a large family of Rab GEFs (Allaire et al.,
2010; Levivier et al., 2001; Sato et al., 2008; Yoshimura et al.,
2010); however, none have been reported to act on Rab11-
related GTPases. In addition to the core DENN domain proteins,
there is a small group of proteins with DENN-related domains
FAM116A, FAM116B, Avl9, FAM45A, and KIAA1147 (Figure S1).
Of these, FAM116 proteins show the highest degree of sequence
similarity to the DENN domain and have been referred to as
DENND6 (Marat et al., 2011). Although there is some evidence
that budding yeast Avl9 is not a Rab GEF, there is no data on
the specificity of the other DENN-related proteins. To test if
any of the DENN or DENN-related proteins were required for
A549 cell migration, they were depleted, and scratch-wound
cell migration assays were performed (Figure 2). This approach
showed that FAM116A-, FAM116B-, and Avl9-depleted cells
showed migration defects comparable to the Rab11 subfamily
(Figure 2A). FAM116A-depleted cells remained as a sheet and
only spread slightly into the wounded area (Figure 2B and Movie
S3). Similarly, Avl9-depleted cells migrated more slowly and
failed to close the wound after 16 hr (Figure 2B and Movie S3).
Comparison of distance migrated over time indicated that
FAM116A and Rab14 showed the strongest migration defect
(Figure 2C). Rab4, Rab11, and Avl9 all migrated more slowly
than the control but moved further than FAM116A- or Rab14-
depleted cells (Figure 2C). The DENN-related candidate Rab
GEFs FAM116A and Avl9 therefore function during cell migration
events, possibly by controlling the Rab11 subfamily of GTPases.
FAM116 Proteins Have Rab14 GEF Activity
To identify the targets of FAM116A, FAM116B, and Avl9,
GDP-GTP exchange factor assays were carried out using puri-
fied recombinant proteins. Despite repeated attempts, it was
not possible to measure Avl9 GEF activity toward any of the
Rabs tested under the assay conditions used. By contrast,
FAM116B displayed activity toward Rab14 and, to a lesser
extent, Rab35 (Figure 3A). No measureable activity toward
Rab4 and Rab11 was observed. Similarly, FAM116A was only
active toward Rab14 when tested against the Rab11 subfamily
(Figure 3B). Together, these findings support the assignment of
FAM116 proteins as physiological GEFs for Rab14.
FAM116 Is Required for Rab14Recruitment toRecycling
Endosomes
Rab GEFs play a crucial role in Rab activation at membrane
surfaces, and loss of Rab GEF function is predicted to result
in altered Rab localization. To test this, cells expressing eGFP-
Rab14 were imaged every 20 s. In control cells, Rab14 was
observed at small slowly moving punctae collected at the cell
periphery,withsomeadditional signal spread throughout thecyto-
plasm (Figure 3C). This localization was strikingly altered in
FAM116A-depleted cells, where eGFP-Rab14 accumulated on
large ring-like structuresadjacent to thenucleus (Figure3C),which
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stained positive for the transferrin receptor (Figure S2A). The clus-
tering of enlarged Rab14 and transferrin receptor positive struc-
tures close to the nucleus is consistent with the report that
Rab14 promotes microtubule-dependent trafficking to the cell
surface (Ueno et al., 2011). By contrast, there was no difference
in the behavior of eGFP-Rab11 in control and FAM116A-depleted
cells (data not shown). FAM116 proteins therefore have GEF
activity toward Rab14 in vitro, and depletion of FAM116A results
in altered localization of eGFP-Rab14 in living cells.
To confirm where FAM116A acts, cells expressing FAM116A
were stained for markers to different cellular organelles. This re-
vealed that FAM116A was present in the cytoplasm and fine
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Figure 1. Rab14 Is Required for Cell Migration In Vitro
(A) A549 cells in 24-well plates were treated with siRNA duplexes targeting the human Rab GTPases family. Similar Rabs were pooled, see bar graph legend,
because of concerns that theymay be functionally redundant. After 72 hr, the cell monolayers werewounded and then after a 30min recovery periodwere imaged
for 16 hr. The distance migrated by the wound front after 16 hr is plotted in the bar graph. Error bars indicate the standard deviation (n = 3). The red dotted line
indicates the median distance migrated, and the light blue-gray shading outlines the boundaries of the standard deviation for all conditions. To test for depletion,
efficiency cells were treated with siRNA control duplex (-) or siRNA duplexes for the Rab GTPases. After 72 hr, the cells were lysed in SDS-PAGE sample buffer
and then western blotted as indicated in the panel inset in the graph. Tubulin was used as a loading control.
(B) Brightfield images from control, FAM116A-depleted, and Avl9-depleted cells are shown at 0, 4, 8, 12, and 16 hr. The dotted red lines mark the edges of the
wound at each time point. The scale bars indicate 50 mm.
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membrane tubules that overlapped with a population of the
transferrin receptor, a recycling endosome marker, but not
markers for early or late endosomes, lysosomes, or the Golgi
apparatus (Figure S2B). Avl9 also showed some overlap with
the transferrin receptor positive recycling endosomes but not
early endosome markers (Figure S2B). However, unlike
FAM116A expression, Avl9 did not trigger tubulation of the trans-
ferrin receptor staining, consistent with the idea that Avl9 and
FAM116 act on different target GTPases. Live cell imaging of
transferrin uptake was then performed on eGFP-FAM116A
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Figure 2. The DENN-Related Proteins FAM116 and Avl9 Are Required for Cell Migration In Vitro
(A) A549 cells in 24-well plates were treated with siRNA duplexes targeting the human DENN and DENN-related proteins described in Figure S1. After 72 hr, the
cell monolayers werewounded and then after a 30min recovery periodwere imaged for 16 hr. The distancemigrated by thewound front after 16 hr is plotted in the
bar graph. Error bars indicate the standard deviation (n = 3). The red dotted line indicates the median distance migrated, and the light blue-gray shading outlines
the boundaries of the standard deviation for all conditions. To test for depletion, efficiency cells were treated with siRNA control duplex (-) or siRNA duplexes for
the DENN-related proteins. After 72 hr, the cells were lysed in SDS-PAGE sample buffer and then western blotted as indicated in the panel inset in the graph.
Tubulin was used as a loading control.
(B) Brightfield images from control, FAM116A-depleted, and Avl9-depleted cells are shown at 0, 4, 8, 12, and 16 hr. The scale bars indicate 50 mm.
(C) A549 cells in 24-well plates were treated with siRNA duplexes targeting Rab4, Rab11, Rab14, FAM116A, and Avl9. After 72 hr, the cell monolayers were
wounded and then after a 30 min recovery period were imaged for 16 hr. The distance migrated by the wound front is plotted over time in the graph; error bars
show the standard deviation (n = 3).
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Figure 3. FAM116 Proteins Have GEF Activity toward Rab14
(A and B) Human FAM116A and FAM116B were tested against a representative panel of human Rab proteins using the GDP-releasing assay. Briefly, 10 mg of
each GST-tagged Rab to be tested was incubated in 50 mM HEPES-NaOH (pH 6.8), 0.1 mg/ml BSA, 125 mM EDTA, 10 mM Mg2+-GDP, and 5 mCi [3H]-GDP
(10mCi/ml; 5000 Ci/mmol) in a total volume of 200 ml for 15min at 30C to load the Rab with the radioactive GDP probe. For standard GDP-releasing GEF assays,
100 ml of the loading reaction was then mixed with 10 ml 10 mMMg2+-GTP, 10 nM Hexahistidine-tagged FAM116A purified from bacteria or a buffer control, and
adjusted to 120 ml final volume with assay buffer. The GEF reaction occurred for 20 min at 30C. After this, 2.5 ml were taken for a specific activity measurement;
the remainder was split into two tubes and then incubated with 500 ml ice-cold assay buffer containing 1 mMMgCl2 and 20 ml packed glutathione-sepharose for
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expressing cells (Figure 3D). Transferrin bound to its receptor
had a diffuse, finely punctate staining pattern at the cell surface
and then rapidly coalesced into larger punctate structures,
expected to be early endosomes, within 6 min (Figure 3D, red
signal). FAM116A was present on a dynamic tubular-reticular
compartment and also gave a diffuse cytoplasmic staining
(Figure 3D, green signal). From 12 to 24 min of uptake when
transferrin is passing through the recycling endosomes, the
transferrin signal overlapped with the tubular component of
FAM116A (Figure 3D, yellow signal marked with arrows; Movie
S4). This overlap diminished after 30 min, and the transferrin
signal was lost after 60 min, as expected if it recycled to the
cell surface (Figure 3D). Together, these findings support the
idea that FAM116A and Rab14 localize to an endocytic recycling
compartment on the transferrin uptake pathway.
Rab14 and FAM116 Function at an Intermediate Step
of the Transferrin Recycling Pathway
Assaysmeasuring the transport of epidermal growth factor (EGF)
and transferrin were performed to identify at which step in the
endocytic pathway Rab14 and FAM116A function (Figure 4).
These assays revealed that EGF uptake and transport were
similar in all conditions (Figures 4A and 4B), suggesting that
the trafficking pathway to early endosomes, late endosomes,
and lysosomes is not perturbed in the absence of Rab14 or
FAM116A. Inspection of the transferrin and transferrin receptor
staining in Rab14- or FAM116A-depleted cells revealed a
5-fold higher signal at all time points. The images shown in the
control and the Rab14- and FAM116A-depleted samples were
captured using 250 and 50 ms exposure times, respectively
(Figure 4A). Western blotting confirmed that this increase in
signal was due to elevated levels of transferrin receptor and
that the level of the lysosome or Golgi proteins, LAMP1 and
GM130, was unchanged (Figure 4C). In addition, endocytosed
transferrin accumulated in large punctate structures in the
Rab14- and FAM116A-depleted cells (Figure 4A), and recycling
was delayed relative to the control (Figure 4B). This was espe-
cially noticeable at 45–60 min, when most of the endocytosed
transferrin had been lost from the control cells (Figure 4A). Live
cell imaging of transferrin uptake confirmed that transferrin
passed through a Rab14-positive compartment (Figure S3A)
and that transferrin recycling was blocked in Rab14-depleted
cells (Figure S3B and Movie S5).
Previous work has shown that Rab5, Rab4, and Rab11 define
discrete membrane domains within the endocytic recycling
pathway (So¨nnichsen et al., 2000). To place these in order with
respect to Rab14, live cell imaging of transferrin recycling in
cells expressing the different Rabs was performed, and the co-
localization of the transferrin and the different Rabs were
measured over time (Figure 5). As expected, Rab5 and Rab11
defined early and late steps in the recycling pathway, and
Rab4 was found on both early and later compartments (Figures
5A and 5B) as shown previously (So¨nnichsen et al., 2000). Rab14
showed maximum colocalization with transferrin at intermediate
time points from 20 to 30 min (Figures 5A and 5B), consistent
with the time at which FAM116A and endocytosed transferrin
overlap (Figure 3D). Direct comparison of Rab14 with Rab11
and Rab4 revealed that these three Rabs define different
compartments (Figure 5C). Rab14 and its GEF FAM116A there-
fore define an intermediate step in the endocytic recycling
pathway, after Rab5 and prior to the action of Rab11. The
increased levels of transferrin receptor seen following Rab14 or
FAM116A depletion indicate that these cells may be starved of
iron and therefore upregulate the levels of the transferrin
receptor to compensate. These findings suggest that an endo-
cytic trafficking defect, specifically in the endocytic recycling
pathway, underpins the cell migration defect of Rab14- and
FAM116A-depleted A549 cells.
N-Cadherin Accumulation at Cell-Cell Junctions in
Rab14-Depleted Cells
Cell migration defects in previous studies have been linked to
defective polarization of the cytoskeleton and Golgi apparatus.
However, in Rab14- and FAM116A-depleted cells, polarization
of the cytoskeleton and Golgi apparatus toward the wound
edge appear normal (Figures S4A and S4B), eliminating this as
the cause of the cell migration defect. Other studies have impli-
cated the Rab11 subfamily GTPases Rab4, Rab11, and Rab25 in
integrin and E-cadherin trafficking during cell migration in
a number of in vitro and in vivo systems. Staining and western
blot analysis of Rab14- or FAM116A-depleted cells did not
show any defects in integrin levels or localization in A549 cells
under the conditions used in this study but did reveal an increase
in the amount of N-cadherin (Figure 6A; data not shown). Deple-
tion of Rab4 or Rab11 did not result in altered N-cadherin levels
(Figure 6A). The levels of E-cadherin, b-catenin, vimentin, and
actin were similar to the control samples (Figure 6A), suggesting
that the cells are not undergoing a transition from an epithelial
to a mesenchymal state or vice versa. The localization of
N-cadherin was then investigated. In control cells, N-cadherin
levels were low, and a higher exposure was needed to visualize
the cell-cell junction staining (Figure 6B). By contrast, a defined
cell-cell junction staining of N-cadherin was visible even with
a short exposure in the Rab14- and FAM116A-depleted
cells (Figure 6B). This suggests that defective regulation of
cell-cell adherens junctions may underlie the migration defect
seen in these cells. To investigate this idea, scratch-wound
migration assays were performed on cells depleted of Rab4,
Rab11, Rab14, FAM116A, or Avl9. In the control cells or
cells depleted of Rab4, Rab11, or Avl9 the cell-cell junction
60 min at 4C to separate Rab-GDP complexes from free ‘‘released’’ GDP. After washing three times with 500 ml ice-cold assay buffer, the sepharose was
transferred to a vial containing 4 ml scintillation fluid and counted. The amount of nucleotide exchange was calculated in pmoles GDP-released. Error bars show
the standard error (n = 4).
(C) HeLa cells were treated with control or FAM116A siRNA duplexes for 48 hr and then transfectedwith eGFP-Rab14 expression constructs. After a further 24 hr,
the cells were imaged every 20 s using a spinning disk confocal microscope. Amaximum intensity projection of the eGFP signal in the entire cell volume is shown.
(D) HeLa cells expressing eGFP-FAM116A were used for live cell imaging of transferrin uptake assays. Maximum intensity projection images of the entire cell
volume are shown for the time points indicated. Arrows mark regions over colocalization at 15–24 min. The scale bar indicates 10 mm in all panels.
See also Figure S2.
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associated staining of N-cadherin was reduced or lost after
4–8 hr when the cells separate from the edge of the cell sheet
and migrate, or attempt to migrate, into the free space created
by the wound (Figure 6C). Rab14- and FAM116A-depleted
cells fail to separate from the edge of the wound and retain
defined staining of N-cadherin at cell-cell junctions after 16 hr
(Figure 6C).
N-Cadherin Silencing Rescues the Rab14 and FAM116
Migration Defect
These findings support the idea that in the absence of the Rab14
and FAM116 recycling pathway, cells are unable to remodel
cell-cell adherens junctions linking cells at the wound edge
with the adjacent cell-sheet. Adherens junctions were therefore
disrupted in two different ways: by specific silencing of
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Figure 4. FAM116 and Rab14 Act on the Transferrin Receptor Recycling Pathway
(A) HeLa cells were treated with control, Rab14, or FAM116A siRNA duplexes for 72 hr. The cells were then used for combined transferrin and EGF uptake assays.
Samples were fixed at 0, 15, 30, 45, and 60 min and then stained with antibodies to the transferrin receptor and DAPI. The scale bar indicates 10 mm.
(B) The amount of cell-associated EGF and transferrin was measured using ImageJ for both control and Rab14-depleted cells and is plotted in the bar charts.
Exposure times were 250ms for transferrin in the control samples and 50ms in the Rab14- and FAM116A-depleted samples. This was not corrected for in the bar
graph. Errors bars indicate the standard deviation (n = 5).
(C) HeLa cells were treated with control, Rab4, Rab11, Rab14, and FAM116A siRNA duplexes for 72 hr and then serum starved for 16 hr to match the conditions
used for transferrin uptake experiments. The cells were then lysed in SDS-PAGE sample buffer andwestern blotted as indicated in the figure. Tubulin was used as
a loading control.
See also Figure S3.
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cadherins or calcium chelation. Cells were simultaneously
depleted of Rab14 or the Rab14 GEF FAM116A and the N-
and E-cadherin adherens junction proteins (Figure 7A). Since
the fibroblast growth factor receptor (FGFR2) has been linked
to N-cadherin function in some cell migration events, this was
also targeted (Cavallaro and Dejana, 2011; Cavallaro et al.,
2001; Hulit et al., 2007; Suyama et al., 2002; Williams et al.,
2001). Depletion of Rab14 or FAM116A resulted in increased
levels of N-cadherin at cell-cell junctions, and this was reversed
by knockdown of N-cadherin but not E-cadherin or FGFR2
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Figure 5. Rab14 Defines an Intermediate Endocytic Recycling Compartment
(A) HeLa cells expressing eGFP-Rab GTPases as indicated were used for live cell imaging of transferrin uptake assays. Maximum intensity projection images of
the entire cell volume are shown for the time points indicated. Arrows mark regions over colocalization.
(B) Colocalization of the eGFP-Rab GTPases and transferrin were calculated using the volume quantitation tools of Volocity 5. Cell volumes were outlined and
Pearson correlation coefficients for colocalization of the twomarkers calculated for each time point. Pearson correlation coefficients are plotted against time, and
error bars indicate the standard error of the mean (n = 5).
(C) HeLa cells coexpressing eGFP-Rab14 and either mCherry-Rab4 or Rab11 were fixed and stained with antibodies to the transferrin receptor. The scale bar
indicates 10 mm in all panels.
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Figure 6. Abnormal Adherens Junctions in
Rab14- and FAM116-Depleted Cells
(A) A549 cells were treated with control, Rab4,
Rab11, Rab14, FAM116A, and Avl9 siRNA
duplexes for 72 hr. The cells were lysed in SDS-
PAGE sample buffer and then western blotted as
indicated in the figure. Tubulin was used as
a loading control.
(B) A549 cells were treated with control, Rab14,
and FAM116A siRNA duplexes for 72 hr, fixed,
and then stained with DAPI and antibodies to
N-cadherin.
(C) A549 cells were treated with control, Rab4,
Rab11, Rab14, FAM116A, and Avl9 siRNA
duplexes for 72 hr. The cell monolayers were then
scratched, samples fixed at 0, 4, 8, and 16 hr,
and then stained with DAPI and antibodies to
N-cadherin. Images are oriented so the wound is
to the right. Scale bar indicates 10 mm in all
images.
See also Figure S6.
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(Figure 7B). Consistent with the hypothesis proposed above, N-
cadherin depletion also rescued the cell migration defect seen in
Rab14- and FAM116A-depleted cells (Figures 7C and 7D).
Depletion of E-cadherin or FGFR2 had no obvious effect on
migration (Figures 7C and 7D). Since cell-cell junctions require
the presence of extracellular calcium, a simple way to disrupt
them is with calcium chelation. The calcium-chelating agent
EDTA was therefore titrated into cell migration assays to define
a concentration that would not prevent cell adhesion to the
dish surface or inhibit migration of control cells. Above 1 mM
EDTA, A549 cell migration and adhesion were reduced (Fig-
ure S5A), and this concentration was therefore used for further
experiments. Addition of 1 mM EDTA to Rab14- or FAM116A-
depleted cells suppressed the cell migration defect (Figures
S5B and S5C). By contrast, the cell migration defects seen
with Rab4, Rab11, or Avl9 were not altered by calcium chelation
(Figures S5B and S5C). Following EDTA treatment, N-cadherin
staining at the cell-cell junctions in Rab14- and FAM116A-
depleted cells at the wound edge was rapidly lost (Figure S5D),
correlating with the increased migration (Figures S5B and
S5C). Together, these results show that the elevated levels of
N-cadherin at the cell-surface and increased cell-cell junction
formation are the primary cause of the migration defect in cells
lacking Rab14 and FAM116 function.
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Figure 7. N-Cadherin Depletion Rescues the Migration Defect in Rab14- and FAM116-Depleted Cells
(A and B) A549 cells were treated with control, Rab14, FAM116A, N-cadherin, E-cadherin, and FGFR2 siRNA duplexes alone or in the combinations indicated for
72 hr (A). The cells were then western blotted for N-cadherin, E-cadherin, or tubulin as a loading control or (B) fixed and then stained with DAPI and antibodies to
N-cadherin. Scale bar indicates 10 mm.
(C) A549 cells were treated with control, Rab14, FAM116A, N-cadherin, E-cadherin, and FGFR2 siRNA duplexes alone or in the combinations indicated for 72 hr.
The cell monolayers were then scratched and imaged for 16 hr. Cell migrationwasmeasured and is plotted on the graph with error bars to show the standard error
of the mean (n = 3).
(D) Images are shown from the 0 and 16 hr time points for the Rab14- and FAM116A-depleted cells in the presence and absence of N-cadherin siRNA. Scale bar
indicates 50 mm.
See also Figure S5.
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Figure 8. Rab14 and FAM116 Regulate ADAM10 Localization and N-Cadherin Shedding
(A) A549 cells were treated with Rab, Rab GEF, and ADAM protease-specific siRNA duplexes as indicated for 72 hr. After 48 hr, the cells were washed three times
in serum-free medium and left in serum-free medium for 24 hr. Proteins in the medium were then recovered by TCA precipitation, and equivalent aliquots of the
cell lysate and medium were western blotted for N-cadherin or tubulin as a loading control. The amount of shed N-cadherin was calculated for two independent
experiments and is plotted in the bar graph.
(B) A549 cells were treated with control, Rab14, ADAM8, ADAM9, and ADAM10 siRNA duplexes for 72 hr. The cell monolayers were then scratched, samples
fixed at 0, 4, 8, and 16 hr, and then stained with DAPI and antibodies to N-cadherin. Images are oriented so the wound is to the right. Scale bar indicates 10 mm in
all images. The distance migrated is shown with a standard deviation (n = 3).
(C) Cells treated as above were used for transferrin uptake assays and then after 30 min were fixed and stained with ADAM10 antibodies.
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N-Cadherin Shedding by ADAM9/10 Is Regulated by
Rab14 and FAM116A
Like numerous other cell-surface membrane proteins, the levels
of cadherins are regulated by transmembrane proteases of the
disintegrin and metalloprotease domain (ADAM) family. ADAMs
cleave the extracellular domain of the target, resulting in its
release from the membrane, a process often termed shedding.
Increased levels of N-cadherin at the cell surface could therefore
be due to altered recycling of an ADAM family protease. To test
this idea, cells were depleted of Rabs and Rab GEFs required for
cell migration, and samples of the cells and growth media were
analyzed by western blotting (Figure 8A). This showed that
N-cadherin shedding was reduced in cells lacking Rab14 or its
GEF FAM116 but was not altered in Rab4-, Rab11-, or Avl9-
depleted cells (Figure 8A). A library of the catalytically active
ADAM proteases was then screened to identify which family
members were required for N-cadherin shedding and cell
migration. Cells depleted of ADAM9 or ADAM10/Kuzbanian but
not of other ADAM family proteases showed reduced levels of
N-cadherin shedding (Figure 8A) and increased cell-surface
staining of N-cadherin (Figure 8B). They also displayed a migra-
tion defect similar to that of Rab14- or FAM116-depleted cells
and retained N-cadherin at cell-cell junctions after 16 hr (Fig-
ure 8B). Cells depleted of ADAM8 showed cell surface levels
of N-cadherin and migration behavior similar to the control
(Figure 8B). These data suggest that altered trafficking of
ADAM10 to the cell surface may explain the migration defect
and altered N-cadherin levels in Rab14- or FAM116-depleted
A549 cells. Supporting this idea, ADAM10 accumulated in an
intracellular transferrin-positive compartment upon depletion of
Rab14 or FAM116 (Figure 8C), and cell-surface levels of
ADAM10 were reduced in cells depleted of Rab14 or FAM116
but not of Rab4 or Rab11 (Figure 8D).
Taken together, the findings in this study show that Rab14 and
its GEF FAM116A are components of the endocytic recycling
pathway. Furthermore, they reveal that Rab14 and FAM116A
define a trafficking route important for regulating N-cadherin by
ADAM family proteases and therefore for the control of cell-cell
adherens junctions.
DISCUSSION
Differential N- and E-Cadherin Processing
Rab11-related GTPases, Rab4, Rab11, and Rab25, have well-
characterized roles in integrin and E-cadherin trafficking through
recycling endosomes during cell migration and epithelial polari-
zation events (Baum and Georgiou, 2011; Caswell et al., 2009).
The results presented here show that Rab14, the final member
of this family, also plays a role in cell migration events by regu-
lating the turnover of N-cadherin at the cell surface. This increase
in N-cadherin levels is due to altered recycling of ADAM family
transmembrane proteases, specifically ADAM9 and ADAM10.
ADAM10 has previously been shown to directly control the
cleavage of cadherins and thereby regulate their levels at the
cell surface (Maretzky et al., 2005; Reiss et al., 2005). Since
ADAM10 accumulates in a transferrin-positive compartment in
cells depleted of Rab14 or FAM116 and is therefore reduced at
the cell surface, this results in less N-cadherin shedding and
increased cell-associated N-cadherin. Interestingly, this may
also explain why levels of the transferrin receptor are increased,
because ADAMs have also been implicated in shedding of this
receptor (Bech-Serra et al., 2006). Other studies have shown
that shedding of some ligands, such as collagen XVII, depends
on both ADAM9 and ADAM10 (Franzke et al., 2009) and that
ADAM9 may act by processing ADAM10 (Tousseyn et al., 2009).
Exactly how N- and E-cadherins would be discriminated by
such a mechanism is not clear, and further regulation inputs
must therefore be required. Interestingly, recent evidence shows
that E-cadherin interacts with ephrin B receptors and modulates
its processing by ADAM10 (Solanas et al., 2011), and it is
possible that mechanisms like this enable independent regula-
tion of the different cadherin subtypes. N-cadherin has been
shown to directly interact with the fibroblast growth factor
(FGF) receptor and to be involved in FGF-receptor signaling
during some cell migration events and in metastasis (Cavallaro
and Dejana, 2011; Cavallaro et al., 2001; Hulit et al., 2007;
Suyama et al., 2002; Williams et al., 2001). Intriguingly, Rab14
has been previously shown to function in the trafficking of
the fibroblast growth factor receptor 2 (FGFR2) during early
embryonic development (Ueno et al., 2011). However, under
the conditions used here, FGFR2 does not appear to be crucial
for explaining the migration defect in Rab14- and FAM116A-
depleted A549 cells, suggesting that it does not play a role in
N-cadherin regulation.
Multiple Rabs Defining an Endocytic Recycling Network
Cells independently regulate the cell-surface recycling of many
different classes of membrane protein to different domains of
the plasma membrane. To date, much of the focus has been
on the role of Rab11 in endocytic recycling. However, Rab11
function alone cannot explain the behavior of all recycling mole-
cules. This is particularly obvious in polarized epithelial cells,
where Rab11 is required for recycling to the basolateral surface
only (Tzaban et al., 2009). By contrast, other evidence suggests
that Rab14 may be required for transport to the apical surface
(Kitt et al., 2008), fitting with the idea that Rab11 and Rab14
control the recycling to different domains of the cell surface.
The results presented here and elsewhere also suggest that
Rab11 and Rab14 also regulate the trafficking of different cargo.
These findings and the observed behavior of different recycling
cargo are difficult to explain in terms of a simple linear transport
pathway. In fact, the apical and basolateral endocytic recycling
pathways in polarized cells form an intersecting network (Gibson
et al., 1998; Odorizzi et al., 1996). The Rab-dependency of
recycling will therefore be determined by the way in which a
particular cargo molecule traverses this network and may not
(D) ADAM10 antibodies were bound to the cell-surface on ice for 60 min; the cells were then fixed and stained with secondary antibodies to detect cell surface
ADAM10 (green). The cells were then postfixed, permeabilized, and stained using a standard protocol to detect the internal pool of ADAM10 (red). The cell
surfaces levels of ADAM10weremeasured as the ratio of surface/internal ADAM10 staining. Error bars indicate the standard deviation (n = 3). The scale barmarks
10 mm in all panels.
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conform to a model invoking simple linear series of membrane
compartments.
Rab GEF Families
Previous studies have shown that the core DENN family of
proteins have specific Rab substrates (Allaire et al., 2010; Sato
et al., 2008; Yoshimura et al., 2010) and explained the structural
basis for this Rab GEF activity (Wu et al., 2011). The best under-
stood of these is the DENND1 subfamily, which has been shown
to control Rab35 in an endocytic pathway required for yolk
protein receptor recycling in C. elegans, MHC-I recycling in
mammals, and the uptake of the causative agent of shigellosis
– Shiga toxin (Allaire et al., 2010; Sato et al., 2008; Yoshimura
et al., 2010). The results presented here extend the known Rab
GEFs by adding the DENN-related proteins to list of proteins
with biochemically defined Rab GEF activity. Because of their
similarity with the core DENN family, FAM116A and FAM116B
have been referred to as DENND6A and B (Marat et al., 2011),
and this seems reasonable, given the fact that they share not
only homology but also Rab GEF activity.
Whether the remaining DENN-related proteins, Avl9,
FAM45A, and KIAA1147, are Rab GEFs remains unclear. Avl9
was first described in budding yeast as a secretion mutant,
showing synthetic lethality with the dynamin Vps1 and the
Apl2 subunit of the clathrin adaptor complex 1 (Harsay and
Schekman, 2007). Subsequent work suggested that Gtr2, a
Ras superfamily GTPase outside the Rab subfamily, was the
target of Avl9 (Zhang et al., 2010). However, direct biochemical
evidence for GEF activity was lacking in these studies. The simi-
larity of the mammalian Avl9 and Rab4 and Rab11 migration
defects suggested that Avl9 might be a Rab11 or Rab4 GEF.
However, despite extensive efforts, it was not possible to
demonstrate GEF activity toward either Rab4 or Rab11. One
possibility is that Avl9, like Rab GEFs of the Mon1-Ccz1 and
Ric1-Rgp1 families, requires an additional subunit for activity
(Barr and Lambright, 2010). The question of whether or not
Avl9 is a Rab GEF therefore remains unresolved, and extensive
further studies will therefore be required. FAM45A and
KIAA1147 depletion did not give rise to migration defects, so
these do not appear to be Rab4 or Rab11 GEFs and might not
even be Rab GEFs. A number of Rabs, including Rab2 found
on the Golgi apparatus and secretory granules, Rab18 found
on lipid droplets, and Rab30, Rab33A, Rab33B, and Rab43
linked to Golgi apparatus function also lack any known GEF
activity. Therefore, even with recent advances in our under-
standing of Rab activation and the function of Rab GEFs, further
work is required to create a complete picture of Rab regulators
and their cellular functions. By describing a GEF regulator
for Rab14 and explaining its cellular function, this study is an
important step toward this goal.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies
General laboratory chemicals were obtained from Sigma-Aldrich (St. Louis,
MO, USA) and Fisher Scientific (Hampton, NH, USA). Antibodies were raised
against full-length recombinant hexahistidine-tagged Rab14 and affinity
purified on the antigen coupled to Affigel-15 (Bio-Rad, Hercules, CA, USA).
Commercially available antibodies were used to a-tubulin (mouse DM1A;
Sigma-Aldrich); EEA1 (rabbit #2411; Cell Signaling, Danvers, MA, USA);
GM130 (mouse clone 35; BD Biosciences, Franklin, NJ, USA), LAMP1 (mouse
1D4B; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City,
IA, USA); TGN46 (sheep AHP500; Serotec, Raleigh, NC, USA), TfR (rabbit
CBL47; Millipore, Billerica, MA, USA); CI-MPR (2G11; Abcam, Cambridge,
UK); Pericentrin (rabbit AB4448; Abcam); E-cadherin (rabbit monoclonal
CDH1; Epitomics, Burlingame, CA, USA); N-cadherin (sheep AF6426; R&D
Systems, Minneapolis, MN, USA), b-catenin (rabbit #9581, Cell Signaling);
b1-integrin (mouse MCA2028, Serotec; mouse 9EG7, BD Biosciences; rat
MAB1997, Millipore). Secondary antibodies raised in donkey to mouse, rabbit,
sheep/goat, and human conjugated to HRP, Alexa-488, Alexa-555, Alexa-568,
and Alexa-647 were obtained from Molecular Probes (Eugene, OR, USA) and
Jackson ImmunoResearch Labs (West Grove, PA, USA).
Molecular Biology
The libraries of Rab GTPases and human DENN coding sequences have been
described previously (Yoshimura et al., 2007, 2010). Mutagenesis was per-
formed using the QuikChange method in accordance with the protocol
(Stratagene, La Jolla, CA, USA). Duplexes for siRNA were obtained from
QIAGEN (Venlo, The Netherlands) or Dharmacon (Lafayette, CO, USA) and
are listed in Table S1. A GL2 duplex was used as a control in all siRNA exper-
iments. Mammalian expression constructs were made using pcDNA4/TO and
pcDNA5/FRT/TO vectors (Invitrogen). Bacterial expression constructs were
made using pQE32 (QIAGEN), pMal (New England Biolabs, Ipswich, MA,
USA), and pFAT2, encoding the Hexahistidine-tag, Hexahistidine-maltose-
binding protein, and Hexahistidine-glutathione-S-transferase, respectively.
Cell Culture and Protein Purification
A549, HeLa, and HEK293 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% bovine calf serum (Invitrogen, Carlsbad,
CA, USA) at 37C and 5% CO2. For plasmid transfection and siRNA transfec-
tion, Mirus LT1 (Mirus Bio LLC, Madison, WI, USA) and Oligofectamine
(Invitrogen), respectively, were used in accordance with the manufacturer’s
instructions. Proteins were purified and expressed in bacteria or mammalian
cells as described previously. Purified proteins were dialysed against Tris-
buffered saline (50 mM Tris-HCl [pH 7.4], 150 mM NaCl) and then snap frozen
in liquid nitrogen for storage at 80C.
Nucleotide Binding and GEF Assays
Nucleotide loading was carried out as follows: 10 mg GST-tagged Rab was
incubated in 50 mM HEPES-NaOH (pH 6.8), 0.1 mg/ml BSA, 125 mM EDTA,
10 mM Mg-GDP, and 5 mCi [3H]-GDP (10 mCi/ml; 5000 Ci/mmol) in a total
volume of 200 ml for 12 hr at 4C. For standard GDP-releasing GEF assays,
100 ml of the loading reaction was mixed with 10 ml 10 mM Mg-GTP,
10-100 nM GEF protein to be tested or a buffer control, and adjusted to
120 ml final volume with assay buffer. The GEF reaction occurred for 20 min
at 30C. After this, 2.5 ml were taken for a specific activity measurement; the
remainder was split into two tubes and then incubated with 500 ml ice-cold
assay buffer containing 1 mMMgCl2 and 20 ml packed glutathione-sepharose
for 60 min at 4C. After washing three times with 500 ml ice-cold assay buffer,
the sepharose was transferred to a vial containing 4 ml scintillation fluid and
counted. The amount of nucleotide exchange was calculated in pmoles
GDP-released. For GTP-binding assays, the following modifications were
made: only unlabelled GDP was used in the loading reaction; in the GEF reac-
tion, 0.5 ml 10 mM GTP and 1 mCi [35S]-GTPgS (10 mCi/ml; 5000 Ci/mmol)
were used. The amount of nucleotide exchange was calculated in pmoles
GTP-bound.
Cell Migration Assays
For live cell imaging, 10,000 A549 cells per well were plated in 24-well plastic
dishes. After 24 hr, cells were treatedwith siRNA duplexes then left for a further
72 hr. Wounds were scratched in the monolayer using a 200 ml pipette tip
(Diamond Standard Tip, Gilson Inc., Middletown, WI, USA), and the cells
then left to recover for 30 min at 37C. All timings start after this recovery
period. Imaging was then performed at 37C in CO2 independent growth
medium (Invitrogen) using an Olympus IX81-ZDC inverted microscope with
a 103 0.6NA air objective, a CoolSNAP HQ2 camera (Roper Scientific,
Trenton, NJ, USA), and an XY motorised piezo Z-stage (Applied Scientific
Instrumentation) under the control of Metamorph 7.5 software (Photometrics
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UK Ltd., London, UK). Brightfield images were collected using 10 ms expo-
sures every 5 min for 16 hr. Images were placed into Adobe Illustrator CS3
to produce the figures. For fixed-cell assays, A549 cells were plated on cover-
slips in 12-well plates and then treated in the same way as live cell assays. At
the time points indicated in the figures, the cells were fixed and then processed
for immune fluorescence microscopy.
Transferrin and EGF Uptake Assays
EGF and transferrin (Tf) coupled to Alexa Fluor 488 or Alex Fluor 555
(403 stock, 200 mg/ml) (Molecular Probes/Invitrogen) were stored as stock
solutions in PBS at 20C. For uptake assays, HeLa cells plated on glass
coverslips at a density of 70,000 cells/well of a 6-well plate were washed three
times with serum-free growth medium 36 hr after plating and then incubated in
serum-free growth medium for 15 to 16 hr at 37C and 5% CO2. Coverslips
were then washed three times in ice-cold PBS and placed on 40 ml drops of
uptake medium (DMEM, 2% [wt/vol] bovine serum albumin, 20 mM HEPES-
NaOH [pH 7.5]) containing 5 mg/ml EGF and Tf on an ice-cold metal plate
covered in Parafilm (Pechiney Plastic Packaging, Menasha, WI, USA). For
some experiments, cells were transfected with eGFP-Rab constructs for
18 hr in advance. After 30 min incubation, the coverslips were washed three
times in ice-cold PBS to remove excess ligand. One coverslip was fixed to
give the total bound ligand, while the remaining coverslips were transferred
to a 6-well plate containing prewarmed growth medium and incubated at
37C and 5% CO2. At the time points indicated in the figures, the cells were
fixed and then processed for immune fluorescence microscopy. For live cell
imaging, cells were plated in 2 cm dishes with a coverglass window in the
bottom. For EGF and Tf binding, a 60 ml drop of uptake medium was placed
on top of the coverglass window. Imaging was performed at 37C in 5%
CO2 using the 6031.42 NA oil immersion objective of an Ultraview Vox
spinning disk confocal system (Perkin Elmer, Waltham, MA, USA). Image
stacks of 25–35 planes spaced 0.5–0.7 mm were taken every minute for 2 hr.
Exposure times were 10–33 ms at 3% laser power for both the 488 and
555 nm probes. Maximum intensity projection images of the fluorescent
channels were cropped in NIH ImageJ and placed into Adobe Illustrator CS3
to produce the figures. Intensity and colocalization measurements were per-
formed on the full 3D data set using the volume quantitation and object
tracking tools of Volocity 5 (Perkin Elmer).
Fixed-Cell Microscopy
Fixed samples on glass slides were imaged using a 603 1.35 NA oil immersion
objective on a standard upright microscope equipped with a CoolSNAP HQ2
camera (Roper Scientific) under the control of Metamorph 7.5 software.
Images were cropped in Adobe Photoshop CS3 or ImageJ and placed into
Illustrator CS3 without performing any other contrast adjustments or image
manipulations to produce the figures.
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Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors.
Shin-ichiro Yoshimura, Andreas Gerondopoulos, Andrea Linford, Daniel J Rigden,
Francis A Barr.
A key requirement for Rab function in membrane trafficking is site-specific activation
by GDP-GTP exchange factors (GEFs), but the majority of the 63 human Rabs have
no known GEF. We have performed a systematic characterization of the 17 human
DENN domain proteins and demonstrated that they are specific GEFs for 10 Rabs.
DENND1A/1B localize to clathrin patches at the plasma membrane and activate Rab35
in an endocytic pathway trafficking Shiga toxin to the trans-Golgi network. DENND2
GEFs target to actin filaments and control Rab9-dependent trafficking of mannose-
6-phosphate receptor to lysosomes. DENND4 GEFs target to a tubular membrane
compartment adjacent to the Golgi, where they activate Rab10, which suggests a func-
tion in basolateral polarized sorting in epithelial cells that compliments the non-DENN
GEF Sec2 acting on Rab8 in apical sorting. DENND1C, DENND3, DENND5A/5B,
MTMR5/13, and MADD activate Rab13, Rab12, Rab39, Rab28, and Rab27A/27B, re-
spectively. Together, these findings provide a basis for future studies on Rab regulation
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Introduction
Rab GTPases are used to encode information about the state 
of a membrane or membrane domain in order to control spe-
cific membrane trafficking events (Zerial and McBride, 2001; 
Behnia and Munro, 2005). Rabs are activated by specific gua-
nine nucleotide exchange factors (GEFs) promoting the release 
of GDP and binding of GTP (Pfeffer and Aivazian, 2004). 
According to the prevailing model, GEFs together with other 
regulatory factors localize to and act at specific membrane sur-
faces, and thus provide a means to locally activate their target 
Rabs (Pfeffer and Aivazian, 2004). This system allows vesicles 
derived from a particular organelle to be tagged with a specific 
Rab GTPase, and their movement along the cytoskeleton and 
tethering to a specified domain on a target membrane to be con-
trolled. Effector protein complexes that are either activated or 
recruited to the membrane surface by the presence of the GTP-
bound Rab mediate these cytoskeletal and membrane tether-
ing functions. GTP hydrolysis triggered either by additional 
GTPase-activating proteins (GAPs) or spontaneously because 
of intrinsic activity of the Rab ends the cycle. GEFs and GAPs 
therefore play a key role in the specific activation and inactiva-
tion of Rab GTPases.
The known Rab GEFs and GAPs typically fall into dis-
crete families defined by conserved protein domains (Barr and 
Lambright, 2010). With the exception of the Rab3GAP1/2 
proteins (Fukui et al., 1997; Nagano et al., 1998), Rab GAPs 
characteristically contain a TBC domain that catalyzes nucleo-
tide hydrolysis by an arginine-glutamine two-finger mechanism 
(Pan et al., 2006). In humans, the TBC domain family has over 
40 members, and it is likely that these regulate all 63 human 
Rabs, with some TBC domain proteins acting on several closely 
related Rabs (Haas et al., 2005, 2007; Fuchs et al., 2007). Rab 
GEFs are more diverse, and several conserved, yet structurally 
unrelated proteins and protein complexes have been shown to 
have specific Rab GEF activity (Barr and Lambright, 2010). 
These are: the TRAPP-I complex activating Ypt1p/Rab1 (Wang 
et al., 2000; Cai et al., 2008), Vps9 domain proteins activating 
Rab5/Ypt51p subfamily GTPases (Delprato et al., 2004; Sato 
et al., 2005; Delprato and Lambright, 2007), Sec2p/Rabin pro-
teins activating Sec4p GTPases (Walch-Solimena et al., 1997; 
A key requirement for Rab function in membrane trafficking is site-specific activation by GDP-GTP exchange factors (GEFs), but the majority of the 
63 human Rabs have no known GEF. We have performed 
a systematic characterization of the 17 human DENN do-
main proteins and demonstrated that they are specific 
GEFs for 10 Rabs. DENND1A/1B localize to clathrin patches 
at the plasma membrane and activate Rab35 in an endo-
cytic pathway trafficking Shiga toxin to the trans-Golgi 
network. DENND2 GEFs target to actin filaments and con-
trol Rab9-dependent trafficking of mannose-6-phosphate 
receptor to lysosomes. DENND4 GEFs target to a tubu-
lar membrane compartment adjacent to the Golgi, 
where they activate Rab10, which suggests a function in 
basolateral polarized sorting in epithelial cells that com-
pliments the non-DENN GEF Sec2 acting on Rab8 in 
apical sorting. DENND1C, DENND3, DENND5A/5B, 
MTMR5/13, and MADD activate Rab13, Rab12, Rab39, 
Rab28, and Rab27A/27B, respectively. Together, these 
findings provide a basis for future studies on Rab regula-
tion and function.
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controlling the activity of Rab3 and Rab27 at the synapse 
(Iwasaki et al., 1997; Mahoney et al., 2006). More recently, a 
screen for defective receptor-mediated yolk protein endocytosis 
in C. elegans identified another DENN domain protein RME-4, 
and indicated that it acted on Rab35 (Sato et al., 2008). This was 
confirmed by complementary studies in mammalian cells show-
ing that the RME-4 homologue DENND1A/connecdenn was in 
fact a Rab35 GEF (Allaire et al., 2010; Marat and McPherson, 
2010). These findings support the idea that DENN domain pro-
teins might form a family of Rab GEFs. To investigate this, we 
have characterized the human DENN domain proteins, and 
identified their target or substrate Rab GTPases.
Results
Identification of human DENN  
domain proteins
Sequence searches of the human genome using the DENN do-
main of the Rab3 GEF MADD reveal the presence of 17 pro-
teins sharing this domain (Fig. 1). All these proteins carry a full 
DENN domain comprising the three upstream (u-DENN), core 
Hattula et al., 2002; Dong et al., 2007; Itzen et al., 2007; Sato 
et al., 2007b), the Ric1p–Rgp1p complex activating Ypt6p and 
possibly Rab6 (Siniossoglou et al., 2000), the Mon1p–Ccz1p 
complex acting on Ypt7p and Rab7 (Nordmann et al., 2010), 
and the RCC1 domain protein claret, which may act as a GEF 
for the unique Rab lightoid in Drosophila (Ma et al., 2004). 
Apart from claret, these GEFs and their target Rab GTPases 
act in trafficking pathways conserved from mammals to yeasts. 
However, mammalian cells possess >60 Rabs, compared with 
the 11 of budding yeast, and therefore require additional GEFs 
to activate these extra Rabs. At present, most of the 60 mamma-
lian Rabs lack a defined GEF activity, and it is therefore unclear 
how they would be specifically activated. Additional Rab GEFs 
are therefore likely to exist.
DENN domain proteins were first implicated as Rab GEFs 
by the biochemical purification of a Rab3 GEF from bovine 
brain (Wada et al., 1997). This was subsequently identified as a 
DENN domain protein, although it remained unclear which do-
main in the protein was responsible for GEF activity (Coppola 
et al., 2002). Further studies revealed that the Caenorhab­
ditis elegans MADD homologue AEX-3 was responsible for 
Figure 1. DENN proteins form a large family in human cells. A schematic showing the human DENN domain proteins, with the upstream (u-DENN), core 
DENN, and downstream (d-DENN) regions indicated. Additional domains likely to be of relevance for DENN targeting or regulation are marked and color 
coded. Sequence alignments of DENNs were done with ClustalX (Chenna et al., 2003) or MUSCLE (Edgar, 2004), and the results were visualized and 
manipulated with Jalview (Waterhouse et al., 2009). Linear sequence motifs were browsed in the ELM database (Gould et al., 2010). Accession numbers 
used for this analysis are listed in Table S1.
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DENND1 regulates Rab35-dependent 
Shiga toxin trafficking to the TGN
As a first step in the systematic characterization of Rab nucleo-
tide exchange activity, it was important to ensure that a known 
Rab GEF would give the expected pattern of specificity. The 
Vps9 domain GEF Rabex-5 was used for this purpose. As ex-
pected, Rabex-5 promoted GDP release from Rab5A-C, and 
displayed some activity toward the Rab5 subfamily GTPases 
Rab17, Rab21, and Rab22A (Fig. 2 A). Other Rabs fell below 
the background value set at twice the median. The short form 
of DENND1B encoding only a DENN domain was then tested 
for GEF activity using the GDP-releasing assay (Fig. 2 B). 
This revealed that DENND1B-S promoted GDP release from 
Rab35 but not the other Rabs tested. For true GEF activities, 
GTP binding rapidly follows GDP release, and it was there-
fore important to test this. DENND1B-S specifically promoted 
(DENN), and downstream (d-DENN) subregions (Levivier 
et al., 2001). Systematic searching of the genome sequence 
databases reveals that although widely conserved in metazoans 
and protozoans, these DENN domain proteins are absent from 
the budding yeast Saccharomyces cerevisiae used as a model 
for trafficking studies. This suggests that DENN domain pro-
teins may act as GEFs for some of the many additional Rabs 
found in humans and other metazoans. Further analysis indi-
cates that in addition to these proteins, there is a group of related 
proteins containing partial DENN homology. Some of these 
such as Avl9 and its homologues are conserved to budding yeast 
and other fungi (Harsay and Schekman, 2007). Because Avl9 
may be a GEF for the non-Rab Ras family GTPase Gtr2 in late 
Golgi trafficking (Harsay and Schekman, 2007; Zhang et al., 
2010), these are unlikely to be Rab GEFs and they were not 
pursued further in this study.
Figure 2. DENND1A/1B are GEFs for Rab35.  
(A) Human Rabex-5 was tested against a representa-
tive panel of human Rab proteins using the GDP- 
releasing assay. In brief, 10 µg of each GST-tagged 
Rab to be tested was incubated in 50 mM Hepes-
NaOH, pH 6.8, 0.1 mg/ml BSA, 125 µM EDTA, 
10 µM Mg-GDP, and 5 µCi [3H]-GDP (10 mCi/ml; 
5,000 Ci/mmol) in a total volume of 200 µl for 15 min 
at 30°C to load the Rab with the radioactive GDP 
probe. For standard GDP-releasing GEF assays, 
100 µl of the loading reaction was then mixed with 
10 µl of 10 mM Mg-GTP and 10 nM His6-tagged 
Rabex-5 purified from bacteria or a buffer control, 
then adjusted to 120 µl final volume with assay buf-
fer. The GEF reaction occurred for 20 min at 30°C. 
After this, 2.5 µl was taken for a specific activity 
measurement; the remainder was split into two 
tubes, then incubated with 500 µl of ice-cold assay 
buffer containing 1 mM MgCl2 and 20 µl of packed 
glutathione-sepharose for 60 min at 4°C to separate 
Rab–GDP complexes from free “released” GDP. 
After washing three times with 500 µl of ice-cold 
assay buffer, the sepharose was transferred to a vial 
containing 4 ml of scintillation fluid and counted. 
The amount of nucleotide exchange was calculated 
in pmoles of GDP released. (B and C) A representa-
tive panel of human Rab proteins was tested against 
10 nM of His6-tagged DENND1B-S in the GDP- 
releasing (B) or GTP-binding assay (C). For GTP-
binding assays, the following modifications were 
made: only unlabeled GDP was used in the loading 
reaction; in the GEF reaction, 0.5 µl of 10 mM GTP 
and 1 µCi [35S]-GTPS (10 mCi/ml; 5000 Ci/mmol) 
were used. The amount of nucleotide exchange was 
calculated in pmoles of GTP bound. (D and E) Human 
DENND1A (D), DENND1B-L (D), and DENND1C 
(E) were tested against a subset of Rab35-related 
Rabs using the GTP-binding assay. For these assays, 
10 nM of FLAG-tagged DENND1A or DENND1C 
purified from HeLa cells, or 10 nM of His6-tagged 
DENND1B-L purified from bacteria were used. 
Errors bars show the standard error from the mean. 
The red line marks double the median value taken 
as a threshold.
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Figure 3. Localization of DENND1A is clathrin dependent. (A) HeLa cells expressing EGFP-tagged DENND1A (green) were fixed and then stained with 
antibodies to clathrin heavy chain, and the AP-1, AP-2, and AP-3 clathrin adaptor complexes (red). DNA was stained with DAPI (blue). (B) DENND1A and 
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GTP binding to Rab35 but not the other Rabs tested (Fig. 2 C). 
Similar results were obtained for DENND1A and the long form 
of DENND1B (Fig. 2 D). DENND1C in contrast was most ac-
tive toward Rab13 and showed no activity to Rab35 (Fig. 2 E). 
Together, these findings show that DENND1A and DENND1B 
are Rab35-specific GEFs, and that this activity is caused by the 
DENN domain.
Human Rab35 has previously been identified in a screen 
for regulators of Shiga toxin trafficking from the plasma 
membrane to the trans-Golgi network (Fuchs et al., 2007). If 
DENND1A and DENND1B are specific GEFs for Rab35, then 
they might be expected to localize to a membrane compartment 
of this trafficking pathway. DENND1A localization was there-
fore examined in HeLa cells, where it was found to target to 
small punctate structures overlapping with clathrin and the 
plasma membrane AP-2 clathrin adaptor (Fig. 3 A). The AP-1 
and AP-3 clathrin adaptors associated with other trafficking 
steps did not overlap with DENND1A (Fig. 3 A). Analysis of 
DENND1A complex using mass spectrometry showed that they 
contained clathrin and components of the AP-2 complex but not 
other clathrin adaptors (Fig. 3 B). Western blotting confirmed 
that DENND1A specifically interacts with clathrin and the AP-2 
 complex but not other adaptors (Fig. 3 C). The other DENND1 
family members DENND1B and DENND1C did not interact 
with clathrin or clathrin adaptors (Fig. 3, B and C). Depletion of 
clathrin caused loss of the punctate DENND1A plasma mem-
brane staining and overlapping with AP-2, and resulted in a dif-
fuse cytoplasmic and reticular pattern (Fig. 3 D). DENND1A 
therefore targets to clathrin and the AP-2–positive patches at the 
plasma membrane, which supports the idea that it functions in 
some form of endocytic trafficking. To test this idea, HeLa cells 
were depleted of DENND1A, DENND1B, and clathrin (Fig. 4 A), 
then tested for receptor-mediated uptake of the growth factor EGF 
or the transport of Shiga toxin B subunit (STxB) to the trans-
Golgi network (Fig. 4, B and C). Cells depleted of DENND1A 
failed to transport STxB to the trans-Golgi network (Fig. 4, 
B and D). In the same cells, the uptake of EGF into punctate 
endosomal structures was not altered (Fig. 4 B). Depletion of 
clathrin strongly reduced EGF uptake and caused the trans-
ferrin receptor to accumulate at the cell surface rather than 
showing its normal punctate recycling endosome distribution 
(Fig. 4 C). Although clathrin depletion did not block STxB up-
take, uptake efficiency was reduced and it failed to overlap with 
the trans-Golgi network marker TGN46 after 60 min (Fig. 4, 
C and D). Together, these findings support the idea that DENND1A 
is a Rab35 GEF regulating an endocytic trafficking pathway 
used by the Shiga toxin to reach the trans-Golgi network, but 
that DENND1A is not essential for the receptor-mediated 
uptake of EGF.
The DENND2 family regulates Rab9  
and lysosome distribution
Having successfully shown that the DENND1 proteins are Rab 
GEFs, other DENN proteins were then investigated starting 
with the DENND2 family. The DENND2 family has four mem-
bers, and one of these, DENND2D, comprises only a DENN 
domain. This was tested first. DENND2D displayed specific 
GDP-releasing activity to both Rab9A and Rab9B but not 
any other Rab tested (Fig. 5 A), which supports the view that 
the DENN domain alone is responsible for GEF activity. This 
specificity was confirmed for the three other DENND2 family 
members (Fig. 5 B). Examination of DENND2 family localiza-
tion revealed that DENND2A and DENND2B were present on 
filaments reminiscent of actin, that DENND2C overexpression 
caused cell shape changes and formed large patches in cell pro-
trusions, and that DENND2D was diffusely located throughout 
the entire cell (Figs. 5 C and S1). The pronounced actin filament 
localization of DENND2A was especially intriguing because 
it was recently shown that the Rho family protein RhoBTB3 
is a Rab9 effector protein (Espinosa et al., 2009). Rho family 
proteins are typically associated with processes controlling the 
actin cytoskeleton, and this suggests there may be a link be-
tween Rab9 function and the actin cytoskeleton. As expected, 
Rab9 was present on LAMP1-positive lysosomes defined by the 
marker LAMP1 (Fig. 5 C). Depletion of Rab9 or DENND2A 
resulted in a similar phenotype, where lysosomes clustered 
adjacent to the perinuclear region and were lost from the more 
peripheral regions of the cells (Fig. 5 D). Depletion of other 
DENND2 family members had no obvious effect in HeLa cells 
(Fig. 5 D and not depicted). Rab9 has a well-documented func-
tion in trafficking of the mannose-6-phosphate receptor (MPR) 
between the TGN and late endosomes (Lombardi et al., 1993; 
Díaz et al., 1997), and this function was therefore investigated. 
Cells depleted of Rab9 or DENND2A showed reduced intensity 
of MPR staining relative to control cells and a loss of MPR-
positive structures in the cell periphery (Fig. 5 E). Fluorescence 
intensity measurements either integrating the total cell associ-
ated signal or taking a transection through the perinuclear re-
gion indicate that there is a >60% reduction in MPR staining 
intensity in DENND2A- and Rab9-depleted cells (Fig. 5 E). 
DENND1B complexes were analyzed by mass spectrometry. The proteins scored highest by the Sequest search algorithm are listed in the table. (C) HeLa 
cells were transfected with constructs encoding FLAG-tagged DENND1A, DENND1B-L, DENND1B-S, and DENND1C for 48 h. The cells were washed from 
the dish using PBS with 1 mM EDTA, and the cell pellets were lysed for 20 min on ice in 1 ml cell of lysis buffer (50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 
150 mM NaCl, 0.5% Triton X-100, and protease inhibitors cocktails). The FLAG-tagged proteins were immunoprecipitated from the clarified lysate using 
20 µl of anti-FLAG M2 affinity gel (Sigma-Aldrich) for 4 h at 4°C. The pellet was washed three times in 1 ml of cell lysis buffer, and bound proteins were 
eluted with 1 ml of 200 µg/ml FLAG peptide in TBS and then precipitated for 60 min on ice using 10% trichloroacetic acid. The FLAG-tagged DENND1A, 
DENND1B-L, DENND1B-S, and DENND1C complexes were analyzed by SDS-PAGE on 4–12% gradient gels and Coomassie blue staining, or Western blot-
ted for clathrin heavy chain (CHC) and the AP-1 and AP-2 clathrin adaptors on 10% gels. Asterisks mark proteins that nonspecifically bind to FLAG-agarose 
and were found in negative control conditions. Molecular mass standards are indicated in kilodaltons. (D) HeLa cells expressing EGFP-tagged DENND1A 
(green) were transfected for 72 h with siRNA duplexes targeting the clathrin heavy chain, fixed, and then stained with antibodies for clathrin and the AP-2 
clathrin adaptor (red). DNA was stained with DAPI (blue). Enlargements are shown to the right to more clearly demonstrate the overlap between DENND1A 
(green), and clathrin or AP2 (red) in control cells, and the loss of punctate DENND1 staining after clathrin heavy chain depletion. Bars, 10 µm.
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DENND4 family proteins showed that these specifically pro-
mote GDP release from and GTP binding to Rab10 and have no 
activity toward Rab8 (Fig. 6, A and B). In contrast, Sec2 domain 
proteins Rabin3/Rabin8 and Rabin3-like/GRAB are specific 
GEFs for Rab8A and Rab8B and have no activity toward Rab10 
(Fig. 6, C and D). Thus, the Sec2 domain proteins Rabin8 and 
GRAB, and the DENN domain proteins of the DENND4 family 
could provide a means to activate Rab8 and Rab10, respectively, 
and thus independently control polarized trafficking. Although 
DENND4A and DENND4C showed a diffuse cytoplasmic 
localization in HeLa cells, DENND4B was present on a tubular 
membrane compartment emanating from the perinuclear region 
(Fig. 6 E and S1). Strikingly, DENND4B staining is coincident 
with that of its target Rab10 (Fig. 6 E). This compartment did 
not overlap with markers for early endosomes, recycling endo-
somes, or lysosomes, but did show partial overlap with the 
Golgi marker GM130 (Fig. 6 E).
Family-wide assignment of DENN specificity
To complete the family-wide assignment of DENN specificity, 
the remaining DENN domains proteins DENND3, DENND5A, 
and DENND5B; the myotubularin-related proteins MTMR5 
and MTMR13; and MADD were tested (Fig. 7). This revealed 
that these proteins also have specific Rab targets. DENND3 is 
a Rab12 GEF (Fig. 7 A), whereas DENND5A/B act on Rab39 
(Fig. 7 B) and MTMR5/13 act on Rab 28 (Fig. 7 C). In agreement 
with previous reports, MADD showed activity toward Rab27 and 
Blocking Rab9 function prevents recycling of MPR from late 
endosomes back to the TGN (Riederer et al., 1994); thus, the 
MPR may become trapped in late endosomes and may enter 
the lysosomes, where it will be degraded. Other TGN recycling 
pathways were not obviously perturbed by Rab9 or DENND2A 
depletion because the TGN marker TGN46 was not changed 
by these treatments (Fig. 5 E). Consistent with the biochemical 
GEF assay data, loss of Rab9 activity either by depleting Rab9 
or its GEF regulator DENND2A causes a similar phenotype. 
These findings support the idea that the DENND2 family mem-
bers act as GEFs for Rab9 in trafficking between the late endo-
somes and the TGN. Interestingly, components of the BLOC 
complex involved in trafficking to lysosome-like organelles 
have been found to associate with actin filaments (Falcón-Pérez 
et al., 2002) and to interact with Rab9 (Kloer et al., 2010). The 
diversity of DENND2 family members suggests that this path-
way is regulated differently in different tissues, possibly linking 
Rab9 regulation at late endosomes and lysosome-related organ-
elles to the status of the actin cytoskeleton.
DENND4 family proteins are specific GEFs 
for Rab10 in apical sorting
The role of Rab8 and Rab10 in apical and basolateral sorting is 
well established. Questions remain, however, about how these 
two GTPases are independently regulated. Two GEFs carrying 
the Sec2 domain have been reported to show activity toward 
Rab8, but the GEF for Rab10 is unknown. Analysis of the 
Figure 4. DENND1A is required for Rab35-dependent Shiga toxin trafficking to the trans-Golgi network. (A) HeLa cells expressing EGFP-tagged DENND1A 
and the long or short forms of DENND1B were transfected with siRNA duplexes to DENND1A, DENND1B, clathrin heavy chain (CHC), or a nonspecific 
control for 72 h, then Western blotted as indicated. Molecular mass standards are indicated in kilodaltons. The asterisk indicates a nonspecific cross re-
action of the clathrin heavy chain antibody. (B) Dual EGF and STxB uptake assays were performed for 60 min as described previously (Fuchs et al., 2007) 
in cells transfected with control or DENND1A duplexes for 72 h. Cells were fixed and then stained for the Golgi marker golgin-160. (C) Uptake assays were 
performed as in B using cells transfected with CHC siRNA duplexes. Cells were fixed and then stained for the transferrin receptor (TfR) to mark recycling 
endosomes or the TGN marker TGN46. Bars, 10 µm. (D) The extent of EGF and Shiga toxin uptake under the various conditions was measured and is 
plotted in the graphs (n = 3). ImageJ was used to measure colocalization of markers. Error bars indicate standard error of the mean.
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Rab39B cause X-linked mental retardation (Giannandrea et al., 
2010). The underlying defect appears to be caused by altered 
trafficking required for growth cone and synapse formation, 
which suggests that further studies of DENND5 should focus on 
neuronal systems rather than fibroblast-like tissue culture cells. 
A homologue of the Myotubularin phosphatase domain contain-
ing DENN proteins MTMR5 and MTMR13, and their target 
Rab28, is present in protozoans (Fritz-Laylin et al., 2010), which 
suggests this has a trafficking function conserved at the cellular 
level rather than in a tissue-specific pathway. Contradicting this 
view somewhat, mutations in human MTMR13 and disruption 
of MMR13 in mice result in an autosomal recessive neuropathy, 
which suggests a function important for nervous system function 
(Azzedine et al., 2003; Robinson et al., 2008). Finally, DENND4 
family GEFs and Rab10 are also always found together in multi-
cellular organisms with polarized epithelial cell layers.
Rabs of the Rab8 and Rab10 families have been impli-
cated in trafficking to polarized membrane domains at the cell 
surface (Babbey et al., 2006; Schuck et al., 2007). In budding 
yeast Sec4p, the Rab8 homologue is required for polarized trans-
port from the late-Golgi into the growing bud (Walch-Solimena 
et al., 1997). In higher eukaryotes, Rab8 has been found to func-
tion in transport to actin-rich membrane protrusions (Peränen 
et al., 1996), the cilium, and apical surface of polarized epithe-
lial cells (Nachury et al., 2007; Sato et al., 2007a; Yoshimura 
et al., 2007; Knödler et al., 2010). In contrast, Rab10 is reported 
to function in basolateral transport (Babbey et al., 2006; Schuck 
et al., 2007). It seems obvious that Rab8 and Rab10 would re-
quire activation by specific GEFs, and this appears to be the 
case. Sec4p and Rab8 are activated by Sec2 domain GEFs 
(Walch-Solimena et al., 1997; Hattula et al., 2002; Dong et al., 2007; 
Itzen et al., 2007; Sato et al., 2007b), whereas DENND4 family 
GEFs activate Rab10. This is supported by observations that muta-
tions in CRAG, the presumed Drosophila orthologue of human 
DENND4, result in missorting of cargo such as perlecan and 
laminin destined for the basolateral surface of cells (Denef et al., 
2008). However, the fruit fly poses a problem for this simple 
idea because it lacks a documented gene encoding a Sec2 domain 
protein. At present, it is only possible to speculate how Rab8 is 
activated in fruit flies, but the two most likely possibilities are ei-
ther that there is a novel Rab8 GEF or that a known GEF family 
has acquired activity toward Rab8. DENND2 specificity raises 
similar issues because Rab9 is present in flies, although a read-
ily discernable DENND2 is not. Flies may have some unique 
features with regard to Rab regulation, and further studies will 
be necessary to address these issues. Interestingly, DENND2B, 
also known as suppressor of tumorigenicity 5 (ST5), is mutated 
in human patients suffering from mental retardation and mul-
tiple congenital abnormalities that can result in deafness, cleft 
palate, and circulatory and kidney function defects (Göhring 
et al., 2010). Our results suggest that these defects may be caused 
by defective regulation of Rab9, and hence trafficking between 
late endosomes and lysosomes. This is reminiscent of lysosomal 
storage disorders, which are long known to cause mental retar-
dation and other developmental abnormalities.
There appear to be no obvious characteristics distinguishing 
DENN-modulated Rabs from those controlled by other classes of 
Rab27B (Figueiredo et al., 2008), although it did not have activ-
ity toward Rab3 family members. This may be caused by the use 
of bacterially expressed Rab proteins, as it has been reported that 
C-terminal prenylation may be important for recognition of 
Rab3 by MADD (Sakisaka and Takai, 2005).
In summary, we have assembled a library of full-length 
human DENN domain proteins and tested their localizations 
and biochemical specificity (Fig. 8). This approach has revealed 
that the different DENN proteins targeted to different subcellu-
lar compartments (Fig. 8), which is consistent with the idea that 
they may control Rab activation at unique membrane or cyto-
skeletal domains. Critically, it also showed that DENN domain 
proteins have unique and nonoverlapping Rab targets. These 
findings will therefore be of relevance for many future studies 
on Rab function in membrane trafficking.
Discussion
DENNs form a conserved family  
of Rab GEFs
The results presented here provide good evidence that DENN 
proteins form a family of highly specific Rab GEF regulators 
controlling specific intracellular transport pathways. DENN 
proteins are conserved in primitive unicellular eukaryotes such 
as protozoans of the Naegleria genus (Fritz-Laylin et al., 2010), 
fission yeast, filamentous fungi, and plants (Levivier et al., 
2001); however, they are absent from budding yeast. Consistent 
with this, none of the DENN target Rabs identified by this study 
are present in budding yeast. As reported previously, MADD 
acts on Rab27A, which functions in melanosome transport 
(Figueiredo et al., 2008). DENND1 and the C. elegans equiva-
lent RME-4 act on Rab35 in endocytic trafficking pathways ab-
sent from budding yeast (Sato et al., 2008). Previous investigation 
of the DENND1/connecdenn proteins in human cells (Allaire 
et al., 2010; Marat and McPherson, 2010) has shown that Rab35 
and DENND1A/connecdenn 1 play a role in recycling of MHC 
class I at an early endosomal compartment (Allaire et al., 2010). 
These authors have also shown that connecdenn proteins inter-
act with clathrin (Allaire et al., 2010; Marat and McPherson, 
2010), and our findings confirm this for DENND1A/connec-
denn 1. We find that clathrin is required for Shiga toxin delivery to 
the TGN, but not its endocytosis (Fig. 4). This fits with the idea 
that the STxB traffics through an early endosomal sorting com-
partment (Fuchs et al., 2007), where it undergoes a clathrin- 
dependent sorting event (Popoff et al., 2007), before delivery to 
the TGN. DENND3 and DENND1C, like their targets Rab12 
and Rab13, respectively, are present in vertebrates but are ab-
sent in invertebrates. In mammalian polarized epithelial cells, 
Rab13 functions in trafficking between recycling endosomes 
and the TGN (Nokes et al., 2008). Together with the data pre-
sented here, this suggests that the DENND1 family controls 
endosomal recycling and endosome–TGN trafficking routes 
involving Rab13 and Rab35.
Putative orthologues of DENND5A/Rab6-interacting 
protein 1 and its target Rab39 exist in worms, flies, and vertebrates. 
Interestingly, Rab39 is localized to the Golgi apparatus like 
its regulators DENND5A/B, and loss-of-function mutations in 
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Figure 5. The DENND2 family regulates Rab9 and lysosomes. (A) A representative panel of human Rab proteins was tested against 10 nM of His6-
tagged human DENND2D purified from bacteria using the GDP-releasing assay. (B) Human DENND2A, DENND2B, and DENND2C were expressed 
as His6-tagged protein in bacteria and then tested against a subset of Rab9-related Rabs. Errors bars show the standard error of the mean. The red line 
marks double the median value. (C) HeLa cells were transfected with EGFP-tagged DENND2A or Rab9A (green), fixed after 24 h, and stained with the 
antibodies indicated (red). DNA was stained with DAPI (blue). Inset enlargements are shown to more clearly demonstrate the relationship between Rab9 
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(green) and LAMP1 (red), which suggests that Rab9 is present on the lysosome membrane. (D) HeLa cells expressing EGFP-tagged Rab9 or DENND2 
constructs as indicated were transfected with control, Rab9A, Rab9B, and DENND2A-D siRNA duplexes for 72 h. Western blotting with EGFP antibodies 
confirmed depletion of the target proteins, whereas tubulin showed that loading was equal for all samples. HeLa cells transfected with control, Rab9A and 
Rab9B, and DENND2A-D siRNA duplexes for 72 h were fixed, then stained for LAMP1 (red) and DAPI to detect DNA (blue). Molecular mass standards 
are indicated in kilodaltons. (E) HeLa cells transfected with control, Rab9A and Rab9B, and DENND2A siRNA duplexes for 72 h were fixed, then stained 
for MPR (green) and TGN46 (red). DNA was stained with DAPI (blue). Bars, 10 µm. (F) Fluorescence intensity for MPR staining from E was measured using 
ImageJ by drawing a box around the entire cell area and integrating the total signal. An equivalent area with no cell was subtracted for the background. 
This was performed for 24 cells, and the mean and standard error are plotted on the bar graph. A 20 × 1 µm line measurement was performed across 
the nuclear region where MPR staining is most clustered. The pixel intensity along the line is plotted in the graph for control, DENND2A, and Rab9a- and 
Rab9b-depleted cells.
 
Figure 6. DENND4 family proteins are specific GEFs for Rab10. (A) A representative panel of human Rab proteins was tested against 10 nM of human 
DENND4B expressed as a FLAG-tagged protein in HeLa cells using the GDP-releasing assay. (B) Human DENND4A, DENND4B, and DENND4C were 
tested against a subset of Rab10-related Rabs using the GTP-binding assay. Again, 10 nM of each FLAG-tagged DENN protein purified from HeLa cells 
was used for these assays. Error bars show the standard error of the mean. The red line marks double the median value. (C and D) A representative panel 
of human Rab proteins was tested against 10 nM of His6-tagged human Rabin3/Rabin8 (C) and Rabin3-like/GRAB purified from bacteria using the GDP- 
releasing assay (D). Error bars indicate standard error of the mean. (E) HeLa cells expressing EGFP-tagged DENND4B were transfected with mCherry-
tagged Rab10, or stained for the markers indicated. 4× enlargements of the Rab10-positive tubules are shown in the top panels. Bar, 10 µm.
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(Barr and Lambright, 2010). This and an apparent lack of signature 
features of DENN-modulated Rabs suggest that only small changes 
and/or changes at different positions may have been responsible for 
altering GEF class specificity during Rab evolution. This conclu-
sion is supported by the close relationships between Rabs that are 
regulated by unrelated GEF classes (Fig. 8).
Are DENN-related proteins Rab GEFs?
As shown here and elsewhere (Allaire et al., 2010; Marat and 
McPherson, 2010), DENN domain proteins are specific Rab 
GEFs. It is interesting to note that some of the DENN-related 
GEFs and Rabs with as yet unknown GEFs. In a sequence align-
ment partitioned into these three groups there were no positions 
that clearly differentiated Rabs under DENN regulation from 
others (unpublished data). Furthermore, when sequence conser-
vation among DENN-modulated Rabs was mapped onto the 
surface of the structure of one of them, no additional conserved 
surface patches—putative DENN-interaction sites—were ob-
served when a comparison was made to Rabs not under DENN 
control (unpublished data). This suggests that DENNs bind to 
sites that overlap those seen for other GEFs, perhaps because 
of shared functional necessities such as switch I displacement 
Figure 7. Family-wide assignment of DENN specificity. Human DENND3 (A), DENND5A and DENND5B (B), MTMR5 and MTMR13 (C), and MADD (D) 
were tested against a representative panel of human Rab proteins using the GDP-releasing assay. All assays used 10 nM of FLAG-tagged DENN protein 
purified from HeLa cells. Errors bars show the standard error of the mean. The red line marks double the median value.
 o
n
 Septem
ber 6, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published October 11, 2010
377Rab specificity of DENN domain exchange factors • Yoshimura et al.
Figure 8. A summary of Rab GEFs indicating their target Rabs. Human (Homo sapiens, hs), fruit fly (Drosophila melanogaster, dm), and nematode 
(C. elegans, ce) Rabs and budding yeast (Saccharomyces cerevisiae, sc) Ypts were aligned using ClustalX and plotted using NJplot (Larkin et al., 2007). 
The alignment is annotated to show the known Rab GEFs: TRAPP, Sec2, the Vps9 domain family, Ric1-Rgp1, Mon1-Ccz1, claret, and the DENN domain 
family. Images to the right indicate the typical localization of the DENN domain family in HeLa cells. The pattern of conservation is summarized in the text 
to the right. The accession nos. for human, mouse, zebrafish, fruit fly, and nematode DENN domains proteins are listed in Table S1. Bar, 10 µm.
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proteins are found throughout the eukaryotic kingdom and are 
therefore likely to function in conserved cellular processes, 
including membrane trafficking events. This suggests that 
the DENN-related proteins might also have Rab GEF activ-
ity. However, the only characterized member of this family, 
budding yeast Avl9p, is possibly a regulator of Gtr2p, a Ras 
superfamily GTPase outside the Rab subfamily (Harsay and 
Schekman, 2007; Zhang et al., 2010). Our preliminary evi-
dence also indicates that human Avl9 does not act on any of 
the human Rabs. Although this supports the idea that DENN 
and DENN-related domains specify GEF activity toward 
GTPases of the Ras superfamily, these findings suggest they 
may not all be Rab GEFs. Further studies will be needed to 
investigate their specificity and define the cellular processes 
they act in.
Many conserved Rabs lack GEF regulators
Despite the advances presented here in assigning the specificity 
of 17 Rab GEFs, several key Rabs involved in membrane traf-
ficking, lipid droplet, and cilium formation are still left without 
GEF activators. It is intriguing that these often cluster into re-
lated groups. For example, see Rab2/4/14 in Fig. 8, which may 
indicate that these share a family of related but as yet unknown 
regulators. Here, we argued that because Rabs form a large 
closely related family, their regulators might do the same and 
share a common domain. This led us to more closely investigate 
the DENN domain proteins. Following this line of argument, it 
may therefore be worthwhile to test conserved domains widely 
associated with proteins functioning in trafficking for GEF 
activity. This might include the DENN-related proteins, although 
there are caveats as discussed, the SNX and BAR domain 
families (van Weering et al., 2010), and RCC1 domain proteins 
(Ma et al., 2004). However, it is possible that common domains 
do not unite the remaining Rab GEFs, and thus other unbiased 
biochemical and genetic strategies will need to be followed if 
they are to be identified. Although the work presented here will be 
useful in informing many future studies on membrane trafficking, 
we are still some way from defining the full complement of Rab 
GEF and GAP regulators and effector proteins necessary for a full 
understanding of Rab function.
Materials and methods
Reagents and antibodies
General laboratory chemicals were obtained from Sigma-Aldrich and 
Thermo Fisher Scientific. Antibody to EGFP was raised in sheep against the 
entire coding region of EGFP and affinity purified. Rabbit anti–golgin-160 
antibodies were raised and affinity purified against the entire coding region 
of rat golgin-160 expressed as a His6-tagged protein in bacteria. Mouse 
anti-clathrin clone X22 was a gift from S. Royle (University of Liverpool, 
Liverpool, England, UK). Commercially available antibodies were used to 
-tubulin (mouse DM1A; Sigma-Aldrich), actin (mouse 2Q1055; Abcam), 
-adaptin (clone 8; BD), -adaptin (mouse clone 88; BD), -adaptin (mouse 
clone 18; BD), EEA1 (rabbit 2411; Cell Signaling Technology), FLAG 
antibodies (mouse M2; Sigma-Aldrich), GM130 (mouse clone 35; BD), 
human LAMP1 (mouse clone 25; BD), TGN46 (sheep AHP500; Serotec), 
TfR (rabbit CBL47; Millipore), and CI-MPR (mouse 2G11; Abcam). Second-
ary antibodies raised in donkey to mouse, rabbit, sheep/goat, and human 
conjugated to HRP, Alexa Fluor 488, Alexa Fluor 555, Alexa Fluor 568, 
and Alexa Fluor 647 were obtained from Invitrogen and Jackson Immuno-
Research Laboratories.
Molecular biology and protein purification from bacteria and insect cells
Human DENNs were amplified from image clones (Source Bioscience 
Geneservice) or human fetal cDNA (Marathon ready cDNA; Takara Bio 
Inc.) using KOD polymerase (EMD). Mutagenesis was performed using the 
QuikChange method according to the protocol (Agilent Technologies). 
Duplexes for siRNA were obtained from QIAGEN or Thermo Fisher Scien-
tific. Mammalian expression constructs were made using pcDNA4/TO 
and pcDNA5/FRT/TO vectors (Invitrogen). Bacterial expression constructs 
were made using pQE32 (QIAGEN), pMal (New England Biolabs, Inc.), 
and pFAT2 encoding the His6 tag, His6–maltose-binding protein, and His6–
glutathione S-transferase, respectively. His6–glutathione S-transferase–
tagged Rab proteins in pFAT2 were expressed in BL21 (DE3) pRIL or BL21 
(DE3) pG-KGE8 (Takara Bio Inc.) at 18°C for 12–14 h, then purified using 
Ni-NTA agarose as described previously (Fuchs et al., 2005). In brief, cell 
pellets were lysed for 20 min in 10 ml IMAC5 (20 mM Tris-HCl, pH 8.0, 
300 mM NaCl, 5 mM imidazole, 0.2% Triton X-100, and protease inhibi-
tor cocktail; Roche) containing 0.5 mg/ml lysozyme, and then sonicated at 
70% power four times for 30 s with a 30-s rest period. Lysates were clari-
fied by centrifugation at 14,000 rpm in a JA-17 rotor for 30 min. To purify 
the tagged protein, 0.5 ml of nickel-charged NTA-agarose (QIAGEN) was 
added to the clarified lysate and rotated for 2 h. The agarose was washed 
three times with IMAC20 (IMAC5 with 20 mM imidazole), then the bound 
proteins were eluted in IMAC200 (IMAC5 with 200 mM imidazole), col-
lecting 0.5 ml fractions. All manipulations were performed on ice or in an 
8°C cold room. His6-tagged Rabex5, Rabin3/8, Rabin3-like/GRAB, 
DENND1B-S, DENND1B-L, and DENND2A-D in pQE32 were expressed 
in JM109 at 18°C for 12–14 h, then purified using nickel-charged NTA 
agarose using the same procedure as the Rabs. Rab12 and Rab39 were 
expressed using the pAcHis-GST vector encoding as His6–glutathione 
S-transferase tag, which is equivalent to that in pFAT2 in the baculovirus/
Sf9 cell expression system (BD). For virus infection, 10 × 15-cm dishes of 
containing 1.5 × 108 at 5 × 105 cells/ml of Sf9 cells were infected with a 
virus moiety of infection of 1.0 for 48 h (Neef et al., 2005). The infected 
cells were harvested, washed once in PBS, and then lysed in IMAC5 for 
20 min on ice. Lysates were clarified by centrifugation at 14,000 rpm in a 
JA-17 rotor (Beckman Coulter) for 30 min. Proteins were purified with the 
same protocol used for bacterial expression with minor modifications: 
100 µl of nickel-charged NTA agarose was used for the purification, and 
100-µl fractions of the elution were collected. Purified proteins were dia-
lyzed against TBS (50mM Tris-HCl, pH 7.4, and 150 mM NaCl) and then 
snap frozen in liquid nitrogen for storage at 80°C. Protein concentration 
was measured using the Bradford assay.
Recombinant STxB was expressed untagged from pTrc99A in Esch-
erichia coli BL21 (DE3) grown in lysogeny broth for 14 h at 37°C. All sub-
sequent steps were performed at 4°C. The bacterial cell pellet from a 1 liter 
culture was resuspended in 20 ml of 20 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, and 0.1 mg/ml polymyxin B. After mixing for 30 min on a roller, 
the sample was sonicated twice at 70% power for 10 s. A periplasmic 
lysate was prepared by removing the cell debris by centrifugation, first at 
13,000 g for 15 min then again at 90,000 g for 35 min. This lysate was 
diluted by the addition of two volumes of 20 mM Tris-HCl, pH 7.5, then 
loaded on to a 5 ml HiTrapQ column (GE Healthcare). The column was 
washed with 20 ml of 20 mM Tris-HCl, pH 7.5, then eluted with a 50-ml 
linear gradient from 0–600 mM NaCl in the same buffer. The flow rate 
was 2 ml/min throughout. Fractions of 2.5 ml were collected and analyzed 
by SDS-PAGE, and the peak of STxB pooled to give a 15-ml solution at 
1 mg/ml. This was then concentrated to 5 mg/ml using Centricon 10K 
units (Millipore) centrifuged at 3,000 g. A 500 µl aliquot was then applied 
at 0.15 ml/min to a Superose 12 gel filtration column equilibrated in PBS, 
and 1-ml fractions were collected. The peak fractions of pentameric STxB 
were pooled to give a 1.1 mg/ml solution. A 1-ml aliquot of this solu-
tion was labeled by the addition of one vial of monoreactive N-hydroxy-
succinimidyl Cy3 (GE Healthcare). After 5 min at room temperature, 100 µl 
of 1 M Tris-HCl, pH 8.0, was added to stop the reaction. Excess dye was 
removed by desalting over PD10 columns (GE Healthcare). Fractions of 
500 µl were collected, and absorption was measured at 280 and 552 nm. 
Using molar extinction coefficients of 150,000 M–1cm–1 for Cy3 and 
170,000 M–1cm–1 for pentameric STxB, dye labeling was calculated as 
1 Cy3 per toxin subunit with a concentration of 0.7 mg/ml.
Cell culture and protein purification from mammalian cells
HeLa and HEK293 cells were cultured in DME containing 10% bovine 
calf serum (Invitrogen) at 37°C and 5% CO2. For plasmid transfection and 
siRNA transfection, Mirus LT1 (Mirus Bio LLC), and Oligofectamine (Invitro-
gen), respectively, were used according to the manufacturers’ instructions. 
FLAG-tagged forms of DENND1A, DENND1C, DENND3, DENND4A, 
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to produce a dendrogram illustrative of sequence relationships. Regions of 
intrinsic disorder were predicted using the metaPrDOS server (Ishida and 
Kinoshita, 2008), and portions of them with energetic properties appropri-
ate for forming protein–protein interactions were highlighted with ANCHOR 
(Mészáros et al., 2009). Linear sequence motifs were browsed in the ELM 
database (Gould et al., 2010).
Online supplemental material
Fig. S1 shows the pattern of localization for all human DENN domain pro-
teins when transfected as EGFP-tagged constructs in Hela cells. Table S1 
lists the DENN domain proteins identified in human, mouse, zebrafish, fruit 
fly, and nematode. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201008051/DC1.
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BLOC-3 Mutated in Hermansky-Pudlak Syndrome Is a Rab32/38 Guanine Nucleotide
Exchange Factor.
Andreas Gerondopoulos, Lars Langemeyer, Jin-Rui Liang, Andrea Linford, Francis A
Barr.
Hermansky-Pudlak syndrome (HPS) is a human disease characterized by partial loss
of pigmentation and impaired blood clotting. These symptoms are caused by de-
fects in the biogenesis of melanosomes and platelet dense granules, often referred
to as lysosome-related organelles. Genes mutated in HPS encode subunits of the
biogenesis of lysosome-related organelles complexes (BLOCs). BLOC-1 and BLOC-
2, together with the AP-3 clathrin adaptor complex, act at early endosomes to sort
components required for melanin formation and melanosome biogenesis away from
the degradative lysosomal pathway toward early stage melanosomes. However the
molecular functions of the Hps1-Hps4 complex BLOC-3 remain mysterious. Like other
trafficking pathways, melanosome biogenesis and transport of enzymes involved in pig-
mentation involves specific Rab GTPases, in this instance Rab32 and Rab38. We now
demonstrate that BLOC-3 is a Rab32 and Rab38 guanine nucleotide exchange factor
(GEF). Silencing of the BLOC-3 subunits Hps1 and Hps4 results in the mislocalization
of Rab32 and Rab38 and reduction in pigmentation. In addition, we show that BLOC-3
can promote specific membrane recruitment of Rab32/38. BLOC-3 therefore defines
a novel Rab GEF family with a specific function in the biogenesis of lysosome-related
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Summary
Hermansky-Pudlak syndrome (HPS) is a human disease
characterized by partial loss of pigmentation and impaired
blood clotting [1–3]. These symptoms are caused by defects
in the biogenesis of melanosomes and platelet dense
granules, often referred to as lysosome-related organelles
[2]. Genes mutated in HPS encode subunits of the biogen-
esis of lysosome-related organelles complexes (BLOCs).
BLOC-1 and BLOC-2, together with the AP-3 clathrin adaptor
complex, act at early endosomes to sort components
required for melanin formation and melanosome biogenesis
away from the degradative lysosomal pathway toward early
stage melanosomes [4–6]. However the molecular functions
of the Hps1-Hps4 complex BLOC-3 remain mysterious [7–9].
Like other trafficking pathways, melanosome biogenesis
and transport of enzymes involved in pigmentation involves
specific Rab GTPases, in this instance Rab32 and Rab38
[10–12]. We now demonstrate that BLOC-3 is a Rab32 and
Rab38 guanine nucleotide exchange factor (GEF). Silencing
of the BLOC-3 subunits Hps1 and Hps4 results in themisloc-
alization of Rab32 and Rab38 and reduction in pigmentation.
In addition, we show that BLOC-3 can promote specific
membrane recruitment of Rab32/38. BLOC-3 therefore
defines a novel Rab GEF family with a specific function in
the biogenesis of lysosome-related organelles.
Results and Discussion
BLOC-3 Is a GEF for Rab32 and 38
Mutations in components of the Rab prenylation machinery
required to link Rabs to membranes result in pigmentation
defects due to altered platelet and melanosome formation
[13]. Moreover, mutations in rat Rab38 cause pigmentation
defects and other changes similar to those found in HPS
[10], and Rab38 and the closely related Rab32 are important
for trafficking of enzymes, such as Tyrp1, involved in pigmen-
tation [11, 12]. However, it is not known how these Rabs
become activated during melanosome biogenesis. This acti-
vation step requires the inactive Rab to release GDP and
bindGTP, a process triggered by a specific guanine nucleotide
exchange factor (GEF) [14]. Bioinformatic analysis of one of the
genes mutated in Hermansky-Pudlak syndrome, Hps4, indi-
cated the amino-terminal 120 amino acids were homologous
to the equivalent region of the Ccz1 subunit of the yeast Ypt7
GEF (Figure 1A) [15–17]. In addition, similarities were noted
between Hps1 and the Mon1 subunit of the Ypt7 GEF (Fig-
ure 1A) [18]. Intriguingly, given these similarities between
Hps1-Hps4 and Mon1-Ccz1, Rab32 and Rab38 fall into the
same subcategory of Rabs as Rab7. To test if BLOC-3 has
Rab GEF activity, recombinant Hps1-Hps4 complexes and
Rab7 GEF complexes were produced (see Figures S1A and
S1B available online). Due to the low sequence similarity of
human and the characterized yeast Mon1-Ccz1 complex, the
human protein complex was first isolated and the subunit
composition confirmed by mass spectrometry (Figure S1C).
These complexes were then tested for GEF activity toward
a panel of Rab7 subfamily Rabs, as well as a selection of other
Rabs (Figure 1B). This analysis showed that the BLOC-3
complex but not the subunits alone had GEF activity toward
Rab32 and the closely related Rab38, but little or no activity
to the other Rabs tested (Figures 1B and S1D). Bacterially
expressed BLOC-3 also showed activity to Rab32 and Rab38
but not Rab7 or Rab7-like (Figure S1E), eliminating the possi-
bility that a eukaryotic cell contaminant was responsible for
the Rab32/38 GEF activity. By contrast, human Mon1a-Ccz1
had activity toward Rab7 but little or no activity toward
Rab32, Rab38, or other Rabs tested (Figure 1B). These
findings supported the idea that BLOC-3 and Mon1a-Ccz1
are specific Rab GEF complexes for Rab32/38 and Rab7,
respectively.
BLOC-3 Promotes Membrane Localization of Rab32 and 38
If BLOC-3, the Hps1-Hps4 complex, acts as a specific GEF for
Rab32/38 in vivo, then the recruitment of Rab32/38 to
membranes, the localization of melanosomal proteins, and
the formation of melanosomes should require the activity of
this complex. All of these properties were therefore tested
using MNT-1 cells, which produce melanosomes. Western
blot analysis of HeLa and MNT-1 cells revealed that the
BLOC-3 subunit Hps4 is enriched in MNT-1 cells, like its target
GTPasesRab32 andRab38, and the tyrosinase-related protein
(Tyrp1), a marker for melanin biogenesis (Figure 2A). Rabs and
regulators required for early endocytic trafficking and lyso-
somal sorting were present in both cell lines, although
MNT-1 cells have lower levels of the Rab7 GEF subunit
Mon1a (Figure 2A). Rab32was present on small ring-like struc-
tures in control cells that overlapped with Tyrp1 (Figure 2B),
characteristic of endosomal and melanosomal structures
required for sorting of melanosome components [12]. When
either the Hps1 or Hps4 subunits of BLOC-3 were depleted
using different siRNA duplexes, Rab32 was lost from these
ring-like membranes and became redistributed to a diffuse
or finely punctate cytoplasmic pattern closer to the nucleus
(Figures 2B andS2A). Thiswas in agreementwith themeasure-
ments showing that both subunits of BLOC-3 are required for
GEF activity towardRab32 or 38. Furthermore, Rab32 localizes
to structures adjacent to those defined by the Hps4 subunit of
its GEF (Figure S2B).
To provide further support for the idea that BLOC-3 is impor-
tant for determining the localization of Rab32, the Hps1-Hps4
complex was relocated to the surface of a heterologous
membrane, the mitochondria (Figure 3A). This resulted in the*Correspondence: francis.barr@bioch.ox.ac.uk
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Figure 1. Hps1-Hps4 and Mon1a-Ccz1 Are Specific Rab GEFs
(A) The putative Rab7 GEF is thought to be a heterodimer comprised of Mon1a and Ccz1 subunits. Each subunit is defined by a conserved domain of
unknown function (DUF), as indicated schematically in the figure. BLOC-3 is a heterodimer comprised of Hps1 and Hps4 subunits. Sequence analysis indi-
cates that Hps4 has 32% similarity throughout its entire length to the DUF1712 longin domain region of Ccz1. This similarity is most pronounced in the
amino-terminal region shaded darker green and shown in the sequence alignment. Yeast Ccz1 is highly divergent and shows only limited similarity to
the higher eukaryote proteins. Hps1 has 38% similarity to the DUF254 region of Mon1a, colored red in the figure. However, in Hps1 this domain is split
into two sequence blocks containing the conserved motifs DxSFL and HFxY, respectively.
(B) BLOC-3 andMon1-Ccz1 complexeswere used for GEF assays toward a representative group of RabGTPases. Error bars indicate the standard deviation
of the mean. The GEF complexes were analyzed by mass spectrometry and western blotting to exclude the presence of other proteins with possible Rab
GEF activity. Protein gels were stained with colloidal Coomassie brilliant blue stain (CBB). Asterisks mark contaminating heat shock proteins in the Hsp1-
Hps4 complexes.
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Figure 2. BLOC-3 Is Required for Rab32 and Rab38 Localization
(A) Equal amounts of HeLa S3 and MNT-1 cell extract were blotted for endocytic Rab GTPases and their GEF regulators. Tyrp1 and LAMP1 were used as
markers for melanosomes and lysosomes, respectively.
(B) MNT-1 cells treatedwith control, Hps1, or Hps4 siRNA duplexes for 6 dayswere washed in growthmedium, replated and transfectedwith GFP-Rab32 for
48 hr, and then PFA-glutaraldehyde fixed. Cells were stained for Tyrp1 and DAPI to detect DNA. A bright-field image (BF) shows the pigmentedmaturemela-
nosome structures. Scale bar represents 10 mm in nonenlarged panels.
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recruitment of Rab32 to the surface of the mitochondria only
when both Hps1 and Hps4 were expressed (Figures 3B, 3C,
and S3A). Importantly, in this system Hps1 and Hps4 formed
a complex at the surface of mitochondria (Figures S3A and
S3B), consistent with the idea that the BLOC-3 complex
and not the subunits alone have GEF activity. Other Rabs
were tested in this assay but did not show mitochondrial
targeting (Figures 3B and 3C), supporting the conclusion that
this reflected a specific activity of BLOC-3 on Rab32 and
Rab38. Together, these data showed that BLOC-3 activity is
required for Rab32 and Rab38 activation and is an important
determinant of its localization to premelanosomal membrane
structures.
BLOC-3 Plays a Role in Melanosome Formation
Finally, the role of BLOC-3 in trafficking of melanosomal cargo
and production of melanosomes was tested. Previous studies
have shown that cells from mice lacking Rab32/38 display
deficiencies in the formation of mature melanosomes and
accumulate early stage melanosomes [11, 12]. If BLOC-3 is
required for Rab32/38 activation, then cells depleted of
Hps1, Hps4, and Rab32/38 should show a similar accumula-
tion of premelanosomal structures and reduced numbers of
mature heavily pigmented melanosomes. For this purpose
the premelanosome marker PMEL was used. PMEL is a trans-
membrane glycoprotein proteolytically cleaved following exit
from the TGN as part of the normal melanosome biogenesis
pathway [19–21]. Precursor forms of PMEL are incorporated
into insoluble fibrils and cleaved to 35–45 kDa fragments that
become buried bymelanin withinmelanosomes [22]. In control
cells, PMEL localizes to a punctate pattern clearly discrete
from the mature melanosomes seen in the inverted bright-
field image (Figure 4). Depletion of Rab32/38, Hps1, or Hps4
resulted in a strongly increased PMEL signal (Figure 4A).
Western blotting showed this was due to increased levels of
an 80 kDa nonprocessed form of PMEL in the cells (Figure 4B),
suggesting that the proteolytic maturation of PMEL and its
burial by melanin was blocked. Furthermore, there was a
decrease in densely pigmented melanosomes in nearly 50%
of cells (Figures 4A and 4C) and a 20%–30% reduction in
pigment production (Figure 4D). This was especially obvious
in bright-field images where the dark, round melanosomes
are clearly reduced or show altered distribution, sometimes
clustering together in large aggregates (Figure S4). BLOC-3
and its targets, Rab32 and Rab38, therefore play an important
role in the control of pigment production and melanosome
biogenesis in cultured MNT-1 cells.
Conclusions
These findings provide insights into membrane trafficking
pathways of great relevance for both normal cellular function
and human diseases. Together the data demonstrate that
Hps1-Hps4 (BLOC-3) and Mon1a-Ccz1 form specific Rab
GEF complexes for Rab7 and Rab32/38, with discrete func-
tions in the biogenesis of lysosome-related organelles and
lysosomes, respectively. The characterization of BLOC-3
and Mon1-Ccz1 therefore defines a new family of Rab GEFs
and supports the view that the longin domain is a signature
for Rab GEF activity [14, 23]. Intriguingly, some SNAREs
possess longin domains [17, 24], suggesting that these might
directly link Rab regulation to vesicle tethering and fusion
events in a manner not previously suspected.
Other unanswered questions relate to the mechanism by
which BLOC-3 is recruited and triggers local activation of
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Figure 3. BLOC-3 Is Sufficient to Determine Rab32 Localization
(A) Schematic outlining the basis of the mitochondrial targeting assay for
Rab GEF activity (MitoGEF assay system).
(B) HeLa cells were cotransfected for 20 hr with eGFP-Rabs and the Tom70-
FLAG-Hps4 fusion (Mito-Hps4), in the presence and absence of Myc-Hps1.
The cells were PFA fixed and then stained with Hps4 antibodies; Rabs were
visualized using GFP fluorescence. The scale bar represents 10 mm.
(C) The extent of mitochondrial recruitment of the different GTPases was
measured by calculating Pearson’s correlation coefficient for the GFP and
Mito-Hps4 signals. This is plotted in the graph, and error bars show stan-
dard deviation from the mean for the number of samples indicated in the
figure.
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Rab32 and Rab38. One possibility is that this takes the form of
a Rab cascade, where an upstream Rab promotes the recruit-
ment of the exchange factor for downstream Rabs in the
pathway [25]. Fitting with this idea, BLOC-3 has been shown
to bind to the activated GTP form of Rab9 [26]. Intriguingly,
the Rab32 and Rab38 GTPase-activating protein RUTBC1 is
also a Rab9 effector [27]. These observations suggest that
Rab9 may play a previously unappreciated role in the forma-
tion of lysosome-related organelles by coordinating the activa-
tion and inactivation of Rab32 and Rab38. In turn, Rab32 and
Rab38 may then feed back to regulate yet further Rabs, since
the VARP exchange factor for Rab21 is a Rab32/38-binding
protein [28]. Further work will be required to shed light on the
currently murky picture of how such a complex cascade might
function.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, four figures, and one table and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2012.09.020.
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Figure 4. BLOC-3 Is Required for Melanosome Formation from Premelanosomes
(A) MNT-1 cells treated with control, Hps1, Hps4, Rab32, and Rab38 siRNA duplexes for 8 days were PFA-glutaraldehyde fixed and then stained for PMEL. A
bright-field image (BF) was taken and inverted to more clearly show the dark melanosomes (Inv BF). Scale bar represents 10 mm in nonenlarged panels.
(B) Equivalent samples were western blotted to confirm depletion of the various target proteins and for melanosome pathway markers Tyrp1 and PMEL.
Tubulin was used as a loading control.
(C) The number of cells showing reduced or altered (aggregated) melanosomes was counted and is plotted in the graph; error bars reflect the standard devi-
ation from the mean (n = 3).
(D) Direct measurements of pigment were carried out using cell pellet-associated absorbance at 490 nm. A representative example from three independent
experiments is shown. Error bars reflect duplicate samples.
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